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Introduction: Cardiovascular disease (CVD) associated metabolic risk factors are a growing human health 
concern in Australia and worldwide. This thesis investigated the small-area geographic variation in the 
distribution of cardiometabolic risk factors (CMRFs) in the Illawarra-Shoalhaven region of Australia, their 
association with area-level disadvantage and access to primary care and whether area-level disadvantage and 
primary care access contribute to the geographic variation of CMRFs. 
Materials and methods: Geographic variation in the distribution of individual CMRFs was analysed at 
Statistical Area Level 1 (SA1), which is the smallest unit that disaggregated census data are reported in 
Australia. Individual-level data used in this thesis included de-identified CMRF test data from non-pregnant 
adult (≥18 years) residents of the Illawarra-Shoalhaven region between 2012–2017, which was sourced from 
the largest pathology service provider in the study region. These data included the most recent individual-level 
test results for: fasting blood sugar level (FBSL); glycated haemoglobin (HbA1c); total cholesterol (TC); high 
density lipoprotein (HDL); albumin creatinine ratio (ACR); estimated glomerular filtration rate (eGFR); body 
mass index (BMI); and diabetes mellitus (DM) status. The test results were dichotomised into higher and lower 
cardiometabolic risk values based on the existing clinical guidelines. Area-level data included:  SA1-level 
disadvantage, sourced from the 2011 Australian Census of Population and Housing Index of Relative 
Socioeconomic Disadvantage; and primary care provider data retrieved from publicly available sources 
current in year 2016.  
Choropleth maps describing the distribution of CMRFs rates were produced using an Empirical Bayes (EB) 
approach to smooth the rates. Spatial clustering of CMRFs was assessed using Moran’s I test and Local 
Indicators of Spatial Autocorrelation (LISA). A two-step floating catchment area (2SFCA) method was used 
to calculate the primary care access index of the SA1s within the study region. Multilevel logistic regression 
models were used to elucidate the association of the area-level socioeconomic disadvantage and primary care 
access with the geographic variation of CMRFs in the study region, after adjusting for individual- and area-
level covariates. 
Results: Analysis of 1, 132, 016 pathology tests contributed by 256, 525 individuals revealed significant 
geographic variation, spatial autocorrelation and clustering of higher cardiometabolic risk findings at the SA1-
level. Multilevel analyses revealed associations between area-level disadvantage and all higher risk CMRFs 
findings, after adjusting for individual-level covariates. Geographic access to primary care was inversely 
associated with higher risk levels of HDL and obesity in the study region after adjusting for the individual and 
area-level covariates but was not associated with the remaining CMRFs. The estimated proportions of the 
geographic variation in the higher cardiometabolic risk values explained by area-level disadvantage ranged 
from 14.3–57.8%, while geographic access to primary care explained   10.5%.  
Conclusion: The findings support future investigations into whether geographically targeted public health 
activities or location-specific interventions in primary care can ameliorate CMRFs. The findings also call for 
universal approaches proportional to the need and disadvantage level of populations for the prevention and 
control of CMRFs. These findings can be used to inform regional health care service commissioning and 
related policy developments, and are highly relevant in the context of the global paradigm shift from 
communicable diseases to cardiovascular diseases (CVD) as the leading cause of human death and health care 
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This thesis is presented as a compilation of manuscripts written for publication. A General Introduction chapter 
is written in the beginning and a General Discussion chapter is written at the end to provide a critical overview 
of the thesis. A Materials and Methods chapter is also included describing the methodologies adopted in 
individual studies. All the remaining core chapters of this thesis represent individual manuscripts as prepared 
for a journal, with specific objectives, methods, results and conclusions. The structure of each chapter is 
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Chapter 1: General Introduction 
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Chapter 1: General Introduction 
“If you want to learn about the health of a population, look at the air they breathe, 
the water they drink and the places where they live.” 
(Hippocrates 5th Century BC) 
1.1 Introduction  
Place has always been a key element in human health and disease. Written documents on the link between 
place and health date back to Hippocrates (~ c. 460- c.370 BC), the father of medicine who stated "airs, waters, 
places" all have significant impact on human health and history.[1] In 1854, John Snow (1813-1858), the father 
of modern epidemiology, undertook his classic work on cholera epidemics by highlighting the importance of 
location on disease.[2] However, subsequent quantitative research developments on the influence of ‘place on 
health’ were slow and sporadic until recent advances in Geographic Information System (GIS) and related 
area-level analytical approaches.[3] 
Advances in area-level analytical methods over the last one quarter of a century have provided powerful tools 
to help understand the impact of place on health.[4] For example, area level visualization and analyses of 
geocoded data became possible through geospatial analytical software such as ArcGIS, GeoDa and SatScan. 
More robust analytical techniques for nested data such as multilevel modelling (MLM) functionalities became 
widely available in popular data analytical software packages, which also mean their use is more widespread. 
These developments have the potential to yield the environmental context of the diseases and their risk factors. 
Meaningful application of the combination of these developments has the potential to become a powerful and 
evidence based tool to plan health care service commissioning at a regional level. This is important especially 
in the context of the global epidemiological transition from infectious diseases to non-communicable diseases 
(NCDs), specifically cardiovascular disease (CVD), as the leading cause of death and health care expenditure 
across the world.[5] 
1.2 Background 
Cardiovascular diseases are the leading cause of death worldwide and also the highest consumer of health care 
expenditure in many developed nations.[6, 7]  Once diagnosed with CVD, the ongoing costs of care and 
productivity loss due to consequent disabilities and premature deaths create a major economic burden not only 
to the individual, but to the family and the community. These burdens get exacerbated when half the people 
dying from CVD were in their prime productive ages.[6]  
In 2017, The World Health Organization (WHO) reported that at least three-quarters of CVD deaths occur in 
low- and middle-income countries.[7] Age-standardised CVD events and mortality were estimated to be 
declining in many nations in recent years, with a more marked decline in developed nations.[8] Within 
developed countries, a dramatic decline was reported among regions with very high sociodemographic indices, 
but only a gradual decrease or no change in most other areas.[8] Despite this, CVD remains the leading cause 
of death and health care expenditure in developed nations, including Australia.[9]  
In Australia, CVD remains the single leading cause of death; largest health problem; and the major health-
related economic cost to the nation.[10]  As per the Australian Bureau of Statistics (ABS) 2019 released Causes 
of Death in 2018, cardiovascular disease accounted for one in four of all deaths in Australia, and on average, 
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76 deaths each day.[11, 12] In addition, the prevalence of CVD is projected to steeply increase in the coming 
decades.[10]  
Cardiometabolic risk factors (CMRFs) are a group of interrelated individual-level metabolic risk factors which 
eventually may lead to the development of CVD.[13] Nine in 10 adult Australians have at least one risk factor 
for CVD; and one in four have the occurrence of an aggregate of three or more risk factors present 
simultaneously.[14] Even though lifestyle changes have the potential to control or prevent most of these risk 
factors, many individuals do not achieve or maintain target risk-reduction through lifestyle changes alone.[15-
17] People belonging to lower socioeconomic groups and those residing in remote areas have been found to 
have higher rates of hospitalisation and death due to CVD in Australia.[10, 14]  This emphasises the necessity 
to look beyond individuals at risk to disadvantaged groups and geographic locations of people at risk, in order 
to effectively mitigate the risk factors of the development of CVD at an early stage. 
Hypercholesterolemia, diabetes mellitus (DM) and chronic kidney disease (CKD) are three major chronic 
cardiometabolic risk conditions. The diagnosis of one or more of these risk conditions places the person at an 
increased lifetime risk for the development of CVD.[13, 18-20] Hypercholesterolemia directly increases the 
risk for CVD through artherosclerosis.[15] Diabetes Mellitus, characterised by elevated blood glucose, over 
time increases the risk of atherosclerosis and microcirculation inadequacies.[18, 19] Impaired fasting blood 
sugar level (FBSL) and glycated haemoglobin (HbA1C) levels are two commonly used clinical laboratory 
parameters to diagnose and monitor DM.[21, 22] Similarly, CKD patients also have a high risk for the 
development of CVD, in part through inappropriate activation of the renin–angiotensin system.[20] In addition, 
obesity is also found to increase the risk for CVD, independently or in combination with any of the above 
chronic conditions.[23, 24] 
The management of these chronic CMRFs demands routine clinical testing and monitoring; and over the time 
this creates a series of data at an individual-level.  For different diagnostic groups of such chronic conditions, 
aggregations of similar series of individual-level data can create large datasets. Considering the nesting of such 
individual-level data within areas, these databases can potentially be used beyond the individual-level, 
especially for area-level health care service commissioning and planning activities.  Figure 1.1 conceptually 
represents the discrete and co-existing measures of CMRFs nested within individuals, individuals nested within 
small geographic areas with defined characteristics, and small-areas constituting larger geographical regions. 
The availability of such nested data would call for appropriate analytical approaches to accurately reflect the 
structuring of the data. 
Multilevel analyses are generally recognised as appropriate for data which are hierarchical in structure.[25-27] 
In these analyses, the unit of analyses would usually be individuals (at the lower level) who are nested within 
areas (at a higher level).[28] Multilevel models address data hierarchies by allowing for residual components 
at each level of the data.[29] For example, a two-level model which enables grouping of individual-level 
outcomes within area-level units would include residuals at the individual-level and area-level. Thus, the 
residual variance can be partitioned into a between-area component (the variance of the area-level residuals) 
and a within-area component (the variance of the individual-level residuals).[30] The area-level residuals, often 
called "area effects", represent unobserved area characteristics associated with individual-level outcomes. It is 
these unobserved variables which lead to a correlation between outcomes for individuals from the same 
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area.[25, 28, 29] Identifying geographic variation in CMRFs would be a useful first step in the analysis of such 
nested data. 
There is consistent evidence in the literature on geographic inequalities of CMRFs which have been reported 
from multiple nations.[31-38] Even though we have a better understanding of the individual-level factors 
contributing to CMRFs due to decades of research, there is relatively less research and a general poorer 
understanding concerning area-level factors. An understanding of these factors can inform area-level health 
care service commissioning and related policy development. Therefore, an initial review of the literature was 
performed to identify existing reports on geographic variation of CMRFs and the area-level factors attributing 
to this variation. 
 
 
Figure 1.1: Conceptual image of the hierarchical nesting of cardiometabolic risk factors within the areas 
1.3 Literature overview  
An initial search for related studies was undertaken in the early phase of the study to construct a broad 
understanding of the literature background. A more detailed systematic review of the literature is presented in 
Chapter 2 of this thesis.  
Preliminary searches revealed that epidemiological analyses of the geographic location and variability in 
diseases had become increasingly common over the last 20 years, in parallel with advances in computing power 
and developments in GIS.[4] Disease atlases were initially constructed using mapping techniques and 
epidemiological data.[39] More recent advances in GIS and multilevel analyses of data have provided various 
tools for the geographical illustration and spatial analyses of area-level data.[40] Visualisation of the 
geographic distribution of various disease and risk factors became possible through geocoding and mapping of 
the data.[41] Spatial analytical methods applied to non-communicable diseases were first used in reporting 
diabetes incidence in Finland, based on methods reported by Whittemore et al (1987).[42] Later, geospatial 
analyses of health related data used geographic location information on occurrences to detect and quantify 
spatial patterns and clustering of area-level health and risk factors. This further extended the scope of the 
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statistical analysis of data at multiple levels to investigate the association between potential area-level risk 
factors and the prevalence of disease risk indicators.[43] 
1.3.1 Geographic variation in the prevalence of cardiometabolic risk factors 
Multiple studies internationally have reported geographic variation in the prevalence of CMRFs at various 
geographic scales.  In the preliminary literature search, the reported geographic scales ranged from 
multinational country aggregations to smaller areas such as cities and towns [37, 44-51], although even finer 
geographic scales have also been used [31-38](see Chapter 2, page 48) Area level features and neighbourhood 
characteristics, such as area-level disadvantage and facilities associated with geographic variation in CMRFs, 
have been analysed more frequently in recent studies than earlier work.[37, 44-51] 
Over time, studies reporting the geographic variation of various CMRFs have reduced the size of the 
geographic unit of analyses compared with earlier studies. Geographic variations in the prevalence of various 
CMRFs have been reported across cohorts of countries in Northern Europe, America and Southern Europe.[50] 
Also between-country level variations in CMRFs have been reported across the USA, Finland, The 
Netherlands, Italy, Croatia, Serbia, Greece and Japan.[49] National level studies reporting geographic variation 
in the prevalence of CMRFs across regions, towns and cities have been reported from Spain, Italy, Britain and 
USA.[34, 37, 45, 46, 48] Within-district level variations in the prevalence of cardiovascular risk factors and 
socioeconomic variables have been examined in Ohio, USA.[47] Within-city level variations in CMRF 
distribution were reported from Sweden and USA, with significant correlation between area-based scores of 
cardiovascular risk and disadvantaged circumstances.[44] 
In addition to geographic variation in prevalence, significant geographic clustering of individual CMRFs has 
been reported in multiple studies.[39, 52-55] The use of GIS software such as SatScan and ArcGIS have been 
among the most common analytical methods for cluster detection and density plot mapping.[39, 52-55] These 
geospatial analytical approaches have demonstrated the potential to illustrate and visually represent the 
interplay of area level risk factors.[39-41, 55-57] Study reports of the geographic clustering of selected CMRFs 
have also pointed to the possible roles of area-level characteristics in the prevalence of  risk factors.[39, 54] 
In recent years there has been an explosion of research reports based on multilevel analysis of CMRF data and 
their association with area-level socioeconomic disadvantage.[58-60] These reports are mainly from 
industrialised nations across the world. The current evidence regarding the association between various CMRFs 
and area-level socioeconomic disadvantage is the focus of the following sections of this chapter.  
1.3.2 Area-level socioeconomic disadvantage and cardiometabolic risk factors 
An initial literature search regarding area-level socioeconomic disadvantage and CMRFs retrieved a total of 
32 studies. The highest numbers of studies retrieved were from the USA (n=13); followed by UK, Australia, 
France, Germany, Sweden, Canada and China. Most studies used a cross sectional design (n= 25), with 
longitudinal studies less frequently reported (n=4). The majority of the studies had used samples from existing 
population based studies/programs, electronic medical record databases and national/regional level surveys or 
surveillance. Census block level aggregates were the most commonly used measure of area-level 
socioeconomic disadvantage. Other measures included: electoral ward level deprivation score; built 
environment status; mixed land use level; and area level unemployment and overcrowding.[58-67]  
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Both the longitudinal and cross sectional studies reported significant association between various CMRFs and 
area-level socioeconomic disadvantage, independent of individual-level characteristics such as socioeconomic 
status, education and duration of exposure to area.[58, 59, 62-68] Less disadvantage was consistently reported 
to have a protective effect on behavioural cardiac risk factors such as smoking, physical inactivity and 
obesity.[59, 63, 69] Men from highly urbanised environments have been reported to have higher incidence of 
heart disease with increasing area-level socioeconomic disadvantage, after adjusting for individual 
characteristics.[61] Type 2 diabetes and high body mass index (BMI) had been reported more prevalent in 
disadvantaged areas.[33, 68, 70-76] However, LDL management had been reported as not being associated 
with area-level disadvantage.[77]  Type of neighbourhood food outlets,[70, 78, 79] poor physical activity 
resources,[78] individual perception of area level features,[80] residential density and service availability[58] 
had all been reported as explanatory variables associated with cardiometabolic risk prevalence among people 
living in disadvantaged areas. 
As the CMRFs are generally chronic in nature, area-level accesses to primary health care services were 
assumed to have an effect on CMRFs resulting from their identification and ongoing management. Primary 
health care relates to people who are not hospitalized for treatment and generally the first contact a person has 
with the health system.[81] Thus, access to primary care may have a direct effect on the geographic distribution 
of CMRFs. Therefore CMRFs studies reporting on the access to primary care were also included in the initial 
review. 
1.3.3 Geographic access to health care services and cardiometabolic risk 
Studies examining the relationship between health care service outcomes and travel time using multilevel 
logistic regression models found that general practitioner (GP) consultations were less likely to happen when 
the travel time was longer in rural areas.[82] When access to adequate treatment and the geographical pattern 
of end stage renal disease (ESRD) across 46 counties in southern California in USA were investigated, ESRD 
incidence was found to be consistently higher in rural compared to urban counties.[51] In addition, the rates 
were found to be inversely associated with physician density, suggesting that access to adequate treatment 
facilities had a role in preventing ESRD.[51] 
A multinational study by the World Health Organisation (WHO), the DiaMond complications study 
(DiaComp), examined the role of availability and access to health care facilities in relation to the complications 
of type 1 DM across 12 countries.[83] Using clinical laboratory data, markers of diabetes complications in 14 
clinical centers across the study nations were assessed and then linked to health care access, cost, and local 
social and economic landscapes. Results of the DiaComp study suggested that health system performance and 
the social distribution of wealth played roles in explaining the geographic variations in resulting complications 
from DM.[83] 
1.4 The extent of current evidence 
This section describes the extent of evidence based on the preliminary literature review. The section outlines 
what we already know; and sets direction on what we need to know with further research which will be 
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1.4.1 What we know: 
Area-level disadvantage and health 
In 2008, the World Health Organization's pioneering Commission on Social Determinants of Health reported 
that a young boy living in a disadvantaged area of Glasgow, Scotland had an average life expectancy of 54 
years when compared with a boy living in an affluent area, only 12 km away, who could expect to live to 82 
years: a loss of 28 years.[84] Michael Marmot, the then chair of the WHO's Commission, later reflected this in 
his book 'The Health Gap' that this "….was a tale of two cities…both in Glasgow".[85] This is a stark example 
of the contextual effect of area-level disadvantage on people.  
The role of socioeconomic contexts on health has been recognised for centuries.[86] Whether it is the mill 
towns of Victorian England [87] or the slums of contemporary India [88], the poorer in every society 
succumbed to morbidity and early death [86]. Moreover, this was observed across history, not as a threshold 
effect of poverty, but a gradient effect where the middle class enjoyed better health than the poor and the 
affluent enjoyed better health than the middle class.[86] A social gradient in health is an exceedingly 
widespread phenomenon.[89] In general, individuals from lower socioeconomic circumstances are at greater 
risk of poorer health outcomes, disability and death.[89] Life and death inequalities underpinned by the 
differences in income, wealth, and power[90], directly points to the levels of justice and fairness in a 
society.[91] 
In the research literature, a direct relationship between the socioeconomic position of populations and their 
health has been a focus for centuries.[92] The earliest available literature on this can be found in the 1567 
writings of Paracelsus—the father of toxicology and pioneer of the "medical revolution" of the Renaissance—
who noted unusually higher rates of diseases among miners of the medieval period Europe.[93] This 
relationship has always been present in society in sometimes prominent and sometimes subtle ways.[86] For 
instance, it is notable that in the Titanic event (1912), women who travelled in the 3rd class had a 20 times 
higher likelihood of dying from drowning mainly due to the socioeconomic stratification in the distribution of 
the resource, here the lifeboat.[94] In recent decades, there has been a notable increase in studies reporting on 
this relationship from various nations across the world and is one of the most consistent findings in 
epidemiology.[95] Area socioeconomic measures reported in the literature include both the component or 
composite measures such as a median or per capita income, median education, unemployment rate, the 
percentage in poverty, white-collar job rates and area socioeconomic scores/indices, or deprivation 
scores/indices.[86] Even though the period and the population are different across historical and recent research 
literature, the socioeconomic pattern of morbidity and early mortality remains the same: that the 
socioeconomically disadvantaged population get sick and die earlier.[86] However, the literature also shows 
that this relationship is not the same in all contexts with political, cultural and institutional factors having 
influential and modifying effects.[86]   
Theoretical and empirical constituents 
Following is an overview of the theoretical and empirical constituents of the socioeconomic position of 
individuals and populations.  
There are three major theories of social stratification: Marxian theory, Weberian theory, and Functionalism. 
The Marxian theory views social stratification as imposed by exploitative resource capitalism.[96] In contrast, 
Weberian theory views the stratification of society as a multidimensional reflection of the interplay between 
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wealth, prestige and power and its role in creating an individual's "life chances" in terms of factors such as 
education, occupation and income which are vital in the unequal distribution of resource within a 
population.[97] Finally, Functionalist concepts originated in the United States of America (USA), which views 
social stratification as a natural and essential part of complex modern societies[98]. To a greater or lesser 
extent, various combinations of these three schools of thought can be found in the measurements of 
socioeconomic position in the health literature.[97, 98] However, it is the individualist Weberian school of 
thought that seems to lead epidemiological researchers to measure indices of "life chances" such as education, 
occupation, income and housing of individuals and their averages to the areas.[86]  
Social determinants of health are the factors present in society that influence individual health.[99] Even 
though individual-level factors such as education provide a logical structural link between the occupation and 
income of an individual, there also exists extra-individual dynamics beyond these individual-level 
factors.[100] For example, beyond the education or income or employment status of an individual, their 
residential area access to primary care services can have a direct influence on the identification and ongoing 
management of CMRFs in an individual.[51, 82, 83] Thus, social and economic resources have the potential 
to configure the health of individuals beyond individual-level factors.[101]Individual-level health is often a 
result of the social determinants of health.[102] It is not an accident that an individual consumes a diet high in 
saturated fat and salt. It also reflects on the food choices available, affordability, cultural practices, and other 
social and marketing influences.[102] Thus the biochemical causes of diseases in an individual are largely 
influenced by the social circumstances of an individual, which been termed “a cause of the cause”.[102] Social 
determinants of health are considered to be mostly responsible for health inequities among populations.[89, 
99]   
Measurement of area-level disadvantage 
The measurement of the socioeconomic position of an area can be either absolute or relative.[91] Both methods 
have their own merits and disadvantages.[103] For example, based on an absolute measure, the average 
financial income level of an area may have increased over time, but in relative terms, this increased income 
may not be sufficient to afford the cost of material resources to benefit health outcomes to the same extent as 
neighbouring areas.[91] However, absolute measures may help in studying changes over time, whereas the 
relative measures are mostly based on concurrent data and statistics, and are often criticised for overestimating 
effects and their interpretive complexity.[104, 105]. It is for this reason, methodological experts and 
organisations including the World Health Organization's Commission on Social Determinants of Health, 
recommend a balanced reporting of both absolute and relative measures, when feasible, for an overall picture 
of socioeconomic inequalities.[101] However, in the absence of access to absolute data, research has often 
relied on relative measures.[104] Review reports indicate that population health inequality studies are most 
commonly reported using relative measures.[104] 
Socio-Economic Indexes for Areas (SEIFA) are relative measures of area-level socioeconomic indices 
developed by the Australian Bureau of Statistics (ABS).[106] SEIFA rank areas in Australia based on how 
advantaged or disadvantaged they are relative to other areas.[106] SEIFA consists of four area indices which 
are constructed using the principal components scores of the data from the five-yearly Census of Population 
and Housing.[106] The four SEIFA indices consist of: i) The Index of Relative Socio-economic Disadvantage 
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(IRSD); ii) The Index of Relative Socio-economic Advantage and Disadvantage (IRSAD); iii) The Index of 
Education and Occupation (IEO); iv) The Index of Economic Resources (IER).[106]  
The thesis uses only one measure of area-level socioeconomic disadvantage (ASED), which is the Index of 
Relative Socioeconomic Disadvantage (IRSD). The IRSD is chosen for the analyses primarily as it is the only 
unitary index of the area-level disadvantage from SEIFA (in distinction to IRSAD), and the other indices are 
more oriented to education, occupation and economic resources. Australian Government agencies use IRSD 
indices for planning of services and funding allocation.[108] As socioeconomically disadvantaged people are 
a priority population for health monitoring, researchers routinely use IRSD to analyse and report the health 
outcomes.[99] The IRSD was chosen as the independent variable for analyses in this thesis because it is 
primarily designed to compare the relative socio-economic characteristics of areas at a given point in time[107] 
and various Australian Government agencies use IRSD by itself or with other more targeted information to 
assist in determining the allocation of resources and services[108]. As one of the main intentions of this 
research programme is informing regional health care service commissioning, the thesis uses IRSD as the only 
measure of ASED. 
The IRSD summarises the socioeconomic disadvantage of an area into an index score based on the aggregate 
characteristics of its usual resident population using variables such as low income, low educational attainment, 
high unemployment, and jobs in relatively unskilled occupations.[106] The areas are then ranked based on the 
scores and grouped based on the ranks, often in quintiles.[99] It should be noted that IRSD reflects the overall 
or average level of disadvantage of an area but does not identify differences between individuals living in the 
same area.[99] Being an average, the score is likely to reduce obvious differences between individuals within 
an area, and between areas.[99] For this reason, IRSD is recommended to be used with the smallest available 
area unit and thus the smallest population size.[99] As socioeconomically disadvantaged people are a priority 
population for health monitoring, researchers routinely use IRSD to analyse and report the health 
outcomes.[99] Thus, IRSD was chosen as the independent variable for analyses in this thesis because it is 
primarily designed to compare the relative socio-economic characteristics of areas at a given point in time[107] 
and various  Australian Government agencies use IRSD by itself, or in conjunction with other (more targeted) 
information to assist in determining the allocation of resources and services[108]. 
Area-level disadvantage had been reported as being inversely associated with different CMRFs in multiple 
studies. Most of these studies were reported from industrialised nations mainly across the USA and European 
regions of the world, but only a few from the Oceania region. The reported associations were mostly identified 
in cross-sectional studies and independent of individual-level factors such as, age, sex, education and income. 
Area-level access to primary care is a correlate of geographic variation of certain CMRFs. Primary care 
consultations have been reported as less likely to occur when the access to care was poor. Therefore access is 
assumed to have a direct effect on the detection and ongoing management of CMRFS, as they are generally 
chronic in nature and require continuous but non-hospitalised care. 
1.4.2 What we need to know: 
Small-area level analyses of CMRFs could be a useful step forward in understanding the geographic variation 
of CMRFs in regional Australia. In selecting a suitable geographic unit for the analyses, the smallest possible 
area-level unit is preferred as it lowers the risk of ecological fallacy.[26] Small-areas are likely to have the 
smallest possible population size and thus a less heterogeneous population than larger geographic areas.[26] 
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This potentially minimises the within-area variations and maximises the between area variations.[26] Previous 
research has demonstrated that it is feasible to produce small-area geospatial maps from health care service 
record data, but that this required significant technical expertise.[109] Previous research also demonstrates 
that when smaller area level units were used, the measured health outcome inequalities were larger in 
comparison with the use of larger area level units.[110] Thus, the geocoding and mapping of CMRF data in 
this thesis may facilitate not only area-level visualisation of the data, but also facilitate generation of 
hypothesis for further area-level analyses. In Australia, regional planning for the prevention and management 
of CMRFs lacks information about its epidemiology within small-areas.[68] Centralised approaches of disease 
prevention and management may not suit regional requirements.[111] The geographic distribution patterns at 
larger geographic scales may not adequately represent significant local geographic variations. Analysis at 
small-area levels is important in order to understand local patterns and requirements.[68] 
Area-level disadvantage had been reported to be associated with individual CMRFs in previous studies.[58-
67] An analysis of this association across multiple risk factors may actually be more informative for the local 
management and prevention of CMRFs. Multiple risk factors occurring simultaneously in disadvantaged areas 
may focus attention and improve area-appropriate preventive approaches and region specific health care service 
commissioning. 
Estimating and analysing primary care access at a small-area level may further extend our understanding of the 
distribution of CMRFs within a geographic region. Previous studies from Australia have reported that using 
the remoteness of the areas alone for health care service planning has significant limitations, but including 
measures of socioeconomic disadvantage and workforce supply may better target health inequities and improve 
resource allocation.[112] Therefore extending the analyses to include access to primary care may help provide 
a better picture of the need for health care services in the region, especially in disadvantaged areas.  
In summary, the geospatial analysis of a wide range of CMRFs. in conjunction with appropriate multilevel 
analyses has the potential to provide valuable evidence for area-level health care service commissioning in 
Australia. The findings may reveal geographic variation in CMRF distribution and the area-level factors 
associated with these inequalities. Geospatial mapping of CMRFs may facilitate the visualisation of the 
geographic variation and generate hypotheses for multilevel analyses.[113] The evidence created from analysis 
of multiple risk factors (if consistent across the factors) could inform future planning of targeted health care 
service commissioning in regional areas.  
1.4.3 Key challenges 
The data and expertise required for area-level analyses is a key challenge in regional studies. The use of hospital 
linkage data would not cover community level distribution of CMRFs, as identification and ongoing 
management of CMRFs would not generally require hospitalisation until severe. However, de-identified data 
from community service providers may be a possible source of population derived data. The feasibility of this 
method has been reported earlier.[68] With area-level analyses, the choice of fitting algorithm and its 
implementation within accessible analytical software would be a key decision. The major analytical platforms 
available for area-level analyses include, but are not limited to R, SAS, MLwiN, Stata,  SPSS,  S-Plus, 
GLLAMM, HLM, MIXREG, SYSTAT, and WinBUGS.[114] 
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1.5 Research plan 
As de-identified data on multiple CMRFs were available from the Southern IML Research (SIMLR) database 
for the Illawarra-Shoalhaven region of NSW Australia, the region was chosen to analyse their geographic 
variation and association with selected contextual factors including area-level socioeconomic disadvantage. 
The Illawarra-Shoalhaven has a diverse socio-economic profile, making it a useful region for area-level 
population health studies. [68] Figure 1.2 shows the study area with SA1 units and the major landmarks of the 
region. 
 The Illawarra-Shoalhaven region covers a land area of 5615 square kilometres and had an estimated residential 
population of 369,469 persons at the 2011 Australian Census of Population and Housing conducted by the 
Australian Bureau of Statistics (ABS), of which 285, 385 (77.24%) were aged 18 years and over.[115] 
Statistical Area Level 1 (SA1) was the smallest geographical unit of the 2011 Census at which data were 
released.[115] SA1s typically have a population size of 200 to 800 persons (average 400)[115], and the 
Illawarra-Shoalhaven region comprises a total of 980 conterminous SA1s.   
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The population profile of the Illawarra-Shoalhaven region is culturally and linguistically diverse, with a 
significant proportion of non-English speaking people (10.5%) residing in this region who have migrated from 
overseas.[116] In addition, at the 2011 Census the region is identified to have more than the NSW state and 
Australian national averages of: 1) Aboriginal and/or Torres Strait Islander peoples (3% versus 2.5% NSW and  
2.5% Australia); 2) aged (>=65 years) population (17.6% versus 14.5% NSW and  13.8% Australia) ; 3) single-
parent households (5.8% versus 5.3% NSW and  5.2% Australia); and 4) unemployment (7.1% versus 5.1% 
NSW and  5.1% Australia) and lower labour force participation rate (57.9% versus 64.6% NSW and 66.2% 
Australia).[116] ABS 2011 census data indicate that more than 31 % people in the Illawarra-Shoalhaven reside 
in Inner Regional areas, and 9.1% households within this region did not have a motor vehicle.[116] The 
Illawarra-Shoalhaven geography and a limited public transport system, especially in isolated communities, 
make it difficult for many people to access health services quickly.[116] These characteristics of the study 
region directly indicate the vulnerability of its population to poorer health outcomes. Thus, the Illawarra-
Shoalhaven geographic area was chosen to study due to data availability and a population likely to benefit from 
the outcomes of the research. Based on the research needs identified in the preliminary literature review, a 
research proposal was prepared, which included the following questions, objectives, hypotheses and expected 
outcomes. 
1.5.1 Research questions  
1. What is the existing level of evidence on the geographic and socioeconomic variation in the distribution of 
CMRFs internationally? 
2. What is the small-area level geographic distribution pattern of cardiometabolic risk factors, within the 
Illawarra-Shoalhaven region of NSW Australia?  
3. What proportion of any geographic variability in the distribution of cardiometabolic risk factors is due to 
small-area level socioeconomic status, within the Illawarra-Shoalhaven region of NSW Australia? 
4. What proportion of any geographic variability in cardiometabolic risk factor distribution is due to 
differences in small-area level primary care access, within the Illawarra-Shoalhaven region of NSW 
Australia? 
Based on the above research questions, following objectives and hypotheses were derived. 
1.5.2 Objectives  
1. Systematically review the existing literature on the geographic and area-level socioeconomic variation in 
cardiometabolic risk factor distribution. 
2. Quantify small-area geographic variation in the distribution of cardiometabolic risk factors, within the 
Illawarra-Shoalhaven region of NSW Australia. 
3. Quantify the proportion of small-area geographic variation in cardiometabolic risk factors explained by the 
area-level socioeconomic disadvantage, within the Illawarra-Shoalhaven region of NSW Australia. 
4. Quantify the proportion of small-area geographic variation in cardiometabolic risk factors explained by the 
differences in geographic access to primary care, within the Illawarra-Shoalhaven region of NSW Australia. 
1.5.3 Hypotheses 
Within the Illawarra-Shoalhaven region of NSW Australia: 
H0 – Cardiometabolic risk factors are distributed in random. 
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H1 – Cardiometabolic risk factor distributions are not related to small-area socioeconomic disadvantage. 
H2 – Cardiometabolic risk factor distributions are not related to small-area access to primary care. 
1.6 Thesis overview 
The thesis design is based on the research questions, objectives and hypotheses outlined in the research plan. 
Figure 1.3 provides an illustration of the thesis design and how the individual studies link together. 
 
Figure 1.3: Thematic representation of the thesis design and the supporting studies 
1.7 Thesis structure  
The thesis is structured as a compilation of publications. A General Introduction is given in chapter 1 and a 
General Discussion and Conclusion is presented in chapter 8. Also, chapter 3 Materials and methods is written 
to supplement the thesis, describing the methodologies adopted in individual studies. All other chapters in this 
thesis are based on the manuscripts written for publication of individual articles. A summary and bibliography 
are provided at the end of each chapter. 
The chapters outlined in this thesis are: 
Chapter 1:  General introduction  
Chapter 2: Geographic and area-level socioeconomic variation in cardiometabolic risk factor distribution: a 
systematic review of the literature.  
Chapter 3:  Materials and methods  
Chapter 4: Geographic variance in cardiometabolic risk distribution: a cross sectional study of 256, 525 adult 
residents in the Illawarra-Shoalhaven region of the NSW, Australia. 
Chapter.5: Geographic variation in cardiometabolic risk factor prevalence explained by area-level disadvantage 
in the Illawarra-Shoalhaven region of the NSW, Australia.  
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Chapter 6: Does access to primary care reduce the geographic variation of cardiometabolic risk factor 
distribution? A multilevel analysis of the adult residents in the Illawarra-Shoalhaven region of Australia. 
Chapter 7: General discussion and conclusion  
1.8 Thesis significance 
The thesis has the potential to inform regional health service commissioning. Information on the geographic 
distribution of cardiometabolic risk factors is essential to that aim. It is important to note that the health care 
management protocols of the individual CMRFs are different from each other.[117-120] Resources required 
for the prevention control and management of diabetes is different from that of hypercholesteremia, or that of 
low renal function.[118, 119] When it comes to areas, some may require more resources for diabetes 
management, such as diabetes clinics, whereas others might require more dialysis units or renal care nurses. 
Some areas might require more exercise or walking facilities, whereas others might require more primary care 
locations. Therefore it is important to analyse data on the distribution of each of these CMRFs. This thesis 
presents a potential approach using a geocoded regional data source. 
The thesis also aims to explore the association of higher risk CMRFs with area-level disadvantage. As 
disadvantaged areas are vulnerable to poor health outcomes[99], it is important to prioritise and plan area-
appropriate approaches to improve the health outcomes of these areas. This study plans to focus on area-level 
disadvantage to describe its association with various CMRFs. This would help to demonstrate the pattern of 
association of a range of CMRFs across the levels of disadvantage. 
Further, the thesis also attempts to explain the geographic variation in CMRFs in relation to the level of primary 
care access of the small areas within the study region. It should be noted that a proportion of the population in 
the study region do not have private vehicles and the public transport system does not cover all the regional 
and remote areas within this study region.[116] In such a context, geographic access to primary care services 
is of vital importance, especially for the early identification and ongoing management of various CMRFs. 
Overall, the measurement of inequalities in health is essential to define, describe, and understand the nature 
of the public health problem.[121] It is  an important step in the development of strategies and policies to 
tackle health inequalities, and in the monitoring and evaluation of the effectiveness of existing approaches. 
The study has the potential to identify the geographic associations of areas and CMRFs, and thus the 
appropriateness of targeted or universal approaches for the prevention and control of CMRFs in the study 
region. Often it would require collaborative policymaking approaches between different sectors such as health, 
education, urban/rural planning, and employment sectors to act together to reach the health and welfare goals 
of a population.[122]  Overall the study can generate evidence for resource allocation, planning and informing 
local solutions to locally raised problems for the long term prevention and management of cardiometabolic 
risk factors in the region and potentially nationally. 
Therefore, this program of study has the potential to make significant impact on regional planning and 
implementation of preventive health care services. Description of small-area geographic variation in CMRFs 
and their environmental contexts in relation to area-level disadvantage and access to primary care are the chief 
outcomes of this research. Quantification of small-area geographic variation in CMRFs associated with area-
level disadvantage at small-area level could assist our understanding of the socioeconomic context of CMRFs 
in the study region. Analysis of the geographic access to primary care may further help to understanding its 
link with the CMRFs, especially in disadvantaged areas.  Cardiometabolic risk mapping of the region visually 
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translates the geospatial analyses of the data along with epidemiological findings. This may make the findings 
of this research more accessible to the end users than traditional graph and table methods to report research 
findings.[123]  
1.9 Summary of the chapter 
Chapter 1 provides a general introduction to the thesis. This chapter summarises the importance of the place of 
living on human health and provides a short literature background on the importance of location on the 
development of CMRFs. Based on the existing research, a research plan was articulated in this chapter. 
Geographic variation in cardiometabolic risk factor prevalence at a small-area level is the major concept dealt 
with in this thesis. The thesis attempts to describe 1) the geographic variation in CMRF distribution in the 
Illawarra-Shoalhaven region of the NSW, in Australia. Also, the contextual associations of 2) area-level 
disadvantage and 3) area-level access to primary health care services – with the geographic variation observed.  
The thesis is presented by compilation of publications. The importance of the thesis is explained in terms of its 
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2.1 Publication profile 
This chapter presents the substantive content of research published in: International Journal of Health 
Geographics, on 08th January 2019. 
 
Journal article  
Toms R, Bonney A, Mayne D J, Feng X, Walsan R. Geographic and area-level socioeconomic variation 
in cardiometabolic risk factor distribution: a systematic review of the literature. International Journal of 
Health Geographics, 2019. 18(1), 1.  
Available from:  https://link.springer.com/article/10.1186/s12942-018-0165-5   
DOI: https://doi.org/10.1186/s12942-018-0165-5       
 
Published version of the article 
The published version of the article is appended within the ‘Supplementary Materials’ section of the 
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2.2 Abstract  
Introduction: A growing number of publications report variation in the distribution of cardiometabolic 
risk factors (CMRFs) at different geographic scales. A review of these variations may help inform policy 
and health service organisation.  
Aim: To review studies reporting variation in the geographic distribution of CMRFs and its association 
with various measures of area-level socioeconomic disadvantage (ASED) among adult (>=18 years) 
population across the world.  
Method: A systematic search for published articles was conducted in four databases (MEDLINE (Ovid), 
PubMed, Scopus and Web of science) considering the interdisciplinary nature of the review question. 
Population-based cross-sectional and cohort studies on: Geographic variations of one or more biological 
proxies of CMRFs, with/without an analysed contextual association with ASED were included. Two 
independent reviewers screened the studies and PRISMA guidelines were followed in the study selection 
and reporting.  
Result: A total of 265 studies were retrieved and screened to 24 eligible studies. The review revealed 
reports of variation in the distribution of CMRFs, at varying geographic scales, in multiple countries. In 
addition, consistent inverse associations between ASED and of CMRFs were demonstrated. The reports 
were mainly from industrialised nations and small-area geographic units were frequently used.    
Conclusion: Geographic variation in cardiometabolic risk exists across multiple spatial scales and is 
positively associated with ASED. This association is independent of individual-level factors and provides 
an imperative for area-based approaches to informing policy and health service organisation. The study 
protocol is registered in International prospective register of systematic reviews (Register No: 
CRD42018115294) PROSPERO 2018.  


















Cardiovascular disease (CVD) associated metabolic risk factors represent major global public health 
concerns. CVD is the leading cause of human death, accounting for 17.7 million (31%) of the 56.4 million 
total deaths reported worldwide in 2015.[1] Coronary heart disease (7.4 million) and stroke (6.7 million) 
were responsible for the greatest mortality within CVD and have remained the leading cause for mortality 
for the last 15 years.[2] CVD and its associated metabolic risk factors are listed in the top 15 causes of 
Disability Adjusted Life Years (DALY) globally.[3] In keeping with historical trends, deaths due to CVD 
are projected to increase steeply and reach more than 23.6 million annually by 2030.[4] 
An important way to control CVD is by focussing on reducing associated metabolic risk factors. In low 
resource settings, vulnerable and disadvantaged groups are more likely to be exposed to unhealthy products 
and practices and develop metabolic risk factors for the development of CVD.[5] Cardiometabolic risk 
factors (CMRFs) such as diabetes mellitus (DM), hyperlipidaemia, high body mass index (BMI) and 
chronic kidney disease (CKD) can predispose and worsen CVD. Individual level approaches to prevent 
and control these risk factors have demonstrated limited success as evidenced by their increasing rates.[6-
8] Thus it is important, in addition, to discern the contextual associations of development of these risk 
factors to assist in mitigating this global epidemic.  
Geographic inequalities in the distribution of CMRFs at varying scales are reported in multiple studies from 
different countries in association with area-level socioeconomic disadvantage (ASED). Critically 
examining the area-level distribution patterns and associated area-level disadvantages reported in these 
studies may deepen our understanding of the higher prevalence of CMRFs in some geographic areas. Most 
recent relevant reviews in this area have broadly covered the influence of physical, social and service 
environment characteristics on CVD risk.[9-12] Systematic synthesis of evidence regarding this globally 
reported variation and association may inform policy development and healthcare service planning to detail 
area-level approaches, in addition to the individual level measures, to prevent and control CMRFs 
effectively. 
Therefore, the questions attempted to answer in this review are: Is there any geographic variation in the 
distribution of CMRFs among adult population (aged 18 years and above) across the world and is this 
variation associated with ASED. The studies expected to include were epidemiological or population based 
cross sectional and/or cohort studies. 
2.4 Methods 
A review protocol was developed and registered in International prospective register of systematic 
reviews, PROSPERO 2018 (Register No: CRD42018115294) Available from: 
http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018115294.  
Four databases: MEDLINE (Ovid), PubMed, Scopus and Web of science databases were chosen for the 
search, considering the breadth of fields they cover and the interdisciplinary nature of the review question. 
Also, hand-search of related articles served as an ‘other source’ of studies. The database search strategy 
commenced with two general search domains:  1) studies on CMRFs in single and multiple reporting forms; 
and 2) geographic and spatial health studies. An intersectional retrieval of studies from both these domains 
yielded a narrower list of studies on geographic variation in CMRFs. A third domain 3) studies addressing 
area-level measures of socioeconomic disadvantage were further intersected with the retrieved studies to 
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create a focal list of studies addressing geographic association of CMRFs with ASED. This approach 
maximised the number of potentially eligible studies identified compared to using single domain searches.  
Figure 2.1 conceptualizes the major search domains and their intersections used in the review. 
 
Figure 2.1: Conceptual representation of the literature search strategy 
The review included epidemiological or population-based cross-sectional and cohort studies on: geographic 
variation of one or more biological proxies of CMRFs, with/without an analysed contextual association 
with ASED. Obesity, diabetes mellitus (DM), hyperlipidaemia and indices of low kidney function were the 
included biological proxies of CMRFs. Hypertension is included only when reported with other biological 
proxies of CMRFs, but not independently considering its limited summation into an overall 
cardiometabolic risk in an individual. Studies involving: type 1 DM and gestational DM were excluded as 
they were out of scope for the current review pertaining the geographic or area based contexts of the 
CMRFs. Studies measuring area-level characteristics other than ASED were also excluded. 
All search outcomes were limited to:  human studies; adult population (>=18 years) and availability in 
English language. The initial search included studies from year 1995; and latter it was modified to 
01/01/2001 due to minimal publications on the review topic between the years 1995 to 2000. The search 
was last updated on 30/11/2018. Adopted search strategy in Ovid MEDLINE and search result URLs of 
remaining databases are available in Appendix I. 
All retrieved studies were screened by two independent reviewers in three stages to reduce the risk of bias. 
In stage 1, articles from all databases were combined and screened to remove duplicates. Titles and 
abstracts of remaining articles were screened for eligibility, in stage 2. The final stage of study selection 
was done after full text reading of the remaining studies. Qualities of the individual studies were assessed 
using the STROBE checklist for cohort, case-control and cross-sectional studies (www.strobe-
statement.org). The second coder repeated all three stages in parallel and selected studies were matched at 
the conclusion of each stage and any differences were resolved by consensus and arbitration. Other review 
team members served as additional reviewers when required. 
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Data extraction and coding of the chosen studies were carried out using two pilot-tested templates for 
consistency. Template 1 focused on the geographic variation in CMRFs and was used to extract information 
on: author, year, nation, study design, sample size and characteristics, geographic unit of reporting, studied 
CMRFs and the study outcome. Data on behavioural risk factors were not extracted as these were not 
included in the current review. Template 2 addressed the association of ASED and cardiometabolic risk 
factor distribution and extracted additional data on the reported proxies of ASED and its association status. 
An additional template was used for thematic mapping of the data in included studies for further qualitative 
syntheses. Study origin, representation, nature of problem, ecological context and evidence strength were 
the mapped themes.  
The two independent review authors extracted and coded the data and any discrepancies were resolved 
through discussions between the authors. Summary measures used in this review are descriptive and based 
on the frequency of relevant studies to its denominator. Endnote software was used to keep track of the 
bibliographic details of the studies throughout the selection and data extraction process. 
2.5 Results 
A total of 265 individual studies were retrieved from four electronic databases (n=251) and hand searches 
of reference lists (n=14). Studies from electronic data bases included 91 Ovid Medline, 80 PubMed, 58 
Scopus and 22 Web of science. Figure 2.2 shows the screening process as per the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses PRISMA guidelines (www.prisma-statement.org). 
Stage 1 screening combined studies from all sources and removed the duplicates (n=99). Duplicates in 
removed order:  Ovid Medline (n=0), PubMed (n=80), Scopus (n=10), Web of science (n=3) and hand-
searches (n=6). After removing duplicates, 166 studies were forwarded for stage 2 screening.  
Stage 2 screening excluded 130 studies based on title and abstract screens, forwarding 36 studies for the 
full text screen. Studies excluded in stage 2 mainly addressed genetic, cellular, instrumental or 
pharmacological research regarding CMRFs. Studies on type 1 DM, paediatric or juvenile DM and 
gestational DM were also excluded at this stage as per the exclusions stated.  Stage 3 screening carefully 
considered the whole full text of articles and 12 records were excluded with reason (list available in 
Appendix II) leaving 24 studies for the systematic synthesis. 
 




Figure 2.2:  Combined PRISMA Flow Chart of the study selection. 
The review is structured into three sections. Screened research articles retrieved through ‘AND’ 
intersections of search domain 1 and 2 (n=8) are reviewed in section 1: Geographic and spatial variation 
in cardiometabolic risk factors.  Screened articles retrieved by intersecting domains 1 and 3 (n=16) are 
reviewed in section 2: Area level deprivation and cardiometabolic risk. Overall synthesis based on the total 
reviewed studies (n=24) are presented in section 3: Overall synthesis of the studies. 
2.5.1 Geographic and spatial variation in cardiometabolic risk factors. 
Table 2.1 summarizes the eight studies reviewed under this section.[13-20] Geographic variation in the 
population distribution of one or more CMRFs is reported in each of these studies. Most of the studies 
(7/8) reported hyperglycaemia as an important biomarker displayed geographic variation in 
cardiometabolic risk[13-15, 17-20], followed by dyslipidaemia (4/8), body mass index (4/8), blood 
pressure (BP) (3/8) and reduced glomerular filtration rate (GFR) (1/8). 
All studies reported geographic variation in the distribution of CMRFs, regardless of the geographic unit 
of analysis used.[13-20] Most of these studies were from Europe (4/8), predominantly from Western 
Europe (3/8).[13, 16, 18, 19] These reports were from UK[16], Spain[19], France[18], and 
Luxembourg[13].  In the UK, geographic variation in the prevalence of risk factors such as obesity, 
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smoking, diabetes, hypertension and high cholesterol were reported across four main regions: South 
England, Midlands and Wales, Scotland and North England.[16] A higher prevalence of CMRFs was 
reported in southern Spain (Andalusia), which was found in close association with sedentary lifestyle and 
markers of socioeconomic disadvantage.[19]  Variation in the distribution of diabetes, high BMI (≥25 
kg/m2), abdominal obesity, hypertension, high cholesterol and low glomerular filtration rate were reported 
at both canton and municipality levels in Luxemburg, Western Europe.[13] BMI and resting heart rate 
were reported to have greater geographic variation among matched cohorts in France and Australia.[18] 
Other reports in this section were from Oceania (2/8), East Asia (2/8) and North America 1/8) - sourced 
from Australia, China, South Korea and US.[14, 15, 17, 18, 20] A geographic variation of 42% was 
reported in the odds of being diagnosed with DM among adults in Sydney, Australia.[14] In another 
Australian metropolitan based cohort, Glycated haemoglobin (HbA1c) was reported to have greatest 
geographic variation among matched cohorts in Australia and France.[18] In China, significant variation 
in the regional prevalence of diabetes was reported after adjusting for age, sex and urban/rural 
socioeconomic circumstances.[20] Geographic clustering of CMRFs were reported at administrative 
district level in South Korea.[17] The presence of a ‘diabetic belt’ with higher prevalence of diagnosed 
diabetes (>11.0%) was reported in the United States, consisting of 644 counties in its 15 mostly southern 
states.[15] Though the risk profiles and parameters varied, all these studies consistently reported 
geographic variation in its CMRFs.  
The geographic scales of area-based units reported in all these studies ranged from large regions[15, 16, 
18], within countries to smaller jurisdictional administration units [13-15, 17, 18], and trended towards 
smaller geographic areas over time. Easily accessible pre-existing geographic units and boundaries were 
used in these studies but most weren’t explicit on the spatial extension and average population within their 
geographic units. Three studies had relied only on self-reports on anthropometric, behavioural, 
biochemical, physiological and diagnostic categories of data, risking for recall bias and 
misclassifications.[14, 15, 17] 
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Table 2.1: List of studies reviewed on geographic variation in CMRFs. 
First Author 
Country (year)  
Sample  
Age group  
Design 
Geographic units 
CMRFs a  
(Data source) 
Outcome  
Lawlor D A  
UK (2003)  
4, 286(women ) 
60-79 years  
Cross-sectional 
4 Regions within country 
HT, BMI , LDL, TC (Data 
collected) 
Geographic variation 
Barker L E 
USA (2011) 
813, 498 DM  
≥18 years  
Cross-sectional 
644 counties in proximity  
DM prevalence >=11.0%, 
(Behavioral Risk Factor 
Surveillance) 
Geographic diabetic belt 
Valdes S 
Spain (2014) 
5, 103 adults 
 ≥18 years 
Cross-sectional 
2 region within country 





114, 755 adults 
≥45 years 
Cross-sectional 
~40 Local Government areas 





98, 058 adults 
 >18 years  
Cross-sectional multilevel 
31 Provinces in country 
DM (National health survey) Geographic variation 
Paquet C 
AU-France (2016) 
Au: 3, 893(≥18 years) 
Fr: 6, 430 (30- 79 years)  
Cross-sectional multilevel 
Au: 767 CDs (SS, POA, SLA 
LGA). Fr: 1866 IRIS (TRIRIS, 
Municipalities) 
BP, BMI, WC, FG, HbA1c, HR, 
TC, HDL, TG, (Au: NWAHS 
study , Fr: RECORD Cohort 
Study) 
Geographic clustering(ICCs) 
Alkerwi  A 
Luxemberg(2017) 
1, 432 subjects 
18-69 years. 
Cross-sectional multilevel 
106 Municipalities (12 cantons)  
BMI, FPG, TC, GFR 
(ORISCAV-LUX national 
survey) 
Geographic variation  
Oh W S 
South Korea(2018) 
228, 921 people  
≥ 19 years 
Cross-sectional 
230 administrative districts 
HT,  DM (Korean Community 
Health Surveys) 
 Geographic clustering 
Abbreviations: AU – Australia; CD -Census Collection District; POA -Postal Area; SLA -Statistical Local Area; LGA - Local Government Area; IRIS - Ilôts regroupés pour l’information statistique; 
TRIRIS - Groups of around three IRIS areas; BP – Blood pressure; BMI – Body mass index; DM – Diabetes mellitus; FBG – Fasting plasma glucose; FPG – Fasting glucose; HbA1c – Glycated 
haemoglobin; HR – Heart rate, HT – Hypertension,  TC- Total cholesterol; TG – Triglycerides; LDL – Low density lipoprotein; GFR – Glomerular filtration rate; WC – Waist circumference 
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2.5.2 Area level deprivation and cardiometabolic risk. 
Table 2.2 summarises the 16 studies reviewed under this section.[21-36]  Reported studies were mainly from 
Europe (7/16) and North America (7/16), followed by Oceania (1/16) and South America (1/16). Studies from 
Europe were predominantly reported from the western region and sourced from UK, Germany, Czech and 
France. Reports from North America were mainly from USA (6/7) and Canada (1/7). There was only one study 
from Oceania, sourced from Australia.[25] Most of these studies were sourced from industrialised nations, 
except one study from Brazil[21], a developing nation in South America. 
All studies reported inverse associations of various CMRFs with ASED.[21-36] Various measures of the 
biological proxies of CMRFs reported include biochemical, anthropometric, physiologic, behavioural and 
diagnostic categories of data. Census sourced data on ASED were used in most of these studies (12 /16), 
whereas other survey sourced data were used in the remaining studies (4/16) to construct summary scores or 
indices on ASED.  The categories of measures used to calculate ASED in these studies were area-level 
proportions of: median income, education, occupation, housing, transport, dependent population, social class, 
social capital, environment, security, family structure, disability, internet access and insurance coverage. A 
minimum of one category of these measures are used in all the studies.[21-36] 
The samples characteristics and variables considered were notably heterogeneous across studies. Sampling 
frame of most (7/16) of these studies were population based lists, however service provider given (4/16) and 
employees (3/16)   lists were also used. Two studies had used a combination of both population lists and service 
provider given lists.[28, 32] Though subjects in all studies qualified adult age limits (>=18 years), divergent 
age groups were sampled across all of the studies. Also gender[33, 34], and race[22, 24], specific sampling 
were done in two studies each. Heterogeneity of these sample characteristics makes a comparison and further 
quantitative synthesis more difficult. 
The samples are mostly accessed from existing study cohorts, laboratory databases, national surveys and audit 
lists. The sample size of studies ranged from 342 adults to a maximum of 91, 776 adults, mostly larger in size. 
Census administration units were the most commonly used neighbourhood proxy, followed by other 
administrative units and electoral wards. Pre-existing geographic boundaries were mostly adopted to define 
the spatial unit, but their spatial extents of the unit of analyses were not stated in most of the studies. 
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Table 2.2: List of studies reviewed on the association of area-level deprivation and cardiometabolic risk factors. 










1 Bonney  A 
Australia (2015) 
91, 776 adults 
55.2 ±15.66 
Cross-sectional higherarchical 
631 Census collection districts 
BMI (The SIMLR Study) Index of Relative 
Socioeconomic Disadvantage 
( (Australian Census 2006) 
+ve 
(women) 
2 Unger E 
USA (2014) 
5, 805 adults 
45 -84 years 
Prospective cohort 
higherarchical 
Census tract level 
BMI, BP, BS, TC - CVH score 
(The MESA study) 
Neighbourhood SES 
(constructed summary score) 
+ve 
3 Maier W 
Germany (2014) 




T2DM,  obesity (GEDA 
national health interview 
survey )‘ 
German Index of Multiple 




4 Silhol R 
France (2011) 




Incidence of CHD (French 
GAZEL cohort Data)  
Area socio - economic 
position  (French Census 
1990) 
-ve 






moving window buffer within 
7 census tracts. 
BMI,  HbA1c, TG, TC, HDL 
– TCR (Montreal 
Neighbourhood Survey of 
Lifestyle and Health) 
Area-level unemployment 
(Canada Census 2001) 
+ve 
6 Cox M 
Scotland (2007) 
3, 917 adults 
< 35 years 
cross-sectional 
3382 Census- Output 
Areas(OA) 
T2DM (DARTS Diabetes 
Audit and Research Tayside 
Scotland  dataset) 
Area deprivation ( The 
Carstairs score based on 2001 
Scotland census data) 
+ve 
7 Andersen A 
UK (2008) 
4, 286 women 
60 -79 years 
Cross-sectional 
457 British Electoral wards 
T2DM,  FBG, IR (British 
Women’s Heart and Health 
Study) 
Area deprivation ( The 
Carstairs score based on 2001 
census data) 
+ve 
8 Gabert  R 
USA (2016) 
63, 053 DM 
18-74 years 
Retrospective observational 
120 zip code areas 
BP, HbA1c, LDL (Minnesota 
Community Measurement 
electronic health records) 
Area-level indicators of SES 
(based on American 
Community Survey 2013) 
+ve 
9 Dragano N 
GR-Czech (2007) 
GR: 4, 814 adults 
CZ: 8, 856 adults 
57.7±6.6  years 
2 longitudinal cohort studies 
326 pre-existing administrative 
units 
Obesity, HT ( GR: 'Heinz 
Nixdorf  Recall (HNR) 
Study', Czech: 'Health, 
Area-level socioeconomic status 
(based on census data) 
+ve 
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Alcohol and Psychosocial 




Cubbin C  
Sweden (2006) 
18, 081 adults 
25 - 64 years 
Pooled cross-sectional data 8624 
SAMS neighbourhoods 
Obesity, DM, HT (Swedish 
Annual Level of Living 
Survey 
(SALLS), 1988–89) 
Neighbourhood deprivation ( 
assessed by Care Need Index 




Mujahid M S 
USA (2005) 
13, 167 adults 
45 -64 years 
Crosssectional and longitudinal 
(3-9 years) Census block 
BMI  (The Atherosclerosis 
Risk in Communities ARIC 
Study) 
Neighbourhood SES score  




Lawlor D A 
UK (2005) 
4, 286 women 
60 -79 years 
Cross-sectional 
457 Electoral wards 
Coronary heart disease 
(British Women's Heart and 
Health Study) 
Residential area deprivation( 
The Carstairs score based on 




Roux A V D 
USA (2002) 
3, 093 adults 
28–40 years 
Cross-sectional 10 years follow 
up 
2, 260 Census block (in 45 states). 
BMI, HDL, TG, BP, FI & 
FG -IRS (Coronary Artery 
Risk Development in Young 
Adults CARDIA Study) 










age > 45 years 
Cross-sectional cohort 
Census block group 














35 -  84 years 
Cross-sectional cohort 
102 Census tracts 
TG, FBG, BP, WC, low-
HDL (Jackson Heart Study). 
Neighborhood socioeconomic 






Barber et al 
Brazil (2018) 
10617 adults  
35 -75 years 
Cross sectional cohort Study 
defined clusters of 
contiguous census tracts 
DM and HT  (Brazilian 
Longitudinal Study of Adult 
Health) 
Area level economic residential 
segregation (IBGE census 2010) 
+ve 
Abbreviations: BMI – Body mass index; BP – Blood pressure; BS – Blood sugar; CHD – Coronary heart disease; CVD – Cardiovascular disease; CVH – Cardiovascular health; DM – 
Diabetes mellitus; eGFR – estimated Glomerular filtration rate; FBG – Fasting blood glucose; FG – Fasting glucose; FI – Fasting insulin; GR- Germany; HbA1c – Glycated haemoglobin; 
HDL – High density lipoprotein; HT – Hypertension; IR – Insulin resistance; IRS – Insulin resistance syndrome ; LDL – Low density lipoprotein; SES – Socioeconomic status; TC- Total 
cholesterol; TCR – Total cardiometabolic risk; T2DM – Type 2 diabetes mellitus; TG – Triglycerides; SAMS– Small area market statistics. 
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2.6 Overall synthesis of the studies 
Significant features of the included studies were identified to aid synthesis of the findings. These features were 
the origin of the study, its representativeness, nature of the CMRFs studied, the ecological context and the 
strength of evidence presented. These features were then formulated into five themes, mapping the related data 
for further analyses (Table 2.3). 
We had plotted all the studies to identify their global region of origin and the economic nature of the source 
country. Most of the studies published were from Europe (11/24), closely followed by America (9/12), (two 
studies were cross national, hence counted under both the nations and corresponding regions). Fewer 
publications were found from Oceania (3/24) and Asia (2/24).However no identified studies were from Africa. 
Studies from developing nations were fewer (3/24) compared with studies from industrialised nations (21/24). 
This emphasises a gap in related publications from Asia-pacific and African regions, especially from nations 
of developing and underdeveloped economies. The global representativeness of this review is hence limited 
and the review findings may be more generalizable to industrialised nations. 
The target populations for included studies are shown in Table 2.3.  The sample frame of most of the studies 
were population based lists (13/24 studies), however service providers’ lists (5/24) and employees lists (3/24) 
were also used. Both population and service providers’ lists were used in three studies (3/24). All the population 
based studies used a random sampling technique to ensure the population representativeness. However, the 
response rates varied (15 - 90.5%) in these studies. Two studies had a response rate < 50%, suggesting a risk 
of responder bias despite a probability sampling method being employed.[31, 35] 
Ecological contexts of the included studies were analysed by extracting area level characteristics (Table 2.3). 
Area level units used in these studies extended from small areas (10/24), to medium areas (9/24) and large areas 
(5/24). Small-area units were mostly based on census, administrative or zip code area with an average ~1000 
residing population.  Medium area units had an average ~ 5000 population and the large area units were mostly 
regions, provinces and districts.  ASED gradients were based on area level measures of ranged from 1 to 7 
measures, however single measures of income or overcrowding as an indirect proxy of ASED raised concerns 
regarding their comprehensiveness in comparison to aggregate measures of ASED. 
The nature of CMRFs and the strength of evidence in relation to associations with outcomes were mapped by 
extracting data on the categories of CMRFs measured, the source of data and the mode of analyses (Table 2.3). 
Biological proxy categories of CMRFs were mostly biochemical (18/24), followed by anthropometric (18/24), 
physiologic (15/24) and diagnostic (4/24) in nature. Self-reported data on these categories of CMRFs had the 
highest risk for misclassification due to reporting bias or errors. Studies which adopted a combined mode of 
both statistical and spatial analyses provided a better ecological context of CMRFs than with statistical analyses 
alone. 
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Table 2.3: Thematic mapping of data categories from all included studies 
Theme  
 
Study origin : Representation: Ecological 
context: 










Response or retention % 




Data source  
Analyses 




North America  
Population  & 
Service provider’s lists 
79% retention 
Small area  







Specimen tests  
Statistical 




Western Europe  
Service provider’s list  
Random  
60% response 






Specimen tests, MR  
Statistical 
 Mujahid et al. 
(2005) USA 
(Industrialised) 





ASED: income,  
education, 
Occupation. 
Anthropometric Self-report, PE  
Statistical 
 




Western Europe  
Service provider’s list 
Random 
60% response 
Median area  
ASED: 
Employment, 






Specimen tests, MR 
Statistical 


















 Cox et al.(2007) 
Scotland 
(Industrialised) 
Western Europe  







Diagnostic – T2DM Medical  record  
Spatial & Statistical 
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Central Europe   
Population list  
Random  














Western Europe   






housing, transport,  
social class 
Biochemical  Self-report, PE, MR 
Statistical 




North America  
Population list  
Stratified cluster sampling  
15% response  






Specimen tests  
Statistical 




North America  
 Population list  
 Random  
50.6 % response 










Western Europe  
Employees lists  
~purposive 




Biochemical Physiological,  
Self-report, 
Employers data, 
Insurance data  
Spatial & Statistical 




North America  










Specimen tests  
Statistical 




Population list  
Random  






PE, Specimen tests  
Statistical 
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North America 6 




Southern Europe  
Population list  
Cluster –random  
54.6% response 







Specimen tests  
Statistical 





 Population (insurance) 
lists  
Random  
Medium  area Biochemical, Physiological  Self-report  
Spatial & Statistical 




North America  
Population and service 
provider’s list 
(~purposive) 









Specimen tests  
Statistical 




 West - Central 
Europe  
Population list  
Random  
29.1% response  

















East Asia  
 


















Service provider’s list 
(~purposive) 
Small-area 








Medical  record  
Statistical 









North America 8 








Medical  record  
Spatial & Statistical 




Oceania - West 
Europe  
Australia: Population list  
(Random 13/ 49.4% 
response 3) France: 









PE, Specimen tests  
Spatial & Statistical 




Western Europe  
Population (survey) list  
stratified random  
32.2% response  






 Spatial & 
Statistical 
 Oh et al. (2018) 
South Korea 
(Developing)  
East Asia  
Population (ministry) lists  
~purposive 





Spatial & Statistical 




South America  
Employees lists  
~purposive 






Specimen tests  
Spatial & Statistical 
 




The systematic review presented in this chapter provides a critical review of the geographic and socioeconomic 
variations of CMRFs reported from various nations. Studies which met the inclusion criteria were mostly from 
the industrialised nations of Europe and America (20/24). This emphasises a gap in reports from Asia-Pacific 
and African regions, especially from nations of developing and underdeveloped economies. Thus, the findings 
from these reports may be more generalisable to industrialised nations rather than providing overall global 
representativeness. In addition, heterogeneity of sample characteristics and divergence of reported CMRFs in 
these studies makes comparisons and further quantitative synthesis difficult. Also, the presence of self-
reported data and reportedly low sampling response rates (< 50%) suggest risks of responder and recall bias 
in at least some of these studies. From a methodological perspective, place of living as the primary focus in 
these studies; an over-emphasis on fixed effects estimates; and underreporting of the components of 
geographic variance are important reporting gaps. Based on the findings from this review, it is recommended 
greater attention is given to a more balanced and consistent reporting of studies and the components of 
variation in the reporting of geographic inequalities of CMRFs’ distribution.  
ASED was repeatedly demonstrated to be associated with higher cardiometabolic risk. Higher ASED was 
consistently reported to have an association with cardiovascular risk; whereas lower ASED was associated with 
reduced cardiovascular risk.  Such associations were often demonstrated independently of individual level 
characteristics such as socioeconomic status, education and duration of exposure to area. Type 2 diabetes and 
high body mass index (BMI) were reported to be more prevalent in disadvantaged areas. Related studies report 
that the type of neighbourhood food outlets [37-39], poor physical activity resources[38], individual perception 
of area level features[40], residential density and service availability[9], were all explanatory variables 
associated with cardiometabolic risk  factors among people living in disadvantaged neighbourhoods.  
Related systematic reviews published in this area of research investigate associations for different 
geographically distributed factors with CVD. Chaix (2009) reviewed the associations between neighbourhood 
social environments and CHD and proposed a theoretical model of a mediating mechanism focussing on the 
social interactional environment.[9] Consistent associations of obesity or hypertension with lower levels of area 
socioeconomic status, urbanization, street intersection, accessibility to supermarkets, social cohesion, service 
availability and residential density; and higher levels of noise pollution and density of convenience stores, were 
reviewed and reported by Leal (2011).[10] Frequent inverse associations of the common indices of ASED with 
childhood obesity were reported in the UK.[12] Consistent associations between socioeconomic disadvantage 
and central adiposity were reported by Slopen (2013).[11] All these reviews report important methodological 
inadequacies and the need for further research in this area, which support the findings of the current review. 
Recent advances in Geographic Information Systems (GIS) and analytical approaches were utilised in the 
studies reporting geographic variation in CMRFs. These studies have demonstrated advances in various 
analytical tools and the potential for plotting area level risk parameters. Geocoding and mapping of existing 
large population based datasets has become feasible with newer computational tools through linking location 
data; such as map co-ordinates, addresses or postcodes.[41] These tools have the capacity to visually display 
area based factors, in contrast with traditional table and graph methods and this has the potential to enhance 
impact on subsequent area level health care policy development and resource allocation.[42-44] In addition, 
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systematic quantitative analyses are possible with these spatial tools which create opportunities to investigate 
the role of environmental factors in explaining any geographic aggregations beyond random effects.[45] 
 National estimates of CVD have limited utility in informing prevention and management of CVD within 
discrete communities. The disease patterns at smaller areas may significantly differ from national and regional 
prevalence reports, thus small-area analysis is important in order to understand local patterns and 
requirements.[46] Small-area level analyses also have the potential to reveal area level contexts and 
dependencies of CMRFs and such analyses can highlight areas for targeted preventive interventions.  
CVD and its associated CMRFs continue to evolve as a major global health threat. It is the highest cause of 
mortality and the highest absorber of health care expenditure in many developed nations.[7, 47, 48] Once 
diagnosed, the ongoing costs of care and productivity loss due to consequent disability and premature death 
creates a large economic burden not only to the individual and family, but to the nation—especially when half 
the people dying are found to be in their prime productive years.[49] Thus, CVD and its associated metabolic 
risk factors emerge as a threat not only to human health and life, but to the sustainable development and 
economies of nations. Hence, improving public health program effectiveness in reducing CVD must be a 
research priority. 
2.8 Limitations 
Firstly, the cross sectional nature of the reviewed studies precluded causative interpretations. Second, the global 
representativeness of the review is limited mainly due to publication gaps from Asia-pacific and African regions 
of the World. Third, the scope of our review excluded examination of behavioural, dietary and activity related 
risk factors and also other area level characteristics to focus only on the biological proxies of CMRFs. The risk 
factors reviewed in this chapter are largely considered as modifiable. However, an exact distinction of familial, 
genetic or non-modifiable risk factors was not possible as the review focus was on the biological proxies of 
CMRFs such as obesity, diabetes mellitus, hyperlipidaemia, and indices of low kidney function. Also, the scope 
of review excluded examination of behavioural, dietary and activity related risk factors, as per the registered 
review protocol. Fourth, methodological heterogeneity within the retrieved studies prohibited a meta-analytical 
synthesis of the findings. The sample characteristics, geographical scales and the CMRFs’ risk profiles varied 
substantially across the studies impeding any further quantitative synthesis. Finally, the systematic review 
presented in this chapter does not exclude the possibility of any simultaneity and/or endogeneity bias within 
the reported studies. Simultaneity refers to the co-occurrence and symbiotic existence of CMRFs with 
ASED[50-52], whereas endogeneity would indicate on the influence of unmodeled covariates which might be 
having an effect on both CMRFs and ASED[53]. Endogeneity can also occur when individuals choose to move 
to a higher ASED area because of an existing CMRF (reverse causation).[54] Examining the temporal sequence 
of occurrences would be required to learn more regarding the possibility of such effects within theses studies. 
However, this has not frequently been undertaken. 
2.9 Recommendations and future directions 
Finding geographic variation in CMRFs (if any) and its association with ASED may assist in understanding the 
contexts of risk. Such studies have the potential to inform contextual planning of interventions for prevention 
and management of cardiometabolic risk. However, most of the studies in this review do not report the spatial 
extents of their units of analysis. This is important as associations are likely to be different at different levels 
of aggregation and limits the ability to assess the likelihood of spatial scale effects in these studies[22, 24], 
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known as the Modifiable Areal Unit Problem (Openshaw & Taylor, 1979; Openshaw, 1984).[55, 56] When 
data are aggregated to larger geographic units, small-area anomalies may be diluted or smoothed over.[24] 
Using smaller rather than larger area scales can help to reduce the likelihood of missing important small-area 
anomalies.[57] Similarly, supplementing individual level data along with area level data could minimise group 
effects due to area level aggregation of data.[57] Leveraging both individual- and area-level data provides a 
more complete picture to inform planning, policy and practice.[45, 57] Future research directions should 
include hierarchical multilevel analyses to yield comprehensive picture of the contextual aspects of risk factors, 
to help aid both individual and area-level better preventive initiatives. 
2.10 Conclusion  
Cardiometabolic risk distribution varied significantly across different geographic scales reported in multiple 
studies. In addition, there is strong evidence that area-level disadvantage is significantly associated with 
CMRFs, irrespective of individual-level characteristics. This review highlights the need for area-based 
preventive approaches in addition to individual-level approaches to prevent and control CMRFs and their 
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Chapter 3: Materials and Methods 
In order to appropriately address the hypotheses stated in Chapter 1, several methodological approaches 
were required. Methodologies relevant to this thesis are described in this chapter.  
3.1 Introduction 
The central aims of this thesis are the geospatial and multilevel analysis of the distribution of 
cardiometabolic risk factors (CMRFs) in the Illawarra-Shoalhaven region of NSW, Australia.  This chapter 
describes the materials and methods adopted to reach these aims, through the objectives listed in section 
1.5 of the Chapter 1. That is to:  
1. Systematically review the existing literature on the geographic and area-level socioeconomic variation 
in cardiometabolic risk factor distribution. 
2. Quantify small-area geographic variation in the distribution of cardiometabolic risk factors, within the 
Illawarra-Shoalhaven region of NSW Australia. 
3. Quantify the proportion of small-area geographic variation in cardiometabolic risk factors explained by 
area-level socioeconomic disadvantage, within the Illawarra-Shoalhaven region of NSW Australia.  
4. Quantify the proportion of small-area geographic variation in cardiometabolic risk factors explained by 
the differences in access to primary care, within the Illawarra-Shoalhaven region of NSW Australia. 
A Directed Acyclic Graph (DAG) of the relationship between exposure, outcome and mediating or 
moderating variables of cardiometabolic risk factors are presented in Figure 3.1. The DAG presents a 
conceptual illustration of the single exposure and multiple outcomes being estimated, the covariates being 
adjusted for in the analyses and other relevant covariates or confounders not been adjusted for given the 
study scope and data access limitations. The DAG was informed based on the literature review, presented 
in chapter 1 and 2. The figure illustrates the variables been included and not included in the analyses, and 
provide a clear basis for the interpretation of results which are dealt in the inferential analyses and 
presented in the subsequent chapters. 







Figure 3.1: Directed acyclic graph illustrating the relationships among the exposures and mediating variables of cardiometabolic risk factors which are analysed and 
not analysed in this thesis
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3.2 Study region 
The research was conducted in the Illawarra-Shoalhaven region of NSW, Australia. This region extends 
south of the metropolitan boundaries of Sydney and stretches along the eastern seaboard of the NSW— 
bordered by the Pacific Ocean to the east and the Southern Tablelands to the west. The region consists of 
multiple cities, towns and rural areas; and encompasses the four local government areas of Wollongong, 
Shellharbour, Kiama and Shoalhaven. The study region covers a land area of 5615 km2; and had an 
estimated residential population of 369, 469 people at the time of 2011 Australian Census of Population 
and Housing.[1] 
The Illawarra-Shoalhaven region is the third-largest regional economy in NSW, Australia.[2] The main 
industries in the area have traditionally been farming, coal mining and steel making. [2] Manufacturing is 
the largest contributor to this regional economy.[2] Australia's largest steel-works, BlueScope, operates at 
Port Kembla in the Illawarra-Shoalhaven region. The region’s natural beauty, diverse economy and relaxed 
coastal lifestyle make it an attractive tourism destination.[2] 
The University of Wollongong is the main tertiary education centers, having multiple campuses across the 
region and attracts thousands of local and international students and staff every year. Health care is also a 
major employment provider in the region. Close proximity of the northern part of the region to Sydney 
also allows for industry, business and residents to connect with metropolitan economic and employment 
opportunities.[2] Table 3.1 shows the age and sociodemographic distribution of the local government areas 
of the study region.  





Table 3.1a: Age distribution of the Local Government Areas of the Illawarra-Shoalhaven region, based on 2011 ABS census estimates. 
Local Govt. Areas Population Age distribution of the population 
 Total Density* 0-4 years 5-14  years 15-24 years 25 – 44 years 45 – 64 years 65 – 74 years  ≥ 75 years 
   n % n % n % n % n % n % n % 
Wollongong 201215 769.6 12494 6.2 24040 11.9 29414 14.6 52990 26.3 49926 24.8 16516 8.2 15835 7.9 
Kiama 20832 80.8 1076 5.2 2540 12.2 2565 12.3 4215 20.2 6253 30.0 2181 10.5 2002 9.6 
Shellharbour  66054 448.2 4453 6.7 9415 14.3 9120 13.8 16912 25.6 16840 25.5 5276 8.0 4038 6.1 
Shoalhaven  96043 89.1 5409 5.6 11460 11.9 10741 11.2 19278 20.1 27241 28.4 11864 12.4 10050 10.5 
Total 384144 67.6 23432 6.1 47455 12.4 51840 13.5 93395 24.3 100260 26.1 35837 9.3 31925 8.3 














* - persons/km2; ** -weighted average scores of the census collection districts; IRSD - Index of relative socio economic disadvantage; 
 NESB - Non-English speaking background; SEIFA - Socioeconomic indices for Areas. 
Local Govt. Areas Population Sociodemographic distribution 
 Total Density* Indigenous NESB Labour force Unemployment SEIFA Score 
   n % n % n % n % IRSD** 
Wollongong 201215 769.6 4229 2.2 27478 14.3 9168 57.9 1093 6.9 980 
Kiama 20832 80.8 285 1.4 906 4.5 1181 59.0 76 3.8 1055 
Shellharbour  66054 448.2 1930 3.0 6029 9.5 2390 59.2 299 7.4 962 
Shoalhaven  96043 89.1 4318 5.2 4484 4.8 5854 58.3 839 8.4 951 
Total 384144 67.6 10762 2.8 38897 10.1 18594 58.3 2307 7.2  
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Statistical Area level 1 (SA1) was used as the geographic unit of analysis in this research, which was the smallest 
geographic unit for the release of Australia census data in 2011.[3] The study region consisted of a total of 980 
conterminous SA1s, with populations approximately between 200 and 800 people (400 averages). Figure 3.2 
shows the map of the study area with SA1 units and the major landmarks of the region. As the SA1s are also 
based on their population size, the very small and crowded SA1s, similar to the areas shown the inset map, 
indicate densely populated SA1s. 
 
Figure 3.2: Map of the Illawarra-Shoalhaven region of NSW Australia 
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3.3 Data source and variables 
Five main data sources were used in this thesis: 
1.  Literature search databases:  MEDLINE (Ovid), PubMed, Scopus, and Web of Science; 
2. Southern IML Research (SIMLR) data;  
3. Australian census of population and housing 2011 data [4]; 
4. Australian Statistical Geography Standard (ASGS) reference data 2011[3]; and 
5. Primary care provider data 2016. 
The details of the study data sources, their location, access and the variables extracted for the analyses are 
detailed in the following. 
3.3.1 Literature search databases 
The systematic review of the existing literature on the geographic and area-level socioeconomic variation in 
CMRFs was undertaken using four databases. They are: MEDLINE (Ovid); PubMed; Scopus; and Web of 
science databases. These databases were chosen for the review, considering the breadth of fields they cover and 
the interdisciplinary nature of the review question. In addition, hand-searching of related articles was also 
undertaken from the retrieved articles. More details on these databases, the search strategy and the number of 
studies retrieved were presented in Chapter 2 of this thesis. 
3.3.2 Southern IML Research (SIMLR) data  
The de-identified, internally linked and geocoded routine pathology data of the Southern IML Pathology Pty 
Ltd, known as the Southern IML Research (SIMLR) data, was the primary data source for the study. Southern 
IML Pathology Pty Ltd. is the largest provider of pathology services in the Illawarra-Shoalhaven region; 
consisting of over 60 licensed collection centres across multiple geographic locations in the study region. The 
individual-level data in SIMLR database are geocoded to their corresponding SA1 areas, but not to their 
residential address, for privacy and confidentiality concerns. More detail on the procurement of SIMLR data is 
beyond the scope of the current thesis, but available in published literature elsewhere.[5, 6] Appendix IV details 
the data specification of the extracted variables and documentation of the data extraction program used. 
The SIMLR data are stored and maintained in the Spatial Analysis Laboratories, within the School of Earth and 
Environmental Sciences of the University of Wollongong. Southern IML Pathology has granted the University 
of Wollongong a non-exclusive royalty free license to access and use these data for research purposes, provided 
the investigators pass through a two-tier approval system and adhere with the data access agreements. 
Data access  
Access to the SIMLR data is strictly controlled through a two-tier structure consisting of the Southern IML 
Research Cohort Management Committee (SIMLR-CMC) and approval through an appropriately constituted 
Human Research Ethics Committee (HREC).  Data access were granted for a defined period as specified in the 
ethics approval, and renewed after the annual progress reporting to the HREC. The studies within this thesis 
were all approved by the University of Wollongong  and Illawarra and Shoalhaven Local Health District Health 
and Medical Human Research Ethics Committee (HREC protocol No: 2017/124). The initial approval was 
obtained in April 2017, and annually renewed thereafter until the completion of thesis related analyses in 2020. 
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Data extraction  
Data were obtained from the SIMLR database for all non-pregnant persons aged ≥18 years with ≥1 
cardiometabolic analyte result between 01 January 2012 and 31 December 2017. For each person, only the most 
recent cardiometabolic test result was extracted to maximise their temporal alignment with the residential 
location at the time of pathology testing. 
Extracted Variables  
1. Unique person identifier 
The unique person identifier is a 7 digit numeric variable that is project specific and cannot be linked back to 
the individual or service provider. 
2. Sex 
The sex of individual clients as recorded at their most recent test result. Southern IML Pathology Pty Ltd have 
indicated that this value is considered the most accurate record of the gender status of their individual clients. 
3. Cardiometabolic analytes 
The extract includes the following cardiometabolic analyte variables:  
a. Fasting blood sugar levels (FBSL); 
b. Glycated haemoglobin (HbA1c); 
c. High density lipoprotein (HDL); 
d. Total (TC) cholesterol; 
e. Albumin creatinine ratio (ACR);  
f. estimated Glomerular Filtration Rate (eGFR); and 
g. Body mass index (BMI).  
For each of these analytes the following related variables were provided:  
a. collection date;  
b. age group at time of collection;  
c. test value in standard units;  
d. geocoding match status for residential address at time of collection;  
e. geocoded Statistical Area 1 (SA1) of residential address at time of collection;  
f. 2011 Index of Relative Socioeconomic Advantage/Disadvantage for geocoded SA1 at time of collection;  
g. 2011 Index of Relative Socioeconomic Disadvantage for geocoded SA1 at time of collection;  
h. 2011 Index of Economic Resources for geocoded SA1 at time of collection;  
i. 2011 Index of Education and Occupation for geocoded SA1 at time of collection; and 
j. Diabetes status 
The SMILR study uses an algorithm to identify the diabetes status of the individuals included in the database.  
Diabetes is indicated when HbA1c is ≥ 6.5%; or FBSL is ≥ 7.0 mmol/l within +/- 24 months of an HbA1c < 
6.5%. This algorithm is consistent with the diagnostic guidelines published by the Royal Australian College of 
General Practitioners (RACGP) and Diabetes Australia[7]; and methods from the National Health Survey of the 
Australian Bureau of Statistics (ABS)[8].  
The diabetes case definition status was set to “Yes” for patients the first time the algorithm criterion was met; 
and then propagated throughout the data set for subsequent testing records in the SIMLR data. Thus, the 
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extracted study data set included both prevalent (diabetes detected before the data period, i.e. 01 January 2012) 
and incident (diabetes detected within the data period, i.e. between 01 January 2012 and 31 December 2017) 
cases of diabetes mellitus.  
3.3.3 Australian Census of Population and Housing data, 2011 
2011 Australian Census of Population and Housing data as released by the Australian Bureau of Statistics (ABS) 
were accessed for this study. The publicly available data cubes pertaining to the population data in the study 
region were accessed from the ABS website and matched to the SA1s within the study region.[4] This data is 
mainly used to derive the population denominators of the total adult (>=18 years) population of the SA1s in the 
study region. The total adult population were used at different phases of the study for various statistical analyses. 
For example, study 1 had used the total adult population of the SA1s for the Empirical Bayes smoothing of the 
SA1 level proportions of the higher risk CMRF test results; study 3 had used the total population size at SA1 
level to calculate the provider to population ratios.  
3.3.4 Australian Statistical Geography Standard (ASGS) reference data, 2011 
The Australian Statistical Geography Standard (ASGS)  reference data of the year 2011 had been accessed for 
the geographic location specific reference details of the study region.[9] This data were used for building the 
base map and SA1 boundaries of the study region. Also, the IRSD scores of the SA1s in the study region as of 
2011 census had been joined based on the SA1 codes from ASGS reference data. 
3.3.5 Primary care provider data: 2016 
The primary care provider data were manually extracted in 2016, from the contact details of the services listed 
in publicly available directories, and included publicly available data sources such as: Yellow pages; White 
pages; online booking services; and location specific Google search results. The database was constructed to 
temporally align within the CMRF data period (2012 – 2017). The primary care locations within 30 km distance 
of the study boundaries were also included in the list to facilitate buffer distance analyses. Geocoding of the 
primary care locations was performed by converting the service providers’ addresses into geographic coordinates 
(latitude and longitude) using Google Map services.[10] The number of general practitioners practicing in each 
service had been retrieved to calculate the total number of providers. The total number of providers in each SA1 
was used to calculate the provider to population ratios of the SA1s in the study region, which was primarily used 
in study 4 of this thesis.  
3.4 Research design 
The study adopted a cross-sectional design. A cross sectional study is a type of observational study that analyses 
data at a defined period of time.[11] The design seeks to identify associations and within cohort relative risk 
estimates, though not causality.[12] Cross-sectional studies are frequently conducted to estimate the rates and 
associations of the outcome of interest for a given population, commonly for the purposes of public health 
planning.  
3.5 Analyses 
The analyses in this thesis were performed in four stages. Study 1 focused on systematic review and thematic 
synthesis of the literature, which provided strong evidence based foundation for the subsequent stages of the 
study. Study 2 concentrated on geographic and spatial analyses of the CMRF study data across the study region, 
which was descriptive and hypothesis generating for the next stages. Study 3 applied multilevel analyses of 
associations between area-level disadvantage and CMRFs within the study region after adjusting for individual 
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level factors. Study 4 extended the multilevel analyses by analysing the association of area-level primary care 
access with CMRF, after adjusting for individual level factors and area-level disadvantage.  
3.5.1 Study 1 - Geographic and area-level socioeconomic variation in cardiometabolic risk factor 
distribution: a systematic review of the literature 
Study 1 was a systematic literature review and thematic synthesis of the existing literature on the geographic 
and area-level socioeconomic variation of CMRFs.  
Systematic literature review is a methodical approach for appraising literature from a selection of studies that 
focuses on a central research question.[13] The objective was to synthesise results and key findings across 
studies to summarise the best available evidence relevant to the central research question. The systematic review 
of the literature required having transparency, i.e. the methods used to conduct the review were reproducible and 
follow commonly accepted guidelines, such as Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) and the International Prospective Register of Systematic Reviews (PROSPERO) 
guidelines.  
As detailed in chapter 2 of this thesis, a systematic search for relevant previous studies had been undertaken 
within four databases (MEDLINE (Ovid), PubMed, Scopus and Web of Science). All search outcomes were 
limited to:  human studies; adult population (>=18 years); and availability in English language. All retrieved 
studies were screened by two independent reviewers in three stages to reduce the risk of bias. In stage 1, articles 
from all databases were combined and screened to remove duplicates. Titles and abstracts of remaining articles 
were screened for eligibility, in stage 2. The final stage of study selection was done after full text reading of the 
remaining studies. Quality of the individual studies were assessed using the STROBE checklist for cohort, case-
control and cross-sectional studies (www.strobe-statement.org). The second coder repeated all three stages in 
parallel and selected studies were matched at the conclusion of each stage and any differences were resolved by 
consensus and arbitration. Supervisors served as additional reviewers when required. 
Data extraction and coding of the chosen studies were carried out using two pilot-tested templates for 
consistency. Template 1 focused on the geographic variation in CMRFs and was used to extract information on: 
author, year, nation, study design, sample size and characteristics, geographic unit of reporting, studied CMRFs 
and the study outcome. Template 2 addressed the association of area-level socioeconomic disadvantage (ASED) 
and cardiometabolic risk distribution and extracted additional data on the reported measures of ASED and 
associations. An additional template was used for thematic mapping of the data from the included studies for 
further qualitative syntheses. Study origin, representation, nature of problem, ecological context and evidence 
strength were the mapped themes. The finalised templates are reported as tables in the published article based 
on study 1 (Chapter 2: Tables 2.1, 2.2 and 2.3). 
Summary measures used in this review were descriptive and based on the frequency of relevant studies to its 
relevant denominator. Endnote software was used to keep track of the bibliographic details of the studies 
throughout the selection and data extraction process. 
3.5.2 Study 2 – Geographic variation in cardiometabolic risk distribution: A cross-sectional study of 256, 
525 adult residents in the Illawarra-Shoalhaven region of the NSW, Australia 
Study 2 aimed to quantify the small-area geographic variation in the distribution of cardiometabolic risk factors 
within the Illawarra-Shoalhaven region of NSW, Australia.  
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The study 2 variables included de-identified laboratory data on eight CMRFs including fasting blood sugar level 
(FBSL); glycated haemoglobin (HbA1c); total cholesterol (TC); high density lipoprotein (HDL); albumin 
creatinine ratio (ACR); estimated glomerular filtration rate (eGFR); body mass index (BMI); and diabetes 
mellitus (DM) status of the adult residents in the study region. The CMRF test results were dichotomised into 
‘higher risk’ and ‘lower risk’ values based on existing risk definitions. The risk definition values (as reported in 
chapter 4, Table 4.1) are as follows: 
Table 3.2: Cardiometabolic risk value definitions. 
 ‘Higher risk’ 
CMRFs 
Value definition Adopted from 
1 High FBSL FBSL ≥7.0 mmol/l RACGP guidelines.[7]  
2 High HbA1c HbA1c > 7.5% RACGP guidelines.[7]  
3 High TC TC ≥ 5.5 mmol/l Australian Health Survey.[8]  
4 Low HDL HDL < 1 mmol/l National heart foundation of Australia.[14] 
5 High ACR ACR ≥ 30 mcg/L to mg/l Kidney Health Australia.[15] 
6 Low eGFR eGFR < 60 mL/min/1.73m2 Kidney Health Australia.[15] 
7 High BMI  BMI ≥ 30(Obese) World Health Organization (WHO).[16] 
8 DM Status +ve DM test algorithm  RACGP guidelines[7], and Australian  
Health Survey[8].  
 
Within-cohort proportion of ‘higher risk’ CMRF findings are calculated using the total number of tests within 
each SA1 as the denominator. The exception were DM cases, which uses an algorithm within the SIMLR 
database to identify DM cases. The DM cases identified prior to the study data period (year 2012 to 2017), were 
forward propagated into the study data extract labelled as ‘existing’ cases. Thus the study data include both the 
‘existing’ and ‘new’ (identified within the study data period) cases of DM. This is likely to include most DM 
cases from the study area, considering the duration and population coverage of the pathology network in the 
study region from which the study data is sourced. Therefore SA1 adult populations aged 18 years and over 
were used as the denominators (accessed from ABS census 2011 data) of SA1’s DM cases. In the year 2011,  
the NSW Health Statistics reported a prevalence of  9.5% DM (95% CI: 7.6 – 11.4) in 16 years or older from 
the Illawarra-Shoalhaven Local health district[17], which stands close to the study 2  identified 9.2% DM in the  
18 years or older study cohort[1].  
Australian Census Statistical Area Level 1 (SA1) was used as the geographic units of analysis. An Empirical 
Bayes (EB) approach was used to smooth all the CMRFs’ raw rates to minimise extreme values arising from 
small sample sizes in SA1s. The EBest function in R was used to calculate the raw and Empirical Bayes 
smoothed proportions, using a ‘binomial’ family option as the higher risk events in the data were not rare.[18] 
The EB smoothed rates were then imported into GIS software for mapping and spatial statistical analyses. 
Choropleth maps demonstrating the distribution of CMRF rates at SA1 level were produced.   
Spatial clustering of CMRFs was assessed using Global Moran’s I test and Local Indicators of Spatial 
Autocorrelation (LISA). Global Moran’s I test was used to identify spatial autocorrelation of CMRFs at a 0.05 
level of significance. Global Moran’s I tests if the geographic distribution of rates is clustered, dispersed or 
random.[19] The global Moran’s I also indicate the general strength of spatial autocorrelation in the study area, 
which theoretically ranges between -1 to +1. Values of I significantly above -1/ (N-1) indicate positive spatial 
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autocorrelation, where N is the number of spatial units indexed.[20] When significant spatial autocorrelation 
was detected, Local Indicator of Spatial Autocorrelation (LISA) spatial statistics were used to identify any 
clustering of CMRFs.[[21] LISA was used to indicate spatial clustering of High-High (HH) or Low-Low (LL) 
CMRFs rates at SA1-level within the study region. HH refers to a statistically significant (0.05 level) cluster of 
high values (HH) and LL refers to a statistical significant cluster of low values (LL). False Discovery Rate (FDR) 
corrections were applied to LISA tests to correct p-values for multiple testing. 
The main strength of this geospatial analytical approach was its ability to visually present area-level data, 
potentially rendering the data more accessible than traditional table and graph methods.[22] Usage of the 
smallest available area-level unit in the maps further enhanced the area-level specificity of the maps.[23] 
However, this approach was not without limitations. Spatial analyses are not free of ecological problems such 
as ecological fallacies and Modifiable Areal Unit Problem or (MAUP).[35] As ecological analyses, they focus 
on geographical variation only.[23] As these approaches were exclusively based on the analysis of area-level 
variance, a question considered was when to consider this area variance as large or important.[24] As statistical 
significance alone was not considered as a satisfying criterion, multilevel models of the individual CMRFs were 
planned for subsequent stages of the study.[25]  
3.5.3 Study 3 – Geographic variation in the distribution of cardiometabolic risk factors explained by area-
level disadvantage in the Illawarra-Shoalhaven region of the NSW, Australia  
Study 3 aimed to quantify the proportion of small-area geographic variation in CMRFs explained by area-level 
socioeconomic disadvantage in the study region.  
The study 3 variables included de-identified laboratory data on seven CMRFs including fasting blood sugar 
level (FBSL); glycated haemoglobin (HbA1c); total cholesterol (TC); high density lipoprotein (HDL); albumin 
creatinine ratio (ACR); estimated glomerular filtration rate (eGFR); and body mass index (BMI) of the adult 
residents in the study region. The diabetes mellitus (DM) status of the individuals were not included in study 3 
and 4 analyses as the covariate information of their denominator population were not available within study 
data. This is because the DM status in the study data set alone is synthesized from other variables (hba1c and 
FBSL results) in the SIMLR source system and included both ‘existing’ (prevalent) and ‘new’ (incident) cases, 
which is likely to include all the cases from the study region and hence the actual population of the study region 
was determined to be their appropriate denominator. However, it wasn’t possible to link the covariate data of 
the denominators to the DM cases in the study data. Hence, DM status codes were excluded from study 3 
analyses onwards. 
To achieve this aim, area-level analyses of the data were undertaken using multilevel logistic regression models. 
Multilevel models or hierarchical models are generally used for data nested in multiple levels.[25] While the 
units of analyses were individuals at level 1, contextual or area-level variables were analysed at level 2. 
Multilevel logistic regression analysis is proposed for studying data with a binary response and multilevel 
nesting.[21] Such analyses identify group-level associations between specific contextual level variables and 
individual health adjusting for area-level clustering.[26] They also have the ability to partition within-area effects 
from the between-area effects.[27] The 2011 ABS census based Index of Relative Socioeconomic Disadvantage 
(IRSD) expressed in quintiles was used as the study variables. The IRSD summarises a range of measures of 
relative socioeconomic disadvantage of people and households within SA1s and includes: level of income; 
education; employment; family structure; disability; housing; transportation; and internet connection.[26] Study 
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3 Analyses used IRSD reported as quintiles at SA1 level; the lowest quintile (Q1) indicating the most 
disadvantaged SA1s and the highest quintile (Q5) the least disadvantaged SA1s.[25] 
Multilevel logistic regression models of the CMRFs data adjusted for individual-level age group and sex.  
The general equations of the fully adjusted model are: 
𝑦𝑖𝑗~𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(1, 𝜋𝑖𝑗)                                                                                        (3.1) 
𝑙𝑜𝑔𝑖𝑡(𝜋𝑖𝑗) = 𝛽0 + 𝛽1𝑎𝑔𝑒𝑖𝑗 + 𝛽2𝑠𝑒𝑥𝑖𝑗 + 𝛽3𝐼𝑅𝑆𝐷𝑖𝑗 + 𝑢𝑗                                  (3.2) 
𝑢𝑗~𝑁(0, 𝜏
2
𝑢)                                                                                                      (3.3) 
where: 𝑦𝑖𝑗denote the binary response of  CMRF test outcome (as ‘higher risk’ or ‘lower risk’, based on the 
adopted definitions)  for individual i  in the area (SA1) j;  𝜋𝑖𝑗  denotes the probability that individual i in area 
(SA1) j has a ‘higher risk’ CMRF test outcome given their individual-level 𝑎𝑔𝑒𝑖𝑗and 𝑠𝑒𝑥𝑖𝑗;  and their area-level 
IRSD index 𝐼𝑅𝑆𝐷𝑖𝑗 .   𝛽1, 𝛽2, 𝛽3 are the regression coefficients which measure the associations between the log-
odds of the CMRF outcome and each covariate all else equal, and when exponentiated these are translated to 
ORs.[25] 𝑢𝑗is the random effect for the area (SA1) j and 𝜏
2
𝑢 is the area level variance, which has to be estimated. 
For each of the seven CMRFs analysed in this study, a hierarchy of four multilevel models at SA1 level were fit 
that included fixed effects for age, sex and IRSD and random effect (intercept) for SA1.  Thus, a total of 28 
logistic regression models were built to quantify the proportion of small-area geographic variation in CMRFs 
explained by the area level socioeconomic status in the study region. Model 1s (M1s) were null models; Model 
2s (M2s) included the individual-level covariates (age and sex); Model 3s (M3s) included the area-level study 
variable (IRSD) only; and Model 4s (M4s) included both individual- and area-level variables (age sex and 
IRSD). The estimated regression coefficients of the derived models were exponentiated to calculate odds ratios 
(ORs) of the variables. The goodness of fit of the models were identified using Likelihood Ratio Tests at p < 
0.05 level of significance. Figure 3.3 provides a schematic representation of the models pattern used in study 3. 
 
Figure 3.3: Schematic representation of the modelling patterns adopted in study 3 
Model comparison 
The Akaike Information Criterion (AIC) was used to evaluate model fit. The derived models were compared 
for: area level variance (τ2)  at SA1 level; proportional change in variance (PCV); Intra-cluster Correlation 
Coefficients (ICC); and Median Odds Ratios (MORs).  
The area-level variances (τ2 s) were initially identified from each model. PCVs were calculated for models M2 
to M4 relative to M1. The ICCs of the fitted models were calculated using the latent variable approach.[28] This 
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approach assumes that a latent continuous outcome underlies the observed dichotomous outcomes and it is this 
latent outcome for which the ICC is calculated and interpreted. The ICC measured the expected correlation in 
CMRF outcomes between two individuals from the same SA1. The higher the ICC, the more relevant area-level 
context is for understanding individual latent outcome variation.[25] The MOR is calculated as an alternative 
way of interpreting the magnitude of area-level variance. The MOR translated the area-level variance which 
were estimated on the log-odds scale to the commonly used OR scale. The MOR result value is interpreted as 
the median increased odds of identifying the outcome if an individual move to another SA1 with higher risk. 
Thus, higher the MOR the greater the general area-level effect.[25] The unique contribution of the area-level 
study variable (IRSD) to the area-level variance of ‘higher risk’ CMRFs were assessed through the PCVs 
between M2s and M4s.  
3.5.4 Study 4 - Does access to primary care reduce the geographic variation of cardiometabolic  risk factor 
distribution? A multilevel analysis of the adult residents in the Illawarra-Shoalhaven region of Australia  
Study 4 aimed to investigate area-level associations between access to primary care and various CMRFs, after 
adjusting for area-level disadvantage. To achieve this, study 4 analyses were done in two steps. Step 1 aimed to 
quantify the area-level access to primary care services in the study region, and step 2 analysed the area-level 
associations between access to primary care and various CMRFs, after adjusting for area-level disadvantage. 
Therefore, the analytical approaches adopted in this study are detailed under two sections as study 4a and study 
4b as follows. 
Study 4a – Deriving the primary care access index of the study region 
Study 4a aimed to quantify the area-level primary care access of the study region. To achieve this aim, the two-
step floating catchment area (2SFCA) method was used to derive an access index for each SA1 in the study 
region.  
The 2SFCA method was created by Luo and Wang in 2003 to measure geographic accessibility of health care 
services.[29] Essentially, the 2SFCA method consists of two steps underpinned by gravity models.[29] The first 
step analysed the availability of primary care providers within 1 km, 16 km and 30 km distance of the geographic 
centroid of SA1s in the study region, to quantify the supply of services to the SA1. The 30 km buffer distance 
was observed to provide a better coverage of the population, and thus adopted for the further analyses. The total 
number of general practitioners (GPs) in the service provider locations within each SA1s had been the 
numerators for the provider to population ratio calculations. The second step considered the total population 
within 30 km of a primary care provider to determine the demand for services. Therefore, this gravity models 
considered the interaction between the supply and the demand of primary care in the study area.  
Thus, step 1:  
 ,                 (3.4) 
where Sj is the number of general practitioners at location j, pi is the number of adult residents in the SA1s 
(Those SA1’s geographic centroids are located within the spatial buffer distance of the primary care locations) 
and Rj is the population-to-provider ratio for service j.[30] 
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 In step 2, a population-to-provider ratio (access score) is computed for each geographic centroid of the SA1s  
by aggregating all primary care service population-to provider ratios of the primary care services that are located 
within the same spatial buffer distance.[30] 
Thus, step 2: 
 ,                      (3.5) 
where Ai is the access index for population location i. 
The resulting access indices had been retained as a continuous variable for the analyses. A higher score indicated 
better geographic access of the populations of SA1s to primary care services, which in practice is defined as an 
improved supply of primary care service locations, in balance with the population size of the small areas within 
the study region. 
Study 4b – Multilevel analysis of the association between CMRFs and area-level access to primary care  
Study 4b aimed to investigate area-level associations between access to primary care and various CMRFs, after 
adjusting for area-level disadvantage. To achieve this, multilevel logistic regression models were fit after 
adjusting for individual and area-level variables. The access index previously derived study was used as the 
study variable and the IRSD scores of the SA1s were used as measures of area-level disadvantage.  
Multilevel logistic regression models were fit for the CMRF test data of individuals (Level 1) nested within 
SA1s (Level 2).  For each of the seven CMRFs analysed in this study, a hierarchy of five multilevel models were 
fit.  The models included fixed effects for sex, age, IRSD score and access index; and random effect (intercept) 
for SA1s. Thus, a total of 35 models were fit to achieve the study objectives. Model 1s (M1s) were null models; 
Model 2s (M2s) included the area-level study variable (access index) only; Model 3s (M3s) included individual-
level covariates (age and sex) only; Model 4s (M4s) included both individual (age and sex) and area-level (IRSD 
score of the SA1s) covariates; and the final models (M5s) included the primary care access index of SA1s, 
adjusting for the individual (age and sex) and area- level (IRSD scores of SA1s) covariates. The goodness of fit 
of the models was estimated through Likelihood Ratio Tests at p < 0.05 level of significance. Figure 3.4 provides 
a schematic representation of the models pattern used in study 4. 
 





Model 1 (M1) : CMRFs ~ 1,   Null model 
Model 2 (M2) : CMRFs ~ Access index Access only model 
Model 3(M3) : CMRFs ~ Age + Sex ,  Adjusted individual-level attributes 
Model 4 (M4): CMRFs ~ Age + Sex + IRSD scores Adjusted individual and area-level 
attributes, 
Model 5 (M5): CMRFs ~ Age + Sex + IRSD score + Access index FINAL MODEL 
Included primary care access, after adjusting for individual and area-level attributes 
 




Model fit was compared using the Akaike Information Criterion (AIC). The models were also evaluated for: 
area-level variance (τ2); proportional change in variance (PCV) in comparison with the null model; Intra-cluster 
Correlation Coefficient (ICC) of the model; and the Median Odds Ratios (MORs). The ICC and MOR of the 
models were used to index the between-area variability. A latent variable approach was used to derive the ICC 
of models.[28] The MOR translates the area-level variance into an easily interpretable OR and is assumed to be 
statistically independent of the test specific distribution of the CMRFs.[31] The unique contribution of the 
primary care access of the SA1s to the area-level variance of CMRF was estimated through the reduction in 
PCV between M4 and M5. 
3.6 Analytical software  
All spatial analyses and mapping were performed using ArcGIS version 10.4.1(ESRI Inc. Redlands, CA, 
USA).[32] Statistical analyses and multilevel models were performed using R version 3.4.4. (R Foundation for 
Statistical Computing, Vienna, Austria).[33] R is a language and environment for statistical computing and 
graphics.[34] R has multiple packages to meet a range of multilevel analytical requirements, for example: Linear 
mixed-effects models using S4 classes (lme4)[35]; Linear Mixed-Effects Models with Censored Responses 
(lmec)[36]; Multilevel Functions (multilevel)[37]; hierarchical generalised linear models (hglm)[38]; 
Generalised Linear Mixed Models and Spatial Models with BUGS (glmmBUGS)[39]; MCMC Generalised 
Linear Mixed Models (MCMCglmm)[40]; Linear and Nonlinear Mixed Effects Models (nlme)[41]; and Mixed 
models for discrete data in R (glmmADMB)[42]. [43, 44] The multi-level models were fit using the glmer 
function in the lme4 package in R; [35] and the likelihood ratio tests were calculated using the lrtest function in 
the lmtest package in R.[45] 
3.7 Ethics committee approval 
The study was approved by the University of Wollongong (UOW) and Illawarra and Shoalhaven Local Health 
District (ISLHD) Human Research Ethics Committee (HREC 2017/124). The ethics committee determined 
informed consent was not required because individual-level data were non-identifiable. 
3.8 Time line 
The study had been initiated in Jan 2016 and extended over 4 years until Feb 2020. Figure 3.5 provides a 
schematic representation of the approximate time line required to complete this thesis. 
 
 Jan  Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec 
2016 Registration of 
PhD 







2017 Study 1:  Systematic review of the literature 
(continual and ongoing…) 
Study 2:   Geographic and spatial analyses of CMRFs Annual 
holiday 
2018 Study 3: Multilevel analyses of area-level 
disadvantage & CMRFs 
Study 4a: Geospatial analysis of the primary care access of 
the study region 
Annual 
holiday 
2019 Study 4b: Multilevel analyses of area-level access & CMRFs, after adjusting 
for area-level disadvantage 
Chapter writing and submission of the 
thesis for examination. 
2020 Thesis examination Thesis revision and 
final examination 
 
*HDRC – Higher degree research committee, UOW 
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Figure 3.5 Schematic representation of the thesis time line 
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Chapter 4: Geographic Variation in Cardiometabolic Risk 
Distribution: A Cross-sectional Study of 256, 525 Adult Residents in 
the Illawarra-Shoalhaven Region of the NSW, Australia  
4.1 Publication profile 
This chapter presents the substantive content of research published in: PLOS ONE, on 1st  October 2019. 
Parts of the methods and findings from this study were also presented in two abstract reviewed conferences, 
WONCA World Rural Health Conference (New Delhi, 2018) and Public Health Association of Australia 
(PHAA) Public Health Prevention Conference (Sydney, 2018). 
 
Journal article 
Toms R, Mayne DJ, Feng X, Bonney A. Geographic variation in cardiometabolic risk distribution: A 
cross-sectional study of 256, 525 adult residents in the Illawarra-Shoalhaven region of the NSW, Australia. 
PLOS ONE, 2019.  14(10): e0223179.  
Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0223179   
DOI: https://doi.org/10.1371/journal.pone.0223179   
 
Published version of the article 
The published version of the article is appended within the ‘Supplementary Materials’ section of the 
thesis as Supplementary Material 2. 
 
Peer reviewed conference abstracts 
1. World Rural Health Conference -2018 (Oral presentation) 
Toms, R., Bonney, A., Mayne, D. J. & Feng, X. Geographic variance in distribution of cardiometabolic 
risk factors in the Illawarra-Shoalhaven region of the NSW, Australia. 15th WONCA World Rural 
Health Conference, 2018. New Delhi, India. (pp.1-11).  
Available from: https://scholars.uow.edu.au/display/publication130220    
2. Public Health Association of Australia (PHAA) – 2018 (Poster presentation) 
Toms, R., Bonney, A., Mayne, D. J., &Feng, X.  Geographic distribution of cardiometabolic risk factors: 
a small area level approach. (Poster presentation) Public Health Prevention Conference – 2018, Public 
Health Association of Australia (PHAA), 4-5 May 2018. Sydney, Australia.  Available from:  












Introduction: Metabolic risk factors for cardiovascular disease (CVD) warrant significant public health 
concern globally. This study aims to utilise the regional database of a major laboratory network to describe 
the geographic distribution pattern of eight different cardiometabolic risk factors (CMRFs), which in turn 
can potentially generate hypothesis for future research into locality specific preventive approaches. 
Method: A cross-sectional design utilising de-identified laboratory data on eight CMRFs including fasting 
blood sugar level (FBSL); glycated haemoglobin (HbA1c); total cholesterol (TC); high density lipoprotein 
(HDL); albumin creatinine ratio (ACR); estimated glomerular filtration rate (eGFR); body mass index 
(BMI); and diabetes mellitus (DM) status was used to undertake descriptive and spatial analyses.  CMRFs 
test results were dichotomised into ‘higher risk’ and ‘lower risk’ values based on existing risk definitions. 
Australian Census Statistical Area Level 1 (SA1) were used as the geographic units of analysis and an 
Empirical Bayes (EB) approach was used to smooth rates at SA1 level. Choropleth maps demonstrating 
the distribution of CMRFs rates at SA1 level were produced. Spatial clustering of CMRFs was assessed 
using Global Moran’s I test and Local Indicators of Spatial Autocorrelation (LISA).  
Results: A total of 1, 132, 016 test data derived from 256, 525 individuals revealed significant geographic 
variation in the distribution of ‘higher risk' CMRFs findings. The populated eastern seaboard of the study 
region demonstrated the highest rates of CMRFs.  Global Moran’s I values were significant and positive 
at SA1 level for all CMRFs. The highest spatial autocorrelation strength was found among obesity rates 
(0.328) and the lowest for albuminuria (0.028). LISA tests identified significant High-High (HH) and Low-
Low (LL) spatial clusters of CMRFs, with LL predominantly in the less populated northern, central and 
southern regions of the study area.  
Conclusion: The study describes a range of CMRFs with different distributions in the study region. The 
results allow generation of hypotheses to test in future research concerning location specific population 
health approaches.  
















Uncontrolled cardiometabolic risk factors (CMRFs) such as hyperglycaemia, dyslipidaemia, albuminuria, 
inadequate glomerular filtration, overweight and/or obesity and diabetes can predispose and heighten the 
risk for cardiovascular disease (CVD).[1-6] Cardiovascular diseases are the leading cause of death 
worldwide and the highest absorber of health care expenditure in many developed nations, including 
Australia.[7-9] 
In Australia, CVDs remain the single leading cause of death; the largest health problem; and a major 
economic burden.[10, 11] Nine in 10 adult Australians have at least one CVD risk factor and one in four 
have three or more risk factors.[10] CVD kills one Australian every 12 minutes and one in six Australians 
(3.7 million people) are thought to be at risk.[12] In addition, the prevalence of CVD is projected to steeply 
increase in the coming decades.[10] A deceleration in the rapid growth of this major health care issue is 
possible only through the prevention and control of CMRFs. The role of CMRFs in the population, over 
and above individual level factors such as age, are being questioned in regard to discriminatory accuracy 
for development of  CVD,[13] however identification of one or more CMRFs in a person at any age can 
initiate preventive lifestyle changes which may have significant benefits.[14-18] Similarly, identification 
of areas with higher rates of CMRFs can potentially trigger further area-level analyses investigating the 
potential for targeted health service commissioning.[19-21] 
Advances in Geographic Information System (GIS) over the last quarter of a century have provided various 
tools to integrate epidemiological and geographical data.[22-24] Geocoding of risk parameters became 
feasible with such tools for its area-level analyses, which has facilitated area-level mapping of risk 
parameters, which has the potential to generate hypothesis for regional health care research.[23] Thus 
integrating risk parameters through GIS has the potential to facilitate area-level health research,[25-28] 
however, not without potential pitfalls.[29-31] A limitation of GIS-based mapping is that its outputs may 
be misleading, especially if maps are not smoothed using appropriate spatial or multilevel analyses.[32-34] 
However, it is well recognised in the literature that area level community interventions based on GIS 
approaches have been successful in a number of countries. [19-21, 35, 36] 
There has been a significant increase in the number of epidemiological studies using spatial analytical 
methods in the last decade, including international studies reporting significant geographic variation in 
CMRFs at different spatial scales of measurements.[37-45] Hyperglycaemia was the most commonly 
reported CMRF displaying variation, followed by dyslipidaemia, overweight and/or obesity and inadequate 
glomerular filtration.[38] Multiple risk factors were rarely analysed in these studies, though most CMRFs 
are interrelated and often coexist.[46] In this study, we aim to demonstrate the feasibility of utilising 
laboratory based routine test data to generate basic distribution maps of eight different CMRFs in regional 
New South Wales (NSW), Australia. The research questions we address are: (1) what is the geographic 
distribution pattern of CMRFs in the study area; and (2) is there any significant spatial clustering of CMRFs 
rates? The research sought to identify area-level patterns in the distribution of CMRFs that could be used 
to generate hypotheses for future research with the goal of improving health service commissioning in the 
study region.  




The study adopted a cross-sectional design and was approved by the University of Wollongong (UOW) 
and Illawarra and Shoalhaven Local Health District (ISLHD) Human Research Ethics Committee (HREC 
2017/124).  
Setting 
The study was undertaken in the Illawarra-Shoalhaven region (ISR) of the NSW, Australia. The ISR region 
stretches from the immediate south of the metropolitan boarders of Sydney and extends along the south-
eastern coastal belt of NSW - bordering Pacific Ocean in the east and the coastal escarpment of the Southern 
Tablelands in the West. This region encompasses multiple cities, towns and rural areas and includes the 
four local government areas of Wollongong, Shellharbour, Kiama and Shoalhaven.  Overall, the ISR covers 
a land area of 5615 square kilometres and had an estimated residential population of 369, 469 persons at 
the 2011 Australian Census of Population and Housing, of which 285, 385 (77.24%) were adults (>=18 
years).[47] De-identified data for this study were obtained from the Southern IML Research (SIMLR) 
Study, a large-scale community-derived cohort of internally-linked and geographically referenced 
pathology data collected in routine practice by the largest pathology provider servicing the study area. More 
details on this data source, its access and maintenance are published elsewhere.[48]  
Statistical Area level 1 (SA1) was used as the geographic unit of analysis in this study, which was the 
smallest geographic unit for the release of Census data in 2011.[49] SA1s generally have a population of 
200 to 800 persons (400 averages) and the ISR includes a total of 980 conterminous SA1s. Figure 4.1 shows 
the study area with SA1 units and the major landmarks of the region. Very small and crowded SA1s similar 
to the areas shown the inset map tend to be more densely populated. Figure 4.2 illustrates distribution of 
the adult population per SA1 in the study region. 




Figure 4.1 Map of the Illawarra-Shoalhaven region of NSW Australia showing SA1 areas and major 
landmarks. 
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Participants and Variables 
The CMRFs test data of the adult residents of ISR between 1 Jan 2012 - 31 Dec 2017 (6 years) were 
extracted for analyses from the SIMLR database.  Test data were extracted for eight CMRFs: fasting blood 
sugar level (FBSL); glycated haemoglobin (HbA1c); total cholesterol (TC); high density lipoprotein 
(HDL); albumin creatinine ratio (ACR); estimated glomerular filtration rate (eGFR); body mass index 
(BMI) and diabetes mellitus (DM) status. The SIMLR database uses an algorithm to identify DM status 
based on diagnosis guidelines published by the Royal Australian College of General Practitioners 
(RACGP) and Diabetes Australia and methods from the National Health Survey of the Australian Bureau 
of Statistics (ABS).[50, 51] The algorithm identifies DM for HbA1c ≥ 6.5% or FBSL ≥ 7.0 mmol/l within 
+/- 24 months of HbA1c < 6.5%.  The study data included both prevalent and incident DM cases. 
Study data included only the most recent CMRF test result for each individual.  We excluded extreme 
BMI values <12 and >80 based on cut-off points reported by Cheng (2016), Li (2009) and Littman 
(2012).[52-54] Table 4.1 lists the CMRFs value definitions adopted in this study and their source 
references.   
Table 4.1 Cardiometabolic risk value definitions 
 CMRFs Value definition Adopted from 
1 High FBSL FBSL ≥7.0 mmol/l RACGP guidelines.[50]  
2 High HbA1c HbA1c > 7.5% RACGP guidelines.[50]  
3 High TC TC ≥ 5.5 mmol/l Australian Health Survey.[51]  
4 Low HDL HDL < 1 mmol/l National heart foundation of Australia.[55]  
5 High ACR ACR ≥ 30 mcg/L to mg/l Kidney Health Australia.[56]  
6 Low eGFR eGFR < 60 mL/min/1.73m2 Kidney Health Australia.[57]  
7 High BMI  BMI ≥ 30(Obese) World Health Organization (WHO).[58]  
8 DM Status +ve DM test algorithm  RACGP guidelines [50];  and Australian  
Health Survey.[51] 
 
Statistical and spatial analyses 
First, individual-level descriptive analyses of CMRFs were performed. The total number of each CMRFs 
tests and summary statistics of each tests’ results are reported. The summary values for eGFR test results 
are calculated using the approach for grouped data as eGFR test result values are truncated at >90 in the 
SIMLR Study data. Test results were dichotomised into ‘higher risk’ and ‘lower risk’ categories based on 
the CMRFs definitions in Table 4.1.  
Second, area-level analyses of CMRFs were undertaken. Within-cohort proportion of ‘higher risk’ CMRFs 
findings are calculated using the total number of tests within each SA1 as the denominator. The exception 
were DM cases, which are likely to include most prevalent cases in the study area, so SA1 adult populations 
aged 18 years and over were used as the denominators (accessed from ABS census 2011 data).  Thereafter, 
an Empirical Bayes (EB) approach was used to smooth all the CMRF’s raw rates to minimise extreme 
values arising from small sample sizes. The EB smoothed rates were then imported into GIS software for 
mapping and spatial statistical analyses.   
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As individuals with CMRFs are assumed randomly distributed within the study area, the geographic 
distribution of CMRFs is assumed spatially independent in this study. Global Moran’s I test was used to 
identify spatial autocorrelation of CMRFs at a 0.05 level of significance. Global Moran's I tests if the 
geographic distribution of rates is clustered, dispersed or random based.[59] The global Moran’s I also 
indicate the general strength of spatial autocorrelation in the study area, which theoretically ranges between 
-1 to +1. Values of I significantly above -1/(N-1) indicate positive spatial autocorrelation, where N is the 
number of spatial units indexed.[60] When significant spatial autocorrelation was detected, Local Indicator 
of Spatial Autocorrelation (LISA) spatial statistics were used to identify any clustering of CMRFs.[61] 
LISA was used to indicate spatial clustering of High-High (HH) or Low-Low (LL) CMRFs rates at SA1-
level within the study region. False Discovery Rate (FDR) corrections were applied to LISA tests to correct 
p-values for multiple testing.  
All descriptive statistics and EB smoothing were performed using R version 3.4.4. (R Foundation for 
Statistical Computing, Vienna, Austria).[62] The EBest function [63] for the ‘binomial’ family from the 
spdep package [64] in R is used for EB smoothing of the SA1’s raw rates. Mapping and spatial analyses 
were performed using ArcGIS version 10.4.1(ESRI Inc. Redlands, CA, USA).[65] 
4.5 Results  
The study sample comprised 1, 132, 016 test results contributed by 256, 525 adult individuals residing in 
the study region. Of the 256, 525 individuals, 193, 679 (75.5%) had FBSL, 73, 885 (28.8%) had HbA1, 
194, 816 (75.9%) had TC, 182, 237 had HDL (71.0%), 50, 790 had ACR (19.8%), 244, 166 had eGFR 
(95.2%) and 192, 443 had BMI (75.0%) test results. It was estimated 23, 704 (9.2%) of persons met the 
clinical criteria for diabetes. Table 4.2 provides the summary statistics of CMRFs test results. Table 4.3 
presents the summary statistics of the total CMRF tests across the SA1s in the study region. Table 4.4 
outlines the descriptive statistics of the individual CMRF tests across the SA1s in the study region. 
Table 4.2 Summary statistics of CMRFs test results 
CMRFs Tests Mean SD Min 1st Qu Median 3rd Qu Max 
FBSL  193679 5.6 1.6 0.7 4.9 5.3 5.8 43.9 
HbA1c 73885 6.0 1.3 2.6 5.3 5.6 6.4 17.8 
TC 194816 5.0 1.1 1.1 4.2 4.9 5.7 39.4 
HDL 182237  1.5 1.2 0.1 0.5 1.4 1.8 5.8 
ACR 50790 7.4 40.3 0.1 0.4 0.8 2.3 1291.5 
eGFR 244166 75.8 13.8 2.0       - 83.2        - >90.0 
BMI 192443 28.4 6.1 12.0  24.1 27.5 31.6 78.1  
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Table 4.4 Summary statistics of the individual CMRF tests across the SA1s in the study region. 
 
 
The CMRFs test result values were dichotomised into ‘higher risk’ and ‘lower risk’ categories based on 
the CMRFs definitions in Table 4.1. The proportion of individuals with ‘higher risk’ CMRFs findings 
varied considerably between tests.  The largest ‘higher risk’ proportions were found for BMI (33.74%) and 
TC (32.55%) and the lowest for ACR (4.03%).  Table 4.5 provides details on the CMRFs test results 
classification and the identified proportions. 
Table 4.5 Frequency and proportion of ‘higher risk’ results of CMRFs tests 
Cardiometabolic risk  Classificatio
n  
Tests n (%)* 
FBSL   193679 (100) 
FBSL ≥7.0 mmol/L Higher risk   16280(8.4) 
FBG < 7.0 mmol/L Lower risk  177399(91.6) 
HbA1c  73885(100) 
HbA1c > 7.5% Higher risk  7927(10.7) 
HbA1c ≤ 7.5% Lower risk  65958(89.3) 
TC  194816(100) 
TC ≥ 5.5 mmol/L Higher risk  63422(32.5) 
TC < 5.5 mmol/L Lower risk  131394(67.5) 
HDL  182237 (100) 
HDL < 1 mmol/l Higher risk  21261(11.7) 
HDL ≥ 1 mmol/l Lower risk  160976(88.3) 
ACR  50790(100) 
ACR ≥30  mcg/L to mg/L Higher risk 2047 (4.1)   
ACR <30 mcg/L to mg/L Lower risk  48743(95.9)  
eGFR  244166(100) 
eGFR < 60 mL/min/1.73m2 Higher risk 27241(11.2)     
eGFR20 ≥ 60 mL/min/1.73m2 Lower risk  216925(88.8) 
BMI  192455(100) 
BMI  ≥ 30 (Obesity) Higher risk  64832(33.7) 
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Geographic distribution of cardiometabolic risk Factors 
Figure 4.3 shows the geographic distribution of CMRFs at SA1-level in the ISR region with red indicating 
the highest and blue the lowest rates of risk. SA1s with no test data appear in white. Areas with higher rates 
of CMRFs were found to be clustering within the study region. The highest rates were found mainly along 
the populated eastern board of the study region; notably among SA1s around Lake Illawarra, south-east of 
Berry’s bay and east of Lake Burill.  However, the high TC rates showed a reversed pattern and higher 
rates were found in the relatively less populated central and westerly aspects of the study area.  HDL rates 
did not follow this reversed pattern. 




Figure 4.3: Geographic distribution of the proportion of CMRFs within the Illawarra Shoalhaven region of the NSW Australia. 
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Spatial Autocorrelation of CMRFs 
The global Moran’s I tests were significant and positive for all CMRFs (Table 4.6). The highest spatial 
autocorrelation strength was found among obesity rates (0.328), followed by high FBSL (0.184) and low HDL 
(0.174). The spatial autocorrelation strength was the lowest for albuminuria (0.028) and low eGFR (0.069). 
Table 4.6: Spatial autocorrelation (Moran’s I) of CMRFs 
CMRFs Moran's I z-score p-value 
DM 0.097 27.952 <0.0001 
Obesity 0.328 92.086 <0.0001 
High FBSL 0.184 51.539 <0.0001 
High HbA1c 0.101 28.030 <0.0001 
High TC 0.146 41.154 <0.0001 
Low HDL 0.174 48.733 <0.0001 
Albuminuria 0.028 8.096 <0.0001 
Low eGFR 0.069 19.699 <0.0001 
 
LISA tests identified significant spatial clustering of CMRFs in the ISR region. The HH clusters were found 
mainly along the populated areas of the study region, except for TC. Areas around the immediate surroundings 
of Lake Illawarra had the most HH clusters, followed by the areas to the south-west of Berry’s Bay and south of 
Jervis Bay. A few areas around Lake Burrill had HH clusters of DM, TC and eGFR.  The LL clusters were mainly 
around the less populated north, central and south ends of the study area, except for TC. The TC clusters 
demonstrated a reverse pattern in comparison with all other CMRFs, where HH clusters were mainly around the 
less populated central and southern ends of the ISR and a few instances in the north-eastern end of the study area. 
LL clusters of TC were found around the immediate surroundings of Lake Illawarra.  Figure 4.4 illustrates the 
spatial clustering of CMRFs in the study area. 




Figure 4.4:  Local Moran’s I cluster maps showing high-high and low-low spatial associations of CMRFs within the Illawarra Shoalhaven region of the NSW  
Australia.




Place has always been a key element in human health and epidemiology. In the present study, we explored the 
geographic distribution of eight CMRFs in 980 SA1s in a regional area of NSW, Australia. The study is a first of 
its kind known to us in providing a comprehensive small-area-level profile of a wide range of CMRFs and 
provides an example of using population-derived routine laboratory data for area-level research.  
Higher rates and clustering of CMRFs were mostly observed along the more densely populated eastern coast line 
of the study region. Also, some areas were common for multiple risk factors as their distribution pattern 
frequently converged in these areas, for example areas around Lake Illawarra, South of Jervis bay etc. However, 
not all populated areas were involved in this pattern and some less populated areas also had higher rates of risk. 
Spatial analyses revealed significant spatial autocorrelation for all eight CMRFs. Patterns of clustering were 
different for each CMRF at the small-area scale used in this study, which provides directions for future research 
using multilevel analytic methods.[66] 
The distribution of high TC values were generally reversed to those distributions of other CMRFs described in 
this study. The reason for this observation is yet to be explored, but a possible treatment effect is suspected as 
the lower risk areas were often densely populated areas. It is possible that the people residing in these areas have 
better access to health care services and more frequently prescribed anti-cholesterol drugs.[67, 68] However, not 
all densely populated areas were involved in this ‘higher risk’ TC distribution pattern and further research is 
required. 
The current study adds to the limited studies from Oceania reporting on geographic variation of CMRFs and the 
first from regional Australia. Previous studies from Australia have reported geographic variation of 42% in the 
odds of being diagnosed with DM among adults living in Sydney.[37] Another study reported geographic 
variation in glycated haemoglobin (HbA1c) values across 767 Census Collection Districts (CDs) in Adelaide.[44] 
The study builds on previous research by investigating the distribution of a wide range of CMRFs, which appears 
to be rare in the literature.   
This study must be considered within its limitations. First, the cross-sectional design of the study precludes causal 
inference. Second, the descriptive analyses performed in this study indicate only significant variations in the 
geographic distribution of CMRFs, but do not differentiate the individual and/or area-level attributes which might 
be contributing to this variation.[13] Third, the maps include areas with no test data.  Fourth, the study data were 
obtained from people attending health care services; therefore its point-estimates may not be representative of 
the general population. Fifth, we cannot exclude the possibility that a higher proportion of positive tests in an 
area could be due to greater access to pathology services; however exploring this possibility was beyond the 
scope of the current study. 
Future research is required to understand the reasons for the geographic variation reported in this paper. The 
findings reported in this study suggest hypotheses that will be further explored using appropriate 
multilevel/hierarchical analyses to differentiate and quantify the individual and area-level contributions to this 
variation.[66, 69-71] Such hierarchical analyses will have the potential to inform development of appropriate 
area-level health care service policy initiatives. It is important to differentiate the contributions of individual 
(e.g. age, sex, etc.) and area-level (e.g. socioeconomic disadvantage, access or proximity to health care services, 
etc) attributes to the different patterns of clustering to inform targeted area-level preventive interventions and 
future health service commissioning decisions to these areas. 




In conclusion, area-level descriptive analyses of CMRFs have the potential to highlight inequalities in the 
geographic distribution of CMRFs. Regional planning for the prevention and management of CMRFs requires 
information about its epidemiology within specific communities or areas. Centralised approaches of disease 
prevention and management may not suit regional requirements as the disease pattern in regional areas may differ 
to those in metropolitan areas and cities. Area specific evidence through regional health care research is important 
to inform health care service commissioning for area specific decisions and policy developments. This paper 
demonstrates an initial step in such regional health care research and a feasible method using population data 
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Chapter 5: Geographic Variation in Cardiometabolic Risk Factor Distribution 
Explained by Area-level Disadvantage in the Illawarra-Shoalhaven Region of the 
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5.1 Publication profile 
This chapter presents the substantive content of research submitted for publication in the journal Nature -
Scientific Reports. Parts of the methods and findings from this study were also presented in a national level 
conference held in Australia.  
 
Journal article 
Toms, R., Mayne, D. J., Feng, X., & Bonney, A. (2020). Geographic variation in cardiometabolic risk 
factor prevalence explained by area-level disadvantage in the Illawarra-Shoalhaven region of the NSW, 
Australia. Nature - Scientific Reports, 10(1), 1-18. 
Available from: https://www.nature.com/articles/s41598-020-69552-4     
DOI: https://doi.org/10.1038/s41598-020-69552-4  
 
Published version of the article 
The published version of the article is appended within the ‘Supplementary Materials’ section of the 
thesis as Supplementary Material 3. 
 
Peer reviewed abstracts 
National Health and Medical Research Council (NHMRC) Symposium  
Toms, R., Bonney, A., Mayne, D. J., &Feng, X. (2019) Area-level socioeconomic disadvantage and 
cardiometabolic risk distribution: an analysis of 256, 565 adult residents in the Illawarra- Shoalhaven region 
of the NSW Australia. (Poster presentation) 8th Annual NHMRC Symposium on Research Translation 
National Health and Medical Research Council 19 - 20 November 2019, Melbourne, Australia. 















Cardiometabolic risk factors (CMRFs) demonstrate significant geographic variation in their distribution. 
The study aims to quantify the general contextual effect of the areas on CMRFs; and the geographic 
variation explained by area-level socioeconomic disadvantage. A cross sectional design and multilevel 
logistic regression methods were adopted. Data included objectively measured routine pathology test data 
between years 2012 and 2017 on: fasting blood sugar level; glycated haemoglobin; total cholesterol; high 
density lipoprotein; urinary albumin creatinine ratio; estimated glomerular filtration rate; and body mass 
index. The 2011 Australian census based Index of Relative Socioeconomic Disadvantage (IRSD) were the 
area-level study variables, analysed at its smallest geographic unit of reporting. A total of 1,132,029 CMRF 
test results from 256,525 individuals were analysed. After adjusting for individual-level covariates, all 
CMRFs significantly associated with IRSD and the probability of higher risk CMRFs increases with greater 
area-level disadvantage. Though the specific contribution of IRSD in the geographic variation of CMRF 
ranged between 57.8 and 14.71%, the general contextual effect of areas were found minimal (ICCs 0.6–
3.4%). The results support universal interventions proportional to the need and disadvantage level of 
populations for the prevention and control of CMRFs, rather than any area specific interventions as the 
contextual effects were found minimal in the study region. 
Key words: cardiometabolic risk factor; area-level disadvantage; multilevel logistic regression models; 

























The distribution of cardiometabolic risk factors (CMRFs) varies geographically.[1, 2] Previous research 
has reported higher prevalence and clustering of CMRFs in certain localities: typically in areas of higher 
socioeconomic disadvantage.[3-23] Quantifying the geographic variation in CMRFs contributed by area-
level socioeconomic disadvantage can aid in designing appropriate area-level preventive approaches for 
CMRFs. Chronic and uncontrolled CMRFs predispose individuals to the development of cardiovascular 
disease (CVD), which continues to be the leading cause of health care expenditure and premature mortality 
worldwide.[24] 
In Australia, a social gradient is observed in the distribution of many chronic conditions including various 
CMRFs (e.g. diabetes and chronic kidney disease).[25] Generally, Australians enjoy better health than 
people in many other countries in the world. However, within Australia this better health is not equally 
distributed.[26] It is well-recognised that socioeconomically disadvantaged individuals in Australia, on 
average, experience a greater disease burden than their less disadvantaged counterparts.[25-28]This 
tendency is also evident at a contextual level when studies have investigated association of CMRFs with 
area-level socioeconomic disadvantage in Australia[4, 17] and globally[5, 6, 8, 10, 11, 14-16, 19, 22, 29-
33]. 
Consistent with this, men from highly urbanised environments have been reported to have higher incidence 
of coronary heart disease with increasing residential area socioeconomic disadvantage, after adjusting for 
individual characteristics.[16]Also, lower area-level disadvantage has been reported as being associated 
with lower rates of behavioural cardiac risk factors such as smoking, physical inactivity and obesity in 
some studies.[10, 11, 34] Most of the reported associations of CMRFs with area-level socioeconomic 
disadvantage were independent of individual-level characteristics such as age and educational attainment. 
Even though the area-level associations of CMRFs were significant in these studies, the results were often 
dependent on the CMRF analysed, the measures of area-level socioeconomic disadvantage and the 
geographic scale at which associations were examined.[35] 
Multilevel analyses of CMRFs based on the average measures of association or variation alone are 
insufficient to report the geographical variance as similar associations were possible with very different 
scenarios of area variance.[36] Multilevel findings extending on the general contextual effects and 
reporting the proportion of the total area-level variance along with the measures of clustering and the 
average measures of association or variation are appropriate and informative in reporting area-level 
influences, but less common.[20, 36-38] To differentiate the relative importance of individual versus area-
level interventions for the prevention and control of CMRFs, the geographical component of the total 
individual risk variance has to be identified in a multilevel approach. 
Therefore, the aims of this study are to (1) quantify the general contextual or geographic effect of areas 
on CMRFs, over and above their individual-level compositions; and to (2) quantify the geographic 
variation across multiple CMRFs specifically explained by area-level socioeconomic disadvantage, within 
the Illawarra-Shoalhaven region of NSW Australia. Quantification of the general contextual effect and the 
variation specifically explained by area-level socioeconomic disadvantage will assist our understanding 
of the socioeconomic context of CMRFs in the study region and provide guidance for health service 
commissioning more generally nationally. 




A cross-sectional multilevel design was adopted to account for the hierarchical nature of the data and 
analyses.  Informed consent was not obtained for the individual-level data used in this study, as the study 
used existing data which were already de-identified. The study was approved by the University of 
Wollongong  and Illawarra and Shoalhaven Local Health District  Health and Medical Human Research 
Ethics Committee (HREC protocol No: 2017/124). All the methods and analyses were performed meeting 
the relevent ethical guidelines and regulations of the committee.  
5.4.1 Study area and data 
The study was conducted in the Illawarra-Shoalhaven region of the New South Wales (NSW) state in 
Australia. The Illawarra-Shoalhaven region is geographically a coastal plain along the south-east of NSW; 
situated at the immediate south of the metropolitan boundaries of Sydney; and encompasses multiple 
regional cities, towns and rural areas. This region covers a land area of 5, 615 km2, and had an estimated 
residential population of 369, 469 at the time of the 2011 Australian Census of Population and Housing 
conducted by the Australian Bureau of Statistics (ABS).[39] Statistical Area level 1 (SA1), the smallest 
geographical unit of the 2011 census data release, was the area-level unit of analysis in this study.[40]SA1s 
typically have a population size of 200 to 800 persons (average 400), and the Illawarra-Shoalhaven region 
covers a total of 980 conterminous SA1s.[40] 
The Illawarra-Shoalhaven has a diverse socio-economic profile, making it a useful region for area-level 
population health studies.[41] The population profile of the Illawarra-Shoalhaven region is culturally and 
linguistically diverse, with a significant proportion of non-English speaking people (10.5%) residing in 
this region who have migrated from overseas. [42]  In addition, at the 2011 Census the region is identified 
to have more than the NSW state and Australian national averages of: 1) Aboriginal and/or Torres Strait 
Islander peoples (3% versus   2.5% NSW and  2.5% Australia);   2) aged (>=65 years) population (17.6% 
versus 14.5% NSW and  13.8% Australia) ; 3) single-parent households (5.8% versus 5.3% NSW and  
5.2% Australia); and 4) unemployment (7.1% versus 5.1% NSW and  5.1% Australia) and lower labour 
force participation rate (57.9% versus 64.6% NSW and 66.2% Australia).[42] ABS 2011 census data 
indicate that more than 31 % of people in the Illawarra-Shoalhaven reside in Inner Regional areas, and 
9.1% of households within this region did not have a motor vehicle.[42] The Illawarra-Shoalhaven 
geography and a limited public transport system, especially in isolated communities, make it difficult for 
many people to access health services quickly.[42]  These characteristics of the study region directly 
indicate the vulnerability of its population to poorer health outcomes. 
The CMRF test data in this study were extracted from the Southern IML Research (SIMLR) Study 
database, which is comprised of de-identified and internally linked pathology results from a major network 
of pathology services in the study region. The individual-level data in SIMLR database are geocoded to 
their corresponding SA1 areas, but not to their residential address, for privacy and confidentiality concerns. 
More details on this data source, procurement and access are published elsewhere.[17] The CMRF test 
data were extracted for non-pregnant individuals aged 18 years or older presenting for testing between 01 
January 2012 and December 2017. Only the most recent test result was included if an individual had 
undergone the same test multiple times in this data period. Test data with missing details on the individual 
and area-level factors analysed in this study were excluded from the analyses. 





Results of the CMRF tests were the individual-level outcome variables. Data on the seven CMRF tests 
analysed in this study included: fasting blood sugar level (FBSL); glycated haemoglobin (HbA1c); total 
cholesterol (TC); high density lipoprotein (HDL); urinary albumin creatinine ratio (ACR); estimated 
glomerular filtration rate (eGFR); and objectively-measured body mass index (BMI). These CMRF test 
results were dichotomised into higher risk and lower risk values based on the current national and 
international guidelines on risk definitions (Table 5.1). 
Table 5.1: Definitions of CMRFs test results 
 ‘Higher risk’ CMRFs Definition  
1. High FBSL FBSL ≥ 7.0 mmol/l.[43] 
2. High HbA1c HbA1c > 7.5%.[43] 
3. High TC TC ≥  5.5 mmol/l.[44] 
4. Low HDL HDL < 1 mmol/l.[45] 
5. High ACR ACR ≥ 30 mcg/L to mg/l.[46] 
6. Low eGFR eGFR < 60 mL/min/1.73m2.[46] 
7. Obesity BMI ≥ 30 kg/m2.[47] 
CMRFs -  Cardiometabolic risk factors; FBSL - Fasting Blood Sugar Level; HbA1c - Glycated Haemoglobin; TC - Total 
Cholesterol; HDL - High Density Lipoprotein; ACR - Albumin Creatinine Ratio; eGFR - estimated Glomerular Filtration Rate; 
BMI - Body Mass Index.  
Study variable 
The 2011 ABS census based Index of Relative Socioeconomic Disadvantage (IRSD) of the SA1s was the 
study variable. IRSD summarises a range of measures of relative socioeconomic disadvantage of people 
and households within SA1s and includes: level of income; education; employment; family structure; 
disability; housing; transportation; and internet connection.[48] This study uses IRSD reported as 
quintiles; the lowest quintile (Q1) indicating the most disadvantaged SA1s and the highest quintile (Q5) 
the least disadvantaged SA1s.[48] The IRSD quintiles in the study were derived by ABS from the 
distribution of IRSD scores for the Illawarra-Shoalhaven region based on the 2011 census. The study 
region has a diverse IRSD profile with representation across IRSD scores in comparison with Australia as 
a whole, making the region useful for population-level studies.[41]  
Covariates 
Analyses were adjusted for sex (male and female) and age group (18–29y, 30–39y, 40–49y, 50–59y, 60–
69y, 70–79y, 80+ years) of each individual at the time of the pathology collection of the CMRFs tests 
analysed in this study. 
5.4.3 Statistical analyses 
Initially, descriptive statistics of all individual and area-level variables were performed. Thereafter, single 
level and multilevel logistic regression models were fitted for the CMRF test data of individuals (Level 
1), nested within SA1s (Level 2). For each of the seven CMRFs analysed in this study, a hierarchy of four 
multilevel models at SA1 level were fit that included fixed effects for age, sex and IRSD and random effect 
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(intercept) for SA1. Model 0 was a single level model adjusted for age and sex; Model 1 (M1) was null 
model at level 2; Model 2 (M2) adjusted for age and sex at level 2; Model 3 (M3) adjusted for the area-
level study variable (IRSD) only at level 2; and the final model Model 4 (M4) included both M2 and M3 
covariates (age, sex and IRSD) at level 2. The estimated regression coefficients of the derived models were 
exponentiated to calculate odds ratios (ORs). The goodness of fit of the models were identified using 
Likelihood Ratio Tests (LRT) at p < 0.05 level of significance.  The general equation of the fully adjusted 
model is: 
𝑦𝑖𝑗~𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(1, 𝜋𝑖𝑗)                                                                                       (5.1) 
𝑙𝑜𝑔𝑖𝑡(𝜋𝑖𝑗) = 𝛽0 + 𝛽1𝑎𝑔𝑒𝑖𝑗 + 𝛽2𝑠𝑒𝑥𝑖𝑗 + 𝛽3𝐼𝑅𝑆𝐷𝑖𝑗 + 𝑢𝑗                                 (5.2) 
𝑢𝑗~𝑁(0, 𝜏
2
𝑢),                                                                                                   (5.3) 
where: 𝑦𝑖𝑗denote the binary response of  CMRF test outcome (as ‘higher risk’ or ‘lower risk’, based on 
the adopted definitions)  for individual i  in the area (SA1) j;  𝜋𝑖𝑗  denotes the probability that individual i 
in area (SA1) j has a ‘higher risk’ CMRF test outcome given their individual-level 𝑎𝑔𝑒𝑖𝑗and 𝑠𝑒𝑥𝑖𝑗;  and 
their area-level IRSD index 𝐼𝑅𝑆𝐷𝑖𝑗 . 𝛽1, 𝛽2, 𝛽3  are the regression coefficients which measure the 
associations between the log-odds of the CMRF outcome and each covariate all else being equal, and when 
exponentiated these are translated to ORs.[36] 𝑢𝑗is the random effect for the area (SA1) j and 𝜏
2
𝑢 is the 
area level variance, which has to be estimated.  
Model comparison 
The Akaike Information Criterion (AIC) was used to evaluate model fit. The derived models were 
compared for: area level variance (τ2) at SA1 level; proportional change in variance (PCV); Intra-cluster 
Correlation Coefficients (ICC); Median Odds Ratios (MORs); area under the receiver operating 
characteristic (AUC) curve; and the change in AUC. 
The τ2 s was initially identified from each model. PCVs were calculated for models M2 to M4 relative to 
M1. The ICCs of the fitted models were calculated using the latent variable approach.[49] This approach 
assumes that a latent continuous outcome underlies the observed dichotomous outcomes and it is this latent 
outcome for which the ICC is calculated and interpreted. The ICC measured the expected correlation in 
CMRF outcomes between two individuals from the same SA1. The higher the ICC, the more relevant area-
level context is for understanding individual latent outcome variation.[36] The MOR is calculated as an 
alternative way of interpreting the magnitude of area-level variance. The MOR translated the area-level 
variance which were estimated on the log-odds scale to the commonly used OR scale. The MOR result 
value is interpreted as the median increased odds of identifying the outcome if an individual move to 
another SA1 with higher risk. Thus, the higher the MOR the greater the general area-level effect and it 
will equal to 1 in the absence of area-level variance.[36] The general contextual effect of the geographic 
areas over and above their individual-level composition of the higher risk CMRFs, is obtained through the 
measure of clustering (ICC) in M2s. The geographic variance and ICC in the null models (M1s) of higher 
risk CMRFs may depend on both the contextual and individual-level variables. Therefore, M2s of the 
higher risk CMRFs which adjusted for individual-level attributes is better to provide information on the 
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‘general contextual effect’ of the areas. The unique contribution of the area-level study variable (IRSD) to 
the area-level variance of higher risk CMRFs were assessed through the PCVs between M2s and M4s. 
The receiver operating characteristic (ROC) curves are created by plotting the true positive rates (TPR) 
i.e. sensitivity, against the false positive rates (FPR), i.e. 1 specificity for different binary classification 
thresholds of the predicted probabilities in all the models.[50] Post-estimation, predicted probabilities (πij) 
are calculated for each individual and are used to calculate the AUC for the model. The AUCs of the 
models measure the capacity of the models to correctly classify individuals with or without the outcome 
of a higher risk CMRFs analysed in this study, as a function of their predicted probabilities.[36]  The AUC 
values range from 1 and 0.5, where 1 is the perfect predictive discrimination and 0.5 have no predictive 
power.[51] The AUCs also indicate the general contextual effects and can be compared it to the ICC and 
the MOR values.[36]  The added value of knowing an individual’s area of residence besides individual-
level information (age and sex) can be obtained through the AUC change in Model 2 in reference to Model 
0, where a higher AUC change would indicate higher relevance of areas in relation to CMRFs. 
Statistical package 
All analyses were performed using R version 3.4.4. (R Foundation for Statistical Computing, Vienna, 
Austria).[52] Multi-level models were fit using the glmer function in the lme4 package[53]; and likelihood 
ratio tests were calculated using the lrtest function in the lmtest package[54]; and ROC curves using the 
roc function in the pROC package[55]. 
5.5 Results 
A total of 1, 132, 029 CMRFs test data which belong to 256, 525 individuals were extracted for the 
analyses. Figure 5.1 provides a flow chart of the individual tests in CMRF test data. The mean number of 
tests per person was 4.4. After removing 1162 (1.0%) test results data with missing details, a total of 1, 
130, 894 tests were included in the analytic data set.  
 
Figure 5.1: Flow chart of the included/excluded tests in the CMRFs test data. 
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Table 5.2 provides details of the missing data and test data distribution of each CMRF tests. Most 
frequently missing data were the IRSD indices from SA1s in the study area for which an IRSD index was 
not available from ABS 2011 census either due to low populations or poor data quality.[56] 
Table 5.2: Table of excluded test data which had missing details 
 
FBSL HbA1c TC HDL ACR eGFR BMI 
 
Total 
Extracted 193680 73885 194816 182237 50790 244166 192455 1132029 
Missing data:         
Test value 1 0 0 0 0 0 0 1 
Age 1 1 1 1 0 2 1 7 
Sex 0 0 0 0 0 0 0 0 
IRSD 182 78 191 174 53 256 193 1154 
SA1 coding 0 0 0 0 0 0 0 0 
Excluded tests: 

























FBSL - Fasting Blood Sugar Level; HbA1c - Glycated Haemoglobin; TC - Total Cholesterol; HDL - High Density Lipoprotein; 
ACR - Albumin Creatinine Ratio; eGFR - estimated Glomerular Filtration Rate; BMI - Body Mass Index; IRSD – Index of the 
Relative Socioeconomic Disadvantage; SA1- Statistical Area level 1.  
 
Table 5.3 presents the summary statistics of the total CMRF tests across the SA1s in the study region and 
Table 5.4 outlines the descriptive statistics of the individual CMRF tests across the SA1s in the study 
region.  
Table 5.3: Summary statistics of the overall CMRF tests across the SA1s in the study region.  
 
 
Table 5.4: Summary statistics of the individual CMRF tests across the SA1s in the study region. 
 
 
Table 5.5and 5.6 shows the frequencies and relative frequencies of CMRF tests results. Overall, the higher 
risk frequencies of all CMRFs increased with increasing area-level socioeconomic disadvantage, except 
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Table 5.5: Cross-tabulation of individual CMRFs (FBSL, HbA1c, TC and HDL) with the variables in 
study 
























Rates 193496 16259(8.4) 73806 7920(10.73) 194624 57506(29.55) 182062 21238(11.67) 
Sex         
Male 83603 9279(4.8) 35757 4, 444(6.02) 90950 23503(12.0) 85266 15872(8.72) 
Female 109893 6980(3.6) 38049 3, 476(4.71) 103674 34003(17.47) 96796 5366(2.95) 
Age(years)         
18 - 29 19747 238(0.1) 3480 250( 0.34)  14247 2127(1.09) 11435 1377(0.76) 
30 - 39 23515 459(0.2) 4889 293( 0.40)  18960 4889(2.51) 16787 2301(1.26) 
40 - 49 29424 1265(0.65) 8447 760( 1.03)  31395 10719(5.51) 29339 3585(1.97) 
50 - 59 37085 2948(1.52) 13510 1507(2.04)   39663 16316(8.38) 37824 4283(2.35) 
60 - 69 37962 4670(2.41) 17665 2064(2.80)  40471 13620(7.00) 39134 4227(2.32) 
70 - 79 29009 4396(2.27) 15715 1860(2.52)   31186 6748(3.47) 30114 3419(1.88) 
80+ 16754 2283(1.18) 10100 1186(1.61) 18702 3087(1.59) 17429 2046(1.12) 
IRSD         
Most D Q-1 38885 4495(2.32) 17024 2429(3.29) 39347 10631(5.46) 36625 5520(3.03) 
Q-2 41545 3757(1.94) 16680 1875(2.54) 41937 12015(6.17) 39050 4901(2.69) 
Q-3 39828 3386(1.75) 15376 1585(2.15) 40401 12045(6.19) 37794 4201(2.31) 
Q-4 37137 2594(1.34) 13101 1138(1.54) 36865 11163(5.74) 34566 3581(1.97) 
Least D Q-5 36101 2027(1.05) 11625 893(1.21) 36074 11652(5.99) 34027 3035(1.67) 
FBSL - Fasting Blood Sugar Level; HbA1c - Glycated Haemoglobin; TC - Total Cholesterol; HDL - High Density Lipoprotein; 




Table 5.6: Cross-tabulation of individual CMRFs (ACR, eGFR, and Obesity) with the variables in study 
CMRFs ACR eGFR Obesity 
 Total  
tests 
Higher risk* 









results, n (%) 
Rates 50737 2046(4.03) 243908 27205(11.15) 192261 64875(33.7) 
Sex       
Male 25043 1265(2.49) 108140 12441(5.1) 86853 29585(15.3) 
Female 25694 781(1.54) 135768 14764(6.05) 105408 35290(18.3) 
Age (years)       
18 - 29 1546 47(0.09) 32961 72(0.03) 23277 4582(2.38) 
30 - 39 2278 71(0.14) 29047 105(0.04) 22799 6535(3.40) 
40 - 49 4870 108(0.21) 35778 330(0.14) 30401 10595(5.51) 
50 - 59 9272 230(0.45) 42695 1112(0.46) 37285 13825(7.19) 
60 - 69 13388 412(0.81) 43423 3626(1.49) 38370 15310(7.96) 
70 - 79 12337 605(1.19) 34406 8507(3.49) 30074 11324(5.89) 
80+ 7046 573(1.13) 25598 13453(5.52) 10055 2704(1.41) 
IRSD       
Most D Q-1 11915 638(1.26) 49288 7061(2.89) 37476 15365(7.99) 
Q-2 11350 485(0.96) 52947 6354(2.61) 40172 14334(7.46) 
Q-3 10494 391(0.77) 50816 5917(2.43) 39133 13007(6.77) 
Q-4 8732 308(0.61) 46440 4406(1.81) 37370  11766(6.12) 
Least D Q-5 8246 224(0.44) 44417 3467(1.42) 38110  10403(5.41) 
ACR - Albumin Creatinine Ratio; eGFR - estimated Glomerular Filtration Rate; BMI - Body Mass Index; Most D – Most 
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Single and multilevel models for each of the CMRFs analysed in this study are presented in Table 5.7- 
5.13. After adjusting for the covariates, all seven CMRFs were found to be significantly associated with 
area-level IRSD in the study region. For all but one variable the associations were positive (i.e. increased 
with area-level disadvantage). TC was the exception; being inversely associated with area-level 
disadvantage, with the most disadvantaged quintile (Q1) displaying the lowest odds for higher risk test 
results. Among the covariates, there was no significant association between gender and higher risk test 
results of eGFR or BMI. It was also noted that the odds of higher risk eGFR tests results accelerated with 
increasing age group, and the 80+ age group demonstrated a very high odds of being identified with a 
higher risk eGFR tests result in the study region. 
Table 5.7: Single and multilevel logistic regression model summaries for high FBSL (FBSL ≥7.0 mmol/l) 
 
*** - p<0.001; † - Change in Model 2 in relation to Model 0; Model 0— Single level model adjusted for 
age + sex;  Model 1—null model at SA1 level; Model 2—M1 + individual-level:  age + sex; Model 3—
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Table 5.8: Single and multilevel logistic regression model summaries for high HbA1c (HbA1c > 7.5%) 
 
*** - p<0.001; † - Change in Model 2 in relation to Model 0; Model 0— Single level model adjusted for 
age + sex; Model 1—null model at SA1 level; Model 2—Model 1 + individual-level:  age + sex; Model 
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Table 5.9: Single and multilevel logistic regression model summaries for high TC (TC ≥ 5.5 mmol/l) 
 
*** - p<0.001; † - Change in Model 2 in relation to Model 0; Model 0— Single level model adjusted for 
age + sex; Model 1—null model at SA1 level; Model 2—M1 + individual-level:  age + sex; Model 3—
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Table 5.10: Single and multilevel logistic regression model summaries for low HDL (HDL < 1 mmol/l) 
 
*** - p<0.001; † - Change in Model 2 in relation to Model 0; Model 0— Single level model adjusted for 
age + sex; Model 1—null model at SA1 level; Model 2—M1 + individual-level:  age + sex; Model 3—
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Table 5.11: Single and multilevel logistic regression model summaries for high ACR (ACR ≥ 30 mcg/L 
to mg/l) 
 
*** - p<0.001; † - Change in Model 2 in relation to Model 0; Model 0— Single level model adjusted for 
age + sex; Model 1—null model at SA1 level; Model 2—M1 + individual-level:  age + sex; Model 3—
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Table 5.12: Single and multilevel logistic regression model summaries for low eGFR (eGFR < 60 mL / 
min / 1.73m2) 
 
*** - p<0.001; † - Change in Model 2 in relation to Model 0; Model 0— Single level model adjusted for 
age + sex; Model 1—null model at SA1 level; Model 2—M1 + individual-level:  age + sex; Model 3—
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Table 5.13: Single and multilevel logistic regression model summaries for obesity (BMI ≥ 30 kg/m2) 
 
*** - p<0.001; † - Change in Model 2 in relation to Model 0 and the rest in relation to Model 2; Model 
0— Single level model adjusted for age + sex; Model 1— Single level model adjusted for age + sex; 
Model 1—null model at SA1 level; Model 2—M1 + individual-level:  age + sex; Model 3—Model 1+ 
Area level: IRSD quintiles of SA1s; Model 4—Model 1+Model 2 + Model 3. 
The overall comparisons of model random effects are presented in Table 5.14. Reductions in the AIC 
values were observed among all CMRFs from the null model (M1) to the final model (M4) indicating a 
better fit for the final models. In the unadjusted null models, higher risk test results of eGFR demonstrated 
the most area-level variance (0.189) and TC the least (0.026). Adjusting the CMRFs for age and sex 
initially increased the τ^2 of M2 for FBSL (PCV = +1.88%), HbA1c (PCV = +3.02%), HDL (PCV = 
+15.25%) and BMI (PCV = +1.48%). The τ^2   was reduced in the final model among all CMRFs 
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Table 5.14: Summary model fit values and comparison of the models 
 
 FBSL HbA1c TC HDL ACR eGFR Obesity 
Model 1 Null Model 
 AIC 111022.8 50114.5 235931.6 130649.7 17130.0 167164.8 242793.2 
 𝜏2 0.101 0.103 0.026 0.071 0.092 0.189 0.115 
  ICC 
(%) 
3.0 3.0 0.8 2.1 2.7 5.4 3.4 
  MOR 1.35 1.36 1.16 1.29 1.34 1.51 1.38 












𝜏2 0.103 0.106 0.020 0.081 0.073 0.024 0.117 
ICC 
(%) 
3.0 3.1 0.6 2.4 2.2 0.7 3.4 
  MOR 1.36 1.36 1.14 1.31 1.30 1.16 1.39 
  PCV + 1.88 % + 3.02 % - 21.76% +15.25% -20.53% - 87.26% +1.48% 





AIC 110552.5 49875.3  235795.4 130294.3 17053.0 166930.0 242443.7 
𝜏2 0.034 0.047 0.018 0.030 0.044 0.138 0.071 
ICC 
(%) 
1.0 1.4 0.6 0.9 1.3 4.0 2.1 
MOR 1.19 1.23 1.14 1.18 1.22 1.43 1.29 
PCV -66.41% -54.82% -27.81% -58.05% -52.88% -26.84% -38.76% 
Model 4 Sex + Age + IRSD Adjusted Model 
 
 
AIC 102689.6 49453.3 227199.2  122328.3 16527.2  115125.7 
 
238748.4 
 𝜏2 0.044 0.049 0.017 0.034 0.036 0.014 0.069 
  ICC 
(%) 
1.3 1.5 0.5 1.0 1.1 0.4 2.0 
  MOR 1.22 1.24 1.13 1.19 1.20 1.12 1.28 
  PCV -56.33% -51.91% -33.27% -51.37% -61.19% -92.79% -40.30% 
AIC - Akaike Information Criterion; 𝜏2 – variance; ICC - Intra-cluster Correlation Coefficients; MOR - Median Odds Ratio; PCV - 
Proportional Change in Variance; FBSL - Fasting Blood Sugar Level; HbA1c - Glycated Haemoglobin ; TC - Total Cholesterol; 
HDL - High Density Lipoprotein; ACR - Albumin Creatinine Ratio; eGFR - estimated Glomerular Filtration Rate.  
 
The Akaike Information Criterion (AIC) was used to evaluate model fit. The derived multilevel models 
were compared for: area-level variance (𝜏2)  at SA1 (level 2) level; proportional change in variance (PCV); 
Intra-cluster Correlation Coefficients (ICC); Median Odds Ratios (MORs); Area under the receiver 
operating characteristic (AUC) curve; and the change in AUC. 
The ICCs of the unadjusted models ranged between 0.8% in high TC to 5.4% in low eGFR. Inclusion of 
IRSD after adjusting for age and sex had reduced the ICCs of all CMRFs in the final models, which ranged 
between 0.4% in low eGFR to 2.0% in obesity test results. The ICCs of the final models were low and 
suggest very limited area-level contextual effects. The AUC changes in model 2 and MORs of the final 
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Figure 5.2 provides a comparison of the ROC curves of the fitted models. Model 4s (age + sex + IRSD 
adjusted models) and models 3s (IRSD adjusted models) were chosen for the ROC curve plotting for 
comparative purpose. The predicted outcomes in the CMRFs plots are for the reference individual, i.e., 
individuals residing in the least disadvantaged areas (model 3) + female + age group 18–29 years (Model4). 
A model curve closer to the top left corner of the subfigures indicate a better predictive accuracy of the 
model. The single measure summary of the ROC curves, AUCs of the final models ranged 0.62 -0.88. The 
highest AUC value was observed for the final model of low eGFR. The AUC changes of model 2s  in 
relation to M0s ranged 0.01 – 0.08, which reconfirm the contextual findings of ICCs that the general 
contextual effects observed in the models were minimal.  
 
 
Figure 5.2: ROC curves of the fitted models (Model 3s and Model4s) of CMRFs for comparison: (a) 
FBSL Models; (b) HbA1c Models; (c) TC Models; (d) HDL Models; (e) ACR Models; (f) FBSL Models; 
(g) Obesity Models; Model 3s— CMRFs adjusted only for IRSD quintiles of areas; Model 4s—Final 
models of CMRFs adjusted for age + sex + IRSD quintiles of area. 
 
The proportions of the geographic variance in CMRFs contributed by IRSD were estimated through the 
PCV between M2 and M4. Adjusting the models for IRSD and individual-level variables explained a 
maximum 92.79% of the variance expressed by the null model of eGFR, reducing the ICC from 5.4% to 
0.4%. The changes were least among the adjusted models of TC, with a marginal reduction of ICC from 
0.8% to 0.5%. Thus, in the final models, the proportional reduction in variance was the largest for eGFR 
(PCV = 92.79%) and the least for TC (PCV = 33.27%).  
The identified specific contribution of IRSD in the geographic variation of CMRF was the highest among 
the geographic variance of higher risk findings of HDL tests (57.8%), which was closely followed by FBSL 
(57.14%); HbA1c (53.31%); and ACR (51.17%) test results. The contribution of IRSD was comparatively 
lower among the geographic variance of the higher risk findings of eGFR (41.75%); BMI (41.06%); and 
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TC (14.71%) test results, though not the least. Even though these specific proportions are large, it should 
be noted that it actually explained a lot of very little (i.e, variance of 0.01 to 0.07) 
5.6 Discussion 
The study reports on the contextual influence of areas on higher risk CMRFs distribution and quantifies 
the specific proportion of geographic variance explained by IRSD. The work adds to the very few studies 
which consider multiple CMRF variables from the same region, or which are based on population derived 
data over extended years; [6, 15, 22, 29-31]  and reports on both single and multilevel analyses.[38, 57] 
The results present both the measures of association and area-level variance based on  multilevel logistic 
regression analyses.[36] The findings of the study add to the existing evidence and discussion regarding 
the relevance of individual versus area-level interventions for the prevention and control of CMRFs. 
We found consistent evidence for the association between area-level disadvantage and seven CMRFs 
among adult health service using residents of the Illawarra-Shoalhaven region in NSW Australia. In 
adjusted models, the odds of a higher risk finding increased with increase in area-level disadvantage 
among all CMRFs excepting TC, which showed an inverse pattern of association with increase in area-
level disadvantage. Thus, in the final models we observed that, over and above individual age and sex, 
living in a disadvantaged neighbourhood proportionally increased the individual-level probability of being 
identified with a higher risk CMRF. The findings highlight the importance of including of area-level 
variables into health risk analyses.  
The ICCs of CMRFs in all the models were comparatively small in all the models (Table 5.14). In the 
fully adjusted models, the ICCs were further reduced and ranged between 0.4% and 2.0% in low eGFR 
and BMI respectively. As per the interpretation framework proposed by Merlo et al (2019), an ICC value 
less than 10% is indicative of very little geographic difference.[58]However, this has to be interpreted 
along with the traditional geographic comparisons such as the proportion of the individuals who are 
affected with higher risk CMRF outcomes. Therefore, a small geographic difference with uniformly 
higher, medium, or lower proportion of affected individuals indicates homogeneity of the higher risk 
CMRF findings within their geographic units.[58] Such a situation would call for balanced universal 
approaches to prevent and control the higher risk CMRFs, with a proportional focus to the need and 
disadvantage level of affected populations.[59, 60] However, it is also worth noting that when the exposure 
to an agent is homogenic in a community, the traditional epidemiological methods are not very helpful in 
identifying markers of susceptibility.[61] 
Our results confirm, and are comparable with, associations between area-level disadvantage and CMRFs 
reported in previous studies, [3-23, 29-31] and extends their findings. The results primarily confirm the 
geographic variation of CMRFs and associations with area level disadvantage, as reported in previous 
studies. Further, the study provides means to compare the observed associations of a range of CMRFs 
concurrently. The study extends on previous reports by differentiating the individual and area-level 
contributors to the exhibited geographic variance of CMRFs. And most importantly, the specific 
contributions of IRSD on the geographic variance of multiple CMRFs were identified, which is unique in 
the literature and informative for health care service commissioning.     
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The TC test results often stood apart from the major findings of this study, demonstrating inverse 
associations with IRSD. This was in contract to the HDL associations, even though both are components 
of the lipid profile in an individual. This raises the possibility of a medication effect on TC in these areas, 
where the lipid lowering drugs have a less consistent effect in raising HDL than in lowering TC.[62] Other 
factors associated with the higher risk HDL test results may include uncontrolled diabetes[63], 
smoking[64], sedentary life style[65-67], obesity[65],  and poor diet quality[68, 69]. However the reason 
for the inverse association demonstrated by TC test results are not clearly established within the current 
study results and requires further research to explore possible individual and area-level contributions.  
The study has to be considered within its limitations. Primarily, the cross sectional nature of analyses 
adopted in this study do not yield support for any causal relationships. In addition, the non-linear and time 
varying effects of covariates analysed in this study restrict generalisability of their findings. Secondly, the 
IRSD quintiles included as the key explanatory variable represent relative disadvantage in an area and 
have limitations intrinsic to aggregate measures. Thirdly, it should be noted that the data used in this study 
are extracted from people already utilising the health care service facilities in the area. This is likely to 
create an overestimation of the odds ratios in the study findings than if it would have been in the actual 
general population. Fourthly, the readers should be mindful that the variance reported in this study are 
attributable to 1) individual-level factors (age, sex), 2) area-level contextual influences (IRSD), and 3) 
other individual and area-level characteristics not considered in this study. However, further individual-
level data analyses are not possible with this study’s dataset as the de-identification process precludes the 
inclusion of any further individual level data. Other individual and area-level factors not considered in this 
study could include individual-level SES [70], smoking, hypertension, diet, and physical activity; type of 
neighbourhood food outlets [71-74], poor physical activity resources [75-77], and service availability. 
Accounting for these factors might have further reduced the estimates of the relationship between area-
level disadvantage and CMRFs. However it should also be noted that acquisition of additional individual-
level data wasn’t possible with the de-identified study data set; and more importantly, unraveling the 
underlying causative structure of the derived estimates were not the primary intention of this study than 
obtaining age and sex standardised effect of ASED on CMRFs to inform evidence for targeted area-level 
health care service and resource allocation planning.  Finally, the standard multilevel logistic regression 
modelling methods adopted in this study would not be able to account for the autocorrelation of the area-
level residuals (if any) of the models. Expected shortcomings due to this could be an overestimation of 
random effects in our models.[78] However, any such effects are not expected to be substantial in our 
results as the random effect estimates are already quite small. While acknowledging this limitation, we 
believe the effects of this are not critical in our results. Hybrid models which provide more precise 
estimates of random effects are becoming increasingly available with advances in computational 
technologies.[79] However, they would not be directly applicable to our data sets, mainly due to the non-
availability of location specific data at individual-level in our study data. 
Notwithstanding these limitations, the study is unique in that it analysed a range of CMRFs across a widely 
dispersed population and included both rural and urban residents. In addition, the study used six years 
(year 2012 –2017) of CMRF tests data from the region in the hierarchical multilevel analyses. The findings 
of the study indicate that those residing in the most disadvantaged areas are more likely to be identified 
Chapter 6: Access to primary care and CMRFs 
126 
 
with higher risk CMRFs than those in lower disadvantage areas. However, the low ICC and MOR values 
of the area-level models do not provide support for contextual approaches. Rather, the findings of the 
study support a proportionate universalism approach in which health resources are made universally 
available but proportional to the need and disadvantage level of the affected population.[59, 60] 
5.7 Conclusion 
The study demonstrates that in the Illawarra Shoalhaven region of Australia, people residing in 
socioeconomically disadvantaged areas have a higher probability of being identified with higher risk 
CMRFs across a range of factors. The low general contextual effects of the areas suggest for universal 
intervention for the prevention and control of CMRFs in this study region, but proportional to the need 
and disadvantage level. The patterns were consistent across the six CMRFs analysed in this study; and 
comparable with similar studies reported nationally and globally. Based on our findings, we recommend 
further area-level research to discern the role of other contextual factors not analysed in this study 
especially the area-level access to health care services to determine its existing role and adequacy; and 
evidence based universal interventions for the prevention and control of CMRFs but proportionate to the 





























1. Toms, R., et al., Geographic and area-level socioeconomic variation in cardiometabolic risk factor 
distribution: a systematic review of the literature. International journal of health geographics, 2019. 18(1): 
p. 1. 
2. Toms, R., et al., Geographic variation in cardiometabolic risk distribution: A cross-sectional study of 
256,525 adult residents in the Illawarra-Shoalhaven region of the NSW, Australia. PloS one, 2019. 14(10): 
p. e0223179. 
3. Alkerwi, A., et al., Geographic variations in cardiometabolic risk factors in Luxembourg. International 
journal of environmental research and public health, 2017. 14(6): p. 648. 
4. Astell-Burt, T., et al., Understanding geographical inequities in diabetes: multilevel evidence from 114,755 
adults in Sydney, Australia. Diabetes research and clinical practice, 2014. 106(3): p. e68-e73. 
5. Maier, W., et al., Area level deprivation is an independent determinant of prevalent type 2 diabetes and 
obesity at the national level in Germany. Results from the National Telephone Health Interview Surveys 
‘German Health Update’GEDA 2009 and 2010. PloS one, 2014. 9(2). 
6. Roux, A.V.D., D.R. Jacobs, and C.I. Kiefe, Neighborhood characteristics and components of the insulin 
resistance syndrome in young adults: the coronary artery risk development in young adults (CARDIA) 
study. Diabetes care, 2002. 25(11): p. 1976-1982. 
7. Valdés, S., et al., Prevalence of obesity, diabetes and other cardiovascular risk factors in Andalusia 
(southern Spain). Comparison with national prevalence data. The Di@ bet. es study. Revista Española de 
Cardiología (English Edition), 2014. 67(6): p. 442-448. 
8. Andersen, A., et al., Life‐course socio‐economic position, area deprivation and Type 2 diabetes: findings 
from the British Women's Heart and Health Study. Diabetic medicine, 2008. 25(12): p. 1462-1468. 
9. Barker, L.E., et al., Geographic distribution of diagnosed diabetes in the US: a diabetes belt. American 
journal of preventive medicine, 2011. 40(4): p. 434-439. 
10. Cubbin, C., et al., Neighborhood deprivation and cardiovascular disease risk factors: protective and 
harmful effects. Scandinavian journal of public health, 2006: p. 228-237. 
11. Dragano, N., et al., Neighbourhood socioeconomic status and cardiovascular risk factors: a multilevel 
analysis of nine cities in the Czech Republic and Germany. BMC Public Health, 2007. 7(1): p. 255. 
12. Inoue, Y., et al., Neighborhood characteristics and cardiovascular risk among older people in Japan: 
findings from the JAGES project. PloS one, 2016. 11(10). 
13. Lawlor, D., et al., Geographical variation in cardiovascular disease, risk factors, and their control in older 
women: British Women's Heart and Health Study. Journal of Epidemiology & Community Health, 2003. 
57(2): p. 134-140. 
14. Lawlor, D.A., et al., Life-course socioeconomic position, area deprivation, and coronary heart disease: 
findings from the British Women’s Heart and Health Study. American journal of public health, 2005. 95(1): 
p. 91-97. 
15. Naimi, A.I., et al., Associations between area-level unemployment, body mass index, and risk factors for 
cardiovascular disease in an urban area. International journal of environmental research and public health, 
2009. 6(12): p. 3082-3096. 
Chapter 6: Access to primary care and CMRFs 
128 
 
16. Silhol, R., et al., Investigating the spatial variability in incidence of coronary heart disease in the Gazel 
cohort: the impact of area socioeconomic position and mediating role of risk factors. Journal of 
Epidemiology & Community Health, 2011. 65(2): p. 137-143. 
17. Bonney, A., et al., Area-level socioeconomic gradients in overweight and obesity in a community-derived 
cohort of health service users–a cross-sectional study. PloS one, 2015. 10(8). 
18. Congdon, P., Estimating diabetes prevalence by small area in England. Journal of Public Health, 2006. 
28(1): p. 71-81. 
19. Mujahid, M.S., et al., Cross‐sectional and longitudinal associations of BMI with socioeconomic 
characteristics. Obesity research, 2005. 13(8): p. 1412-1421. 
20. Paquet, C., et al., Geographic clustering of cardiometabolic risk factors in metropolitan centres in France 
and Australia. International journal of environmental research and public health, 2016. 13(5): p. 519. 
21. Sundquist, K., et al., Neighborhood walkability, deprivation and incidence of type 2 diabetes: a population-
based study on 512,061 Swedish adults. Health & place, 2015. 31: p. 24-30. 
22. Unger, E., et al., Association of neighborhood characteristics with cardiovascular health in the multi-ethnic 
study of atherosclerosis. Circulation: Cardiovascular Quality and Outcomes, 2014. 7(4): p. 524-531. 
23. Zhou, M., et al., Geographical variation in diabetes prevalence and detection in China: multilevel spatial 
analysis of 98,058 adults. Diabetes care, 2015. 38(1): p. 72-81. 
24. World Health Organisation. The top 10 causes of death 2017  [cited 2017; Available from: 
https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. 
25. Australian Institute of Health and Welfare. Indicators of socioeconomic inequalities in cardiovascular 
disease, diabetes and chronic kidney disease. 2019; Available from: 
https://www.aihw.gov.au/getmedia/01c5bb07-592e-432e-9fba-d242e0f7e27e/aihw-cdk-
12.pdf.aspx?inline=true. 
26. Australian Institute of Health and Welfare. Australian burden of disease study : impact and causes of illness 
and death in Australia 2011. 2016; Available from: https://www.aihw.gov.au/getmedia/d4df9251-c4b6-
452f-a877-8370b6124219/19663.pdf.aspx?inline=true. 
27. Australian Institute of Health and Welfare. Australia’s Health 2014. 2014; Available from: 
https://www.aihw.gov.au/reports/australias-health/australias-health-2014/contents/table-of-contents. 
28. Australian Institute of Health and Welfare. Cardiovascular disease, diabetes and chronic kidney disease: 
Australian facts: morbidity—hospital care. 2017; Available from: https://www.aihw.gov.au/reports/heart-
stroke-vascular-disease/cardiovascular-diabetes-chronic-kidney-morbidity/contents/table-of-contents. 
29. Clark, C.R., et al., Neighborhood disadvantage, neighborhood safety and cardiometabolic risk factors in 
African Americans: biosocial associations in the Jackson Heart study. PloS one, 2013. 8(5). 
30. Gabert, R., et al., Identifying high-risk neighborhoods using electronic medical records: a population-based 
approach for targeting diabetes prevention and treatment interventions. PLoS One, 2016. 11(7). 
31. Keita, A.D., et al., Associations of neighborhood area level deprivation with the metabolic syndrome and 
inflammation among middle-and older-age adults. BMC Public Health, 2014. 14(1): p. 1319. 
32. Laraia, B.A., et al., Place matters: neighborhood deprivation and cardiometabolic risk factors in the 
Diabetes Study of Northern California (DISTANCE). Social science & medicine, 2012. 74(7): p. 1082-1090. 
Chapter 6: Access to primary care and CMRFs 
129 
 
33. Cox, M., et al., Locality deprivation and Type 2 diabetes incidence: a local test of relative inequalities. 
Social science & medicine, 2007. 65(9): p. 1953-1964. 
34. Mobley, L.R., et al., Environment, obesity, and cardiovascular disease risk in low-income women. 
American journal of preventive medicine, 2006. 30(4): p. 327-332. e1. 
35. Riva, M., L. Gauvin, and T.A. Barnett, Toward the next generation of research into small area effects on 
health: a synthesis of multilevel investigations published since July 1998. Journal of Epidemiology & 
Community Health, 2007. 61(10): p. 853-861. 
36. Merlo, J., et al., An original stepwise multilevel logistic regression analysis of discriminatory accuracy: the 
case of neighbourhoods and health. PloS one, 2016. 11(4). 
37. Merlo, J., et al., Diastolic blood pressure and area of residence: multilevel versus ecological analysis of 
social inequity. Journal of Epidemiology & Community Health, 2001. 55(11): p. 791-798. 
38. Merlo, J., et al., Bringing the individual back to small-area variation studies: a multilevel analysis of all-
cause mortality in Andalusia, Spain. Social science & medicine, 2012. 75(8): p. 1477-1487. 
39. Australian Bureau of Statistics. 2011 Census data [cited 2020 Sept 5]; Available from: 
https://www.abs.gov.au/websitedbs/censushome.nsf/home/historicaldata2011?opendocument&navpos=280. 
40. Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS): Volume 1 - Main 
Structure :STATISTICAL AREA LEVEL 1 (SA1). 2016; Available from: 
https://www.abs.gov.au/websitedbs/D3310114.nsf/home/Australian+Statistical+Geography+Standard+(AS
GS). 
41. Ghosh, A., et al., Using data from patient interactions in primary care for population level chronic disease 
surveillance: The Sentinel Practices Data Sourcing (SPDS) project. BMC Public Health, 2014. 14(1): p. 
557. 
42. Ghosh A, M.K., Marshall K. . Illawarra-Shoalhaven Medicare Local - Population Health Profile: 2013. 
2013; Available from: https://www.gph.org.au/assets/Main-Site/Uploads/Resources/Improving-population-
health/ISML-Population-Health-Profile-2013-FINAL.pdf. 
43. The Royal Australian College of General Practitioners & Diabetes Australia. General Practice Management 
of Type 2 Diabetes 2016-2018. . The Royal Australian College of General Practitioners 2016; Available 
from: Doi: 10.1007/s00125-010-2011-6. 
44. Australian Bureau of Statistics. Australian Health Survey: Biomedical Results for Chronic Diseases,2011-
12 . 2013; Available from: https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4364.0.55.0052011-
12. 
45. National heart foundation of Australia. Lipid management profile for health professionals. . Available from: 
https://www.heartfoundation.org.au/for-professionals/clinical-information/lipid-management. 
46. National Kidney foundation(USA). Albumin creatinine Ratio (ACR). 2018; Available from: 
https://www.kidney.org/kidneydisease/siemens_hcp_acr. . 
47. World Health Organization. Obesity : Preventing and managing the global epidemic: Technical Report 
Series. WHO Technical Report Series, no. 894. 2000; Available from: doi:ISBN 92 4 120894 5. 
48. Australian Bureau of Statistics. Main Features - IRSD.; Available from: 
https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/2033.0.55.001main+features100052011. 
Chapter 6: Access to primary care and CMRFs 
130 
 
49. Goldstein, H., W. Browne, and J. Rasbash, Partitioning variation in multilevel models. Understanding 
Statistics: Statistical Issues in Psychology, Education, and the Social Sciences, 2002. 1(4): p. 223-231. 
50. Wagner, P. and J. Merlo, Measures of discriminatory accuracy in multilevel analysis. Eur J Epidemiol, 
2013. 28(1): p. 135. 
51. Pepe, M.S., et al., Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or 
screening marker. American journal of epidemiology, 2004. 159(9): p. 882-890. 
52. R Core Team. R: A language and environment for statistical computing.R Foundation for Statistical 
Computing,Vienna, Austria. 2018; Available from: https://www.R-project.org/. 
53. Bates, D., et al., Fitting linear mixed-effects models using lme4. arXiv preprint arXiv:1406.5823, 2014. 
54. Zeileis, A. and T. Hothorn, Diagnostic checking in regression relationships. R News 2: 7–10. Available at 
(accessed August 2011). http://CRAN. R-project. org/doc/Rnews/(http://CRAN. R-project. 
org/doc/Rnews/), 2002. 
55. Robin, X., et al., pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC 
bioinformatics, 2011. 12(1): p. 1-8. 
56. AUSTRALIAN BUREAU OF STATISTICS. Technical Paper: Socio-Economic Indexes for Areas 
(SEIFA). 2011; Available from: 
https://www.ausstats.abs.gov.au/Ausstats/subscriber.nsf/0/22CEDA8038AF7A0DCA257B3B00116E34/$Fi
le/2033.0.55.001%20seifa%202011%20technical%20paper.pdf. 
57. Merlo, J., et al., Individual and collective bodies: using measures of variance and association in contextual 
epidemiology. Journal of Epidemiology & Community Health, 2009. 63(12): p. 1043-1048. 
58. Merlo, J., P. Wagner, and G. Leckie, A simple multilevel approach for analysing geographical inequalities 
in public health reports: The case of municipality differences in obesity. Health & place, 2019. 58: p. 
102145. 
59. Lu, D. and I. Tyler, Focus on: a proportionate approach to priority populations. Public Health Ontario. 
https://www. publichealthontario. ca/en/eRepository/Focus_On_Priority_Populations. pdf. Accessed, 2016. 
29. 
60. Marmot, M. and R. Bell, Fair society, healthy lives. Public health, 2012. 126: p. S4-S10. 
61. Rose, G., Sick individuals and sick populations. International journal of epidemiology, 2001. 30(3): p. 427-
432. 
62. Barter, P.J., et al., Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis 
of the VOYAGER Database. Journal of lipid research, 2010. 51(6): p. 1546-1553. 
63. Mooradian, A.D., Dyslipidemia in type 2 diabetes mellitus. Nature Reviews Endocrinology, 2009. 5(3): p. 
150-159. 
64. Frei, B., et al., Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein 
properties in human blood plasma. Protective effects of ascorbic acid. Biochemical Journal, 1991. 277(1): 
p. 133-138. 
65. Arai, T., et al., Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism 
for the reduction of serum HDL cholesterol levels in obesity. Arteriosclerosis and thrombosis: a journal of 
vascular biology, 1994. 14(7): p. 1129-1136. 
66. Hu, F.B., Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids, 2003. 38(2): p. 103-108. 
Chapter 6: Access to primary care and CMRFs 
131 
 
67. Thorp, A.A., et al., Deleterious associations of sitting time and television viewing time with cardiometabolic 
risk biomarkers: Australian Diabetes, Obesity and Lifestyle (AusDiab) study 2004–2005. Diabetes care, 
2010. 33(2): p. 327-334. 
68. McNaughton, S.A., et al., Dietary quality is associated with diabetes and cardio-metabolic risk factors. The 
Journal of nutrition, 2009. 139(4): p. 734-742. 
69. Williams, E.D., et al., Health behaviours, socioeconomic status and diabetes incidence: the Australian 
Diabetes Obesity and Lifestyle Study (AusDiab). Diabetologia, 2010. 53(12): p. 2538-2545. 
70. Sodjinou, R., et al., Obesity and cardio-metabolic risk factors in urban adults of Benin: relationship with 
socio-economic status, urbanisation, and lifestyle patterns. BMC public health, 2008. 8(1): p. 84. 
71. Cummins, S. and S. Macintyre, Food environments and obesity—neighbourhood or nation? International 
journal of epidemiology, 2006. 35(1): p. 100-104. 
72. Fraser, L.K., et al., The geography of fast food outlets: a review. International journal of environmental 
research and public health, 2010. 7(5): p. 2290-2308. 
73. Macdonald, L., S. Cummins, and S. Macintyre, Neighbourhood fast food environment and area 
deprivation—substitution or concentration? Appetite, 2007. 49(1): p. 251-254. 
74. Pearce, J., et al., Neighborhood deprivation and access to fast-food retailing: a national study. American 
journal of preventive medicine, 2007. 32(5): p. 375-382. 
75. Buttar, H.S., T. Li, and N. Ravi, Prevention of cardiovascular diseases: Role of exercise, dietary 
interventions, obesity and smoking cessation. Experimental & clinical cardiology, 2005. 10(4): p. 229. 
76. Chomistek, A.K., et al., Healthy lifestyle in the primordial prevention of cardiovascular disease among 
young women. Journal of the American College of Cardiology, 2015. 65(1): p. 43-51. 
77. Fiuza-Luces, C., et al., Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk 
factors. Nature Reviews Cardiology, 2018. 15(12): p. 731-743. 
78. Xu, H., Comparing spatial and multilevel regression models for binary outcomes in neighborhood studies. 
Sociological methodology, 2014. 44(1): p. 229-272. 
79. Chaix, B., J. Merlo, and P. Chauvin, Comparison of a spatial approach with the multilevel approach for 
investigating place effects on health: the example of healthcare utilisation in France. Journal of 














Role of Area-level Access to Primary Care on the Geographic 
Variation of Cardiometabolic Risk Factor Distribution: A 
Multilevel Analysis of the Adult Residents in the Illawarra- 




























Chapter 6: Access to primary care and CMRFs 
133 
 
Chapter 6: Role of Area-level Access to Primary Care on the 
Geographic Variation of Cardiometabolic Risk Factor Distribution: A 
Multilevel Analysis of the Adult Residents in the Illawarra- Shoalhaven 
Region of NSW, Australia 
 
6.1. Publication profile 
This chapter presents the substantive content of research published in the International Journal of 
Environmental Research and Public Health, on 14th June 2020. 
 
Journal article 
Toms, R., Feng, X., Mayne, D. J., & Bonney, A. Role of area-level access to primary care on the 
geographic variation of cardiometabolic risk factor distribution: a multilevel analysis of the adult 
residents in the Illawarra—Shoalhaven Region of NSW, Australia. International journal of 
environmental research and public health, 2020. 17(12), 4297. 
Available from: https://www.mdpi.com/1660-4601/17/12/4297    
DOI: https://doi.org/10.3390/ijerph17124297  
 
Published version of the article 
The published version of the article is appended within the ‘Supplementary Materials’ section of the 





















Introduction: Previous research reports geographic variation in cardiometabolic risk factors (CMRFs), 
with higher prevalence often in disadvantaged areas. Access to primary care is important for the 
identification, control and management of CMRFs. This study investigated whether geographic access to 
primary care contributed to the area-level variation in CMRFs.  
Methods: A cross-sectional study design was used to analyse data on seven CMRFs collected from 2012 
to 2017: fasting blood sugar level (FBSL); glycated haemoglobin (HbA1c); total cholesterol (TC); high 
density lipoprotein (HDL); urinary albumin creatinine ratio (ACR); estimated glomerular filtration rate 
(eGFR); and body mass index (BMI). Multilevel logistic regression models were used to derive the 
association between area-level access to primary care and geographic variation of CMRFs after adjusting 
for individual and area-level co-variates. Two-step floating catchment area method was used to calculate 
primary care access for small areas within the study region. Primary care provider data were retrieved 
from publicly available sources current in 2016. 
Results: Multilevel logistic regression models indicated that after adjusting for age, sex and area-level 
disadvantage, primary care access was inversely associated with low HDL (OR 0.94, CI 0.91-0.96) and 
obesity (OR 0.91, CI 0.88-0.93), but was not associated with five of the remaining CMRFs. The area-level 
variation in CMRFs explained by primary care access was ≤ 10.5% and didn’t demonstrate any attenuating 
effect on the association between area-level disadvantage and CMRFs shown in previous models. The 
ICCs of the fully adjusted models ranged between 0.4 -1.8% in low eGFR and BMI respectively.  
Conclusion: The amount of geographic variation in CMRFs in the study region specifically explained by 
geographic access to primary care was small and did not have an attenuating effect on the association 
between area-level disadvantage and CMRFs. Thus, the observed geographic variation in CMRFs in the 
study region could be better explained by the area-level disadvantage rather than their area-level 
geographic access to primary care services. The findings are consistent with the previous findings from 
Australia but suggest both the complexity of defining access and desirability of future studies to gain more 
understanding of performance measures for health outcomes associated with primary care access.  
Keywords: geographic access; cardiometabolic risk factor; geographic variation; multilevel logistic 















Cardiometabolic risk factors (CMRFs) demonstrate significant variation in geographic distribution within 
countries globally.[1-10] Higher prevalence and clustering of CMRFs is often reported for 
socioeconomically disadvantaged areas.[11-20] Area-level access to primary care is essential for the 
identification and management of CMRFs, especially when considering their chronic nature after 
detection.[21-23] Therefore, access to primary care may have an associating role in the geographic 
variation of CMRFs.[24] 
Previous studies have reported that access to primary care can play a role in the control and management 
of certain CMRFs.[21, 25-28] Research indicates that access to primary care varies across areas, as the 
locations of primary care physicians and services is tends to be positively correlated with population 
distributions.[29, 30]There is evidence that medical consultations were reported less likely to happen when 
physical access to health care services is lower.[21] Also, access to adequate treatment facilities were 
reported to have an inverse association with certain CMRFs, such as hypertension [31, 32], end stage renal 
disease[33], and diabetes mellitus[34].  However, these reports are based on individual risk factors and 
consistent evidence across a range of CMRFs may provide a stronger evidence base for healthcare service 
commissioning across areas.  
Evidence regarding the association of CMRFs with primary care access over and above area-level 
disadvantage may inform area-level resource allocation of primary care services in disadvantaged 
areas.[24, 35] The aim of this study was to quantify the amount of geographic variation in CMRFs within 
the Illawarra-Shoalhaven region of Australia explained by differences in area-level primary care access 
after adjusting for area-level disadvantage. 
6.4 Methods 
A retrospective cross-sectional design was adopted to analyse the association between the area-level access 
to primary care and the geographic distribution of CMRFs among the residents of Illawara-Sholhaven 
region and to quantify the extent to which primary care access accounts for geographic variation in 
CMRFs. The study was approved by the University of Wollongong and Illawarra and Shoalhaven Local 
Health District  Health and Medical Human Research Ethics Committee (HREC protocol No: 2017/124). 
The study focused on the Illawarra-Shoalhaven region of New South Wales (NSW), Australia. The study 
area consists of multiple regional cities, smaller towns and rural areas; including the local government 
areas of Kiama, Shellharbour, Shoalhaven and Wollongong. The region covers a geographical area of 
5,615 square kilometres and had a population of 369,469 people at the 2011 Australian Census of 
Population and Housing.[36] The geographic unit of analysis used in this study was the Statistical Area 1 
(SA1), which is the smallest statistical output unit of the 2011 Census and have an average population of 
400 people (range: 200 to 800).[37] The study area encompasses 980 conterminous SA1s.[38] Figure 6.1 
shows the study area showing SA1s and major landmarks of the region.  
The Illawarra-Shoalhaven has a diverse socio-economic profile, making it a useful region for area-level 
population health studies.[39] The population profile of the Illawarra-Shoalhaven region is culturally and 
linguistically diverse, with a significant proportion of non-English speaking people (10.5%) residing in 
this region who have migrated from overseas. [40]  In addition, at the 2011 Census the region is identified 
to have more than the NSW state and Australian national averages of: 1) Aboriginal and/or Torres Strait 
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Islander peoples (3% versus   2.5% NSW and  2.5% Australia);   2) aged (>=65 years) population (17.6% 
versus 14.5% NSW and  13.8% Australia) ; 3) single-parent households (5.8% versus 5.3% NSW and  
5.2% Australia); and 4) unemployment (7.1% versus 5.1% NSW and  5.1% Australia) and lower labour 
force participation rate (57.9% versus 64.6% NSW and 66.2% Australia).[40] ABS 2011 census data 
indicate that more than 31 % of people in the Illawarra-Shoalhaven reside in Inner Regional areas, and 
9.1% of households within this region did not have a motor vehicle.[40] The Illawarra-Shoalhaven 
geography and a limited public transport system, especially in isolated communities, make it difficult for 
many people to access health services quickly.[40]  These characteristics of the study region directly 
indicate the vulnerability of its population to poorer health outcomes. 
 
 
Figure 6.1: Map of the Illawarra-Shoalhaven region of NSW, Australia, showing SA1 areas and major 
landmarks. 




The study used three different databases: the CMRF pathology test data; primary care provider data; and 
the estimated resident populations from the 2011 Australian Census of Population and Housing. The 
CMRF test data were extracted from the Southern IML Research (SIMLR) Study database. The SIMLR 
Study database comprises de-identified and internally linked pathology results from a major pathology 
provider in the study region and provides near-census coverage of the study population.[41] The CMRF 
test data were extracted for multiple risk factors on the most recent test results, of non-pregnant adults 
aged 18 years and over, undergoing a laboratory test between 01 January 2012 and 31 December 2017.   
The primary care provider data were manually extracted in 2016 from publicly available data sources, 
including Yellow Pages, White Pages, online general practitioner (GP) appointment booking services and 
Google search results. The 2011 Australian Census of Population and Housing data was accessed to extract 
the population denominator data of the study region at SA1 level.[42] 
Variables 
Dependent variable 
Dichotomised results of the CMRF tests were the individual-level dependent variables. The test results 
analysed in this study included: fasting blood sugar level (FBSL); glycated haemoglobin (HbA1c); total 
cholesterol (TC); high density lipoprotein (HDL); urinary albumin creatinine ratio (ACR); estimated 
glomerular filtration rate (eGFR); and objectively-measured body mass index (BMI). The CMRF test 
results were dichotomised into higher risk and lower risk values based on established risk classification 
guideline values used previously.[10]  Table 6.1 shows the CMRF definitions used in this study. 
Table 6.1: Definitions of CMRFs test results 
 ‘Higher risk’ CMRFs Definition  
1. High FBSL FBSL ≥ 7.0 mmol/l.[43] 
2. High HbA1c HbA1c > 7.5% .[43] 
3. High TC TC ≥  5.5 mmol/l.[44] 
4. Low HDL HDL < 1 mmol/l.[44] 
5. High ACR ACR ≥ 30 mcg/L to mg/l.[45] 
6. Low eGFR eGFR < 60 mL/min/1.73m2[45] 
7. Obesity BMI ≥ 30 kg/m2.[46] 
CMRFs -  Cardiometabolic risk factors; FBSL - Fasting Blood Sugar Level; HbA1c - Glycated Haemoglobin; TC - Total 
Cholesterol; HDL - High Density Lipoprotein; ACR - Albumin Creatinine Ratio; eGFR - estimated Glomerular Filtration Rate; 
BMI - Body Mass Index.  
Independent variable 
Primary care access calculated at the SA1-level was the independent study variable. An access index score 
was calculated for each SA1 using a two-step floating catchment area (2SFCA) method, which balanced 
both supply and demand of primary care services in the study region. 
The 2SFCA method was developed by Luo and Wang in 2003 to measure geographic accessibility of 
health care services.[47] The method has undergone several enhancements since its inception but 
essentially consists of two steps underpinned by a gravity model.[47, 48]  The first step computes a 
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population-to-provider ratio for each primary care service location by aggregating the population size of 
the SA1s whose centroids are located within a defined spatial buffer distance.[49] The total number of 
general practitioners working in the primary care service locations within this buffer distance were the 
numerators for the provider to population ratio calculations.  
Thus, step 1:  
 ,                 (6.1) 
where Sj is the number of general practitioners at location j, pi is the number of adult residents in the SA1s 
(Those SA1’s geographic centroids are located within the spatial buffer distance of the primary care 
locations)  and Rj is the population-to-provider ratio for service j.[49] 
 In step 2, a population-to-provider ratio (access score) is computed for each geographic centroid of the 
SA1s  by aggregating all primary care service population-to provider ratios of the primary care services 
that are located within the same spatial buffer distance.[49] 
Thus, step 2: 
 ,                     (6.2) 
where Ai is the access index for population location i. 
The resulting access indices were retained as a continuous variable for the analyses. A higher score 
indicated better geographic access of the SA1s to primary care services. 
A spatial radial buffer distance of 30 km was chosen to compute primary care access for SA1s in the study 
region.  In the preliminary stage, sensitivity analyses were performed using 1 km, 16 km and 30 km spatial 
radial buffer distances. In step 1 2SFCA analyses, the 1 km distance covered only 545 (56%) SA1 centroids 
in the study region in relation to the primary care provider locations, whereas a 16 km radial buffer distance 
covered 973 (~99%) and a 30 km radial buffer distance covered 978 (~100%) SA1s’ geographic centroids.  
Therefore, a radial buffer distance of 30 km was chosen to determine the access which was observed to 
cover the mixed rural, semi-rural and urban distribution of the population in the study region well. 
Covariates 
The individual-level variables adjusted for in the study were: sex (male and female) and age group (18–
29, 30–39, 40–49, 50–59, 60–69, 70–79 and 80+ years). The area-level covariate was the area-level 
socioeconomic disadvantage of the SA1s. The Index of Relative Socioeconomic Disadvantage (IRSD) 
score of the SA1s in the study region was used as the measurement variable for the area-level 
socioeconomic disadvantage of the SA1s. The IRSD summarises a range of measures of relative 
socioeconomic disadvantage of people and/or households within SA1s and includes: level of income; 
education; employment; family structure; disability; housing; transportation; and internet connection.[50] 
A higher IRSD score indicated lower levels of disadvantage.[50] 
Statistical analyses 
Multilevel logistic regression models were fitted to individual CMRF test data (Level 1) nested within 
SA1s (Level 2).  For each of the seven CMRFs analysed in this study, five multilevel models were fit that 
included fixed effects for sex, age, IRSD score and access index; and random effect intercepts for SA1s. 
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Model 1 (M1) was a null model; Model 2 (M2) included the area-level study variable (access index) only; 
Model 3 (M3) included individual-level factors (age and sex) only; Model 4 (M4) included individual and 
area-level factors (age, sex and IRSD score); and Model 5 (M5) included M4 variables plus access index. 
Thus, the final model (M5) estimated the effect of primary care access after adjusting for individual and 
area-level factors. Odds ratios (ORs) were derived from the exponentials of regression coefficients from 
fitted models. As the IRSD scores and access index of the SA1s were fitted as mean-centred continuous 
variables, ORs were expressed per standard deviation unit change in these variables. Statistical 
significance of the models was evaluated using likelihood ratio tests and a type I error rate of 0.05. 
Model comparison 
Model fit was compared using the Akaike Information Criterion (AIC). The models were also evaluated 
for: area-level variance (τ2); proportional change in variance (PCV) in comparison with the null model; 
Intra-cluster Correlation Coefficient (ICC) of the model; and the Median Odds Ratios (MORs). The ICC 
and MOR of the models were used to index the between-area variability. A latent variable approach was 
used to derive the ICC of models.[51] The MOR translates the area-level variance into an easily 
interpretable OR and is assumed to be statistically independent of the test specific prevalence of the 
CMRFs.[52] The unique contribution of the primary care access of the SA1s to the area-level variance of 
CMRF was estimated through the reduction in PCV between M4 and M5. 
Statistical package 
All mapping and geospatial measurements were performed using ArcGIS version 10.4.1(ESRI Inc. 
Redlands, CA, USA).[53] All statistical analyses were performed using R version 3.4.4. (R Foundation 
for Statistical Computing, Vienna, Austria).[54] Multilevel models were fit using the glmer function in the 
lme4 package[55]; and likelihood ratio tests were calculated using the lrtest function in the lmtest 
package[56]. 
6.5 Results 
A total of 1, 132, 029 CMRF test results for 256, 525 individual residents in the Illawarra-Shoalhaven 
region between 2012 and 2017 were extracted for analysis. The mean number of tests undertaken per 
person was 4.4 (SD = 1.8, range = 1-7). After excluding 1, 162 (1.0%) test results with incomplete details, 
a total of 1, 130, 894 tests were retained in the final data set.  IRSD score of the SA1s were the most 
frequent missing variable, as this was not available for some SA1s in the study region.[57] Available IRSD 
scores ranged between 446.7 and 1143.7 (mean = 976.7, SD = 98.6) for SA1s, with a higher score 
indicating lower area-level disadvantage. Table 6.2 details the individual-level CMRFs risk proportions of 
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1 High FBSL 193679  16280(8.4) 9289 (4.8) 6991 (3.6) 
2 High HbA1c 73885 7927(10.7) 4448(6.0) 3479(4.7) 
3 High TC 194816 63422(32.6) 26139(13.4) 37283(19.1) 
4 Low HDL 182237  21261(11.7) 15885(8.7) 5376(3.0) 
5 High ACR 50790 2047(4.0) 1266(2.5) 781(1.5) 
6 Low eGFR 244166 27241(11.2) 12456(5.1) 14785(6.1) 
7 Obesity 192455 64832(33.7)     29613(15.4) 35319(18.4) 
      *The denominators of the percentages are the total number of each CMRFs tests.  
 
Table 6.3 presents the summary statistics of the overall CMRF tests across the SA1s in the study region. 
Table 6.4 outlines the descriptive statistics of the individual CMRF tests across the SA1s in the study 
region. 
Table 6.3: Summary statistics of the overall CMRF tests across the SA1s in the study region. 
 
 
Table 6.4: Summary statistics of the individual CMRF tests across the SA1s in the study region. 
 
A total of 165 primary care service locations with 611 general practitioners were identified in the study 
area in 2016.  The primary care access index of the SA1s in the study region ranged between 0 and 5.41 
general partitioners per 1000 people (mean = 2.1, SD = 0.77). Figure 6.2 illustrates the distribution of the 
primary care access index within the within the study region. Multilevel logistic regression models for 
each CMRF are presented in Table 6.5(a-g) and comparisons of the random effects of the models are 
presented in Table 6.6. 
 




Figure 6.2: Geographic access to primary care services in the Illawarra-Shoalhaven region of the NSW, 
Australia 
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Table 6.5a: Multilevel logistic regression model summaries of high FBSL (FBSL ≥ 7.0 mmol/l). 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) P value OR (95% CI P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
High FBSL            
Intercept 0.09(0.09 - 0.09) p < 0.001 0.09(0.09 - 0.09) p < 0.001 0.01(0.01-0.01) p<0.001 0.01(0.01 - 0.01) p<0.001 0.01(0.01 - 0.01) p<0.001 
Access   0.89(0.87 - 0.92) p < 0.001       
Sex: Female     Reference      
Male     1.63 (1.58-1.69) p<0.001 1.63(1.58 - 1.69) p<0.001 1.63(1.58 - 1.69) p<0.001 
Age:18—29     Reference      
30—39     1.63(1.40-1.90) p<0.001 1.65(1.41 - 1.92) p<0.001 1.65(1.41 - 1.92) p<0.001 
 40—49     3.53(3.08-4.05) p<0.001 3.57(3.11 - 4.10) p<0.001 3.57(3.11 - 4.10) p<0.001 
50—59     6.77(5.93-7.72) p<0.001 6.81(5.97 - 7.77) p<0.001 6.80(5.97 - 7.75) p<0.001 
60—69     11.07 (9.72-12.6) p<0.001 11.07(9.7 - 12.6) p<0.001 11.05(9.7 - 12.6) p<0.001 
70—79     13.93 (12.2-15.9) p<0.001 13.8(12.1 - 15.7) p<0.001 13.8(12.1 - 15.7) p<0.001 
80+     12.33 (10.8-14.1) p<0.001 12.1(10.6 - 13.9) p<0.001 12.1(10.6 - 13.8) p<0.001 
IRSD        0.79(0.77 - 0.80) p<0.001 0.79(0.77 - 0.81) p<0.001 
Access          0.98(0.96 - 1.00) 0.111 
AIC 111022.8 110962.3 103066.2 102652.6 102652.0 
Variance 0.101 0.091 0.103 0.040 0.039 
PCV - - 9.98% + 1.88 % -60.90% -61.05%   
ICC (%) 3.0 2.7 3.0 1.2 1.2 
MOR 1.36 1.334 1.36 1.209 1.209 
Proportional variance explained by Access to primary care: - 0.38%    
FBSL – Fasting blood sugar level; IRSD - Index of relative socioeconomic disadvantage; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; 
Model 3—M1 + individual-level:  age + sex; Model 4—Model 3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care 












Table 6.5b: Multilevel logistic regression model summaries of high HbA1c (HbA1c > 7.5%). 
 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) P value OR (95% CI P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
High HbA1c            
Intercept 0.12(0.11 - 0.12) p < 0.001 0.12(0.11 - 0.12) p < 0.001 0.07 (0.06 - 0.07) p<0.001 0.07(0.06 - 0.08) p<0.001 0.07(0.06 - 0.08) p<0.01 
Access   0.95(0.92 - 0.98) p < 0.001       
Sex: Female     Reference      
Male     1.38 (1.3 - 1.45) p<0.001 1.39(1.32 - 1.45) p<0.001 1.39(1.32 -1. 45) p<0.001 
Age:18—29     Reference      
30—39     0.81(0.68 - 0.96) p<0.01 0.81(0.68 - 0.96) p<0.01 0.81(0.68 -0. 97) p<0.01 
 40—49     1.24(1.07 - 1.44) p<0.001 1.25(1.08 - 1.45) p<0.001 1.26(1.08 -1. 46) p<0.001 
50—59     1.56(1.36 - 1.80) p<0.001 1.56(1.36 - 1.80) p<0.001 1.57(1.36 -1. 81) p<0.001 
60—69     1.64(1.43 - 1.88) p<0.001 1.64(1.43 - 1.88) p<0.001 1.64(1.43 -1. 89) p<0.001 
70—79     1.64(1.42 - 1.88) p<0.001 1.62(1.41 - 1.86) p<0.001 1.63(1.42 -1. 87) p<0.001 
80+     1.63(1.41 - 1.88) p<0.001 1.62(1.40 - 1.87) p<0.001 1.62(1.41 -1. 87) p<0.001 
IRSD        0.79(0.77 - 0.81) p<0.001 0.79(0.77 -0. 81) p<0.001 
Access          1.00(0.97-1. 03) 0.750 
AIC 50114.5 50105.9 49690.2 49438.2 49440.0 
Variance 0.103 0.100 0.106 0.048        0.047 
PCV - - 2.430% + 3.02 % - 53.78% - 53.80% 
ICC (%) 3.0 3.0 3.1  1.4 1.4 
MOR 1.36 1.353 1.358 1.231 1.231 
Proportional variance explained by Access to primary care: - 0.04%    
HbA1c - Glycated Haemoglobin;  IRSD - Index of Relative Socioeconomic Disadvantage; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of 
SA1s; Model 3—M1 + individual-level:  age + sex; Model 4—Model 3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary 











Table 6.5c: Multilevel logistic regression model summaries of high TC (TC ≥  5.5 mmol/l). 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) P value OR (95% CI P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
high TC            
Intercept 0.42(0.41- 0.43) p < 0.001 0.42(0.41- 0.43) p < 0.001 0.20 (0.19 - 0.21) p<0.001 0.20(0.19 - 0.21) p<0.001 0.20(0.19 - 0.21) p<0.01 
Access   1.02 (1.00 - 1.03) p < 0.01       
Sex: Female     Reference      
Male     0.69 (0.68 - 0.71) p<0.001 0.69(0.68 - 0.71) p<0.001 0.69(0.68 - 0.71) p<0.001 
Age:18—29     Reference      
30—39     2.02 (1.91 - 2.14) p<0.001 2.01(1.90 - 2.13) p<0.01 2.01(1.90 - 2.13) p<0.001 
 40—49     3.01 (2.86 - 3.17) p<0.001 3.00(2.85 - 3.16) p<0.001 3.00(2.85 - 3.16) p<0.001 
50—59     4.08 (3.88 - 4.29) p<0.001 4.07(3.87 - 4.28) p<0.001 4.07(3.87 - 4.28) p<0.001 
60—69     2.95 (2.80 - 3.10) p<0.001 2.95(2.80 - 3.10) p<0.001 2.95(2.80 - 3.10) p<0.001 
70—79     1.60 (1.52 - 1.69) p<0.001 1.61(1.52 - 1.69) p<0.001 1.61(1.52 - 1.69) p<0.001 
80+     1.13 (1.07 - 1.20) p<0.001 1.14(1.07 - 1.21) p<0.001 1.14(1.07 - 1.21) p<0.001 
IRSD        1.06(1.04 - 1.07) p<0.001 1.06(1.04 - 1.07) p<0.001 
Access          1.00(0.98 - 1.01) 0.616 
AIC 235931.6 235927.9 227254.6 227193.8 227195.5 
Variance 0.0255 0.0250 0.020 0.01703 0.01705      
PCV - -1.69% -21.76% -33.11% -33.07% 
ICC (%) 0.8 0.8 0.6 0.5 0.5 
MOR 1.16 1.163 1.14 1.133 1.133 
Proportional variance explained by Access to primary care: + 0.12%    
TC - Total Cholesterol;  IRSD - Index of Relative Socioeconomic Disadvantage; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; Model 3—
M1 + individual-level:  age + sex; Model 4—Model 3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care access index of 
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Table 6.5d: Multilevel logistic regression model summaries of Low HDL ( < 1 mmol/l). 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) P value OR (95% CI P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
low HDL            
Intercept 0.13(0.13—0.13) p < 0.001 0.13(0.13—0.18) p < 0.001 0.06 (0.06—0.07) p<0.001 0.06(0.06—0.07) p<0.001 0.06(0.06—0.07) p<0.001 
Access   0.92(0.90—0.94) p < 0.001       
Sex: Female     Reference      
Male     3.98(3.85—4.11) p<0.001 3.98 (3.85—4.11) p<0.001 3.98(3.85—4.11) p<0.001 
Age:18—29     Reference      
30—39     1.11(1.03—1.20) p<0.001 1.12 (1.04—1.21) p<0.001 1.12(1.04—1.21) p<0.001 
 40—49     0.99(0.92—1.05) 0.658 1.00 (0.93—1.07) 0.957 1.00(0.93—1.07) 0.947 
50—59     0.88(0.82—0.94) p<0.001 0.89 (0.83—0.95) p<0.001 0.88(0.83—0.95) p<0.001 
60—69     0.82(0.77—0.88) p<0.001 0.83 (0.77—0.88) p<0.001 0.82(0.77—0.88) p<0.001 
70—79     0.86(0.80—0.92) p<0.001 0.85 (0.80—0.91) p<0.001 0.85(0.79—0.91) p<0.001 
80+     0.93(0.86—1.00) p<0.010 0.92 (0.85—0.99) p<0.010 0.91(0.85—0.99) p<0.010 
IRSD        0.81 (0.80—0.82) p<0.001 0.82(0.80—0.83) p<0.001 
Access          0.95(0.93—0.97) p<0.001 
AIC 130649.70 130601.4 122700.0 122291.9 122271.4 
Variance 0.07 0.064 0.081 0.031 0.029 
PCV - -9.48% +15.25% -55.90% -59.05% 
ICC (%) 2.1 1.9  2.4 0.9 0.9 
MOR 1.289 1.273 1.313 1.183 1.183 
Proportional variance explained by Access to primary care: - 6.61%   6.61% 
HDL - High Density Lipoprotein;  IRSD - Index of Relative Socioeconomic Disadvantage; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; 
Model 3—M1 + individual-level:  age + sex; Model 4—Model 3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care 
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Table 6.5e: Multilevel logistic regression model summaries of High ACR (≥ 30 mcg/L to mg/l) 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) P value OR (95% CI P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
High ACR            
Intercept 0.04(0.04 - 0.04) p < 0.001 0.04(0.04 - 0.04) p < 0.001 
0.02(0.02 - 0.03) 
p < 
0.001 
0.02(0.02 - 0.03) p < 0.001 0.02(0.02 - 0.03) p < 
0.001 
Access    0.91(0.86 - 0.96) p < 0.001       
Sex: Female     Reference      
Male     
1.75(1.60 - 1.92) 
p < 
0.001 
1.76(1.60 - 1.93) 
p<0.001 
1.75(1.60 - 1.92) p < 
0.001 








30—39     1.00(0.69 - 1.45) 0.985 1.01(0.69 - 1.46) 0.978 1.00(0.69 - 1.46) 0.982 
 40—49     0.69(0.47 - 0.97) p<0.01 0.70(0.50 - 1.00) p<0.01 0.70(0.50 - 1.00) p<0.01 
50—59     0.77(0.56 - 1.05) 0.101 0.77(0.56 - 1.07) 0.115 0.77(0.56 - 1.06) 0.115 
60—69     0.95(0.70 - 1.30) 0.762 0.96(0.71 - 1.31) 0.794 0.96(0.70 - 1.30) 0.777 
70—79     1.55(1.15 - 2.10) p<0.001 1.55(1.14 - 2.09) p<0.001 1.54(1.14 - 2.08) p<0.001 
80+     2.74(2.02 - 3.71) p<0.001 2.71(2.00 - 3.67) p<0.001 2.70(1.99 - 3.66) p<0.001 
IRSD        0.82(0.78 - 0.85) p<0.001 0.82(0.79 - 0.86) p<0.001 
Access          0.97(0.91 - 1.02) 0.206 
AIC 17130.0 17119.9 16585.2 16510.8 16511.2 
Variance 0.092 0.085 0.073 0.028 0.025 
PCV - -7.92% -20.53% -69.14% -72.39% 
ICC (%) 2.7 2.5 2.2 0.9 0.8 
MOR 1.34 1.321 1.30 1.175 1.165 
Proportional variance explained by Access to primary care: -10.53%    
ACR - Albumin Creatinine Ratio;  IRSD - Index of Relative Socioeconomic Disadvantage; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; 
Model 3—M1 + individual-level:  age + sex; Model 4—Model 3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care 
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Table 6.5f: Multilevel logistic regression model summaries of low eGFR ( < 60 mL/min/1.73m2) 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) P value OR (95% CI P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Low eGFR            
Intercept 0.11(0.11 - 0.12) p < 0.001 0.11(0.11 - 0.12) p < 0.001 0.00(0.00 - 0.00) p < 0.001 0.00(0.00 - 0.00) p < 0.001 0.00(0.00 - 0.00) p < 0.001 
Access    0.89(0.86 - 0.92) p < 0.001       
Sex: Female     Reference      
Male     0.98(0.95 - 1.01) 0.208 0.98(0.95 - 1.01) 0.258 0.98(0.95 - 1.01) 0.248 
Age:18—29     Reference p < 0.001     
30—39     1.66(1.25 - 2.20) p < 0.001 1.66(1.24 - 2.23) p < 0.001 1.65(1.22- 2.24) p < 0.001 
 40—49     4.26(3.35 - 5.41) p < 0.001 4.27(3.34 - 5.50) p < 0.001 4.30(3.32- 5.58) p < 0.001 
50—59     12.26(9.8 - 15.3) p < 0.001 12.29(9.73 - 15.52) p < 0.001 12.28(9.63- 15.66) p < 0.001 
60—69     41.8(33.6 - 51.8) p < 0.001 41.84(33.29 - 52.57) p < 0.001 41.83(32.97- 53.06) p < 0.001 
70—79     150.7(121.3 - 187.1) p < 0.001 149.69(119.3 - 187.9) p < 0.001 149.6(118.1- 189.5) p < 0.001 
80+     509.3(410.1 - 632.4) p < 0.001 503.19(400.9 - 631.6) p < 0.001 503.0(396.9- 637.4) p < 0.001 
IRSD        0.90(0.88 - 0.91) p < 0.001 0.90(0.88- 0.91) p < 0.001 
Access          1.00(0.98- 1.02) 0.925 
AIC 167164.8 167113.4 115257.1 115109.2 115111.2 
Variance 0.189 0.176 0.024 0.013 0.013 
PCV - -6.53% -87.26% -93.31% -93.26% 
ICC (%) 5.4 5.1 0.7 0.4 0.4 
MOR 1.51 1.492 1.16 1.113 1.113 
Proportional variance explained by Access to primary care: (+) 0.63%    
eGFR - estimated Glomerular Filtration Rate;  IRSD - Index of Relative Socioeconomic Disadvantage; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; Model 
3—M1 + individual-level:  age + sex; Model 4—Model 3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care access index of SA1s; SA1 — 
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Table 6.5g: Multilevel logistic regression model summaries of obesity (BMI ≥ 30 kg/m2) 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 
Significance  
(LRT) 
p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
 OR (95% CI) P value OR (95% CI P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Obesity            
Intercept 0.51(0.50 - 0.52) p < 0.001 0.51(0.50 - 0.52) p < 0.001 0.25(0.24 - 0.26) p < 0.001 0.25(0.24 - 0.25) p < 0.001 0.25(0.24 - 0.26) p < 0.001 
Access    0.88(0.86 - 0.90) p < 0.001       
Sex: Female     Reference      
Male     0.99(0.97 - 1.01) 0.214 0.99(0.97 - 1.01) 0.195 0.99(0.97 - 1.01) 0.193 
Age:18—29     Reference p < 0.001     
30—39     1.63(1.56 - 1.71) p < 0.001 1.64(1.57 - 1.71) p < 0.001 1.64(1.57 - 1.71) p < 0.001 
 40—49     2.20(2.11 - 2.29) p < 0.001 2.21(2.12 - 2.30) p < 0.001 2.20(2.12 - 2.30) p < 0.001 
50—59     2.44(2.34 - 2.53) p < 0.001 2.45(2.35 - 2.54) p < 0.001 2.44(2.34 - 2.53) p < 0.001 
60—69     2.73(2.63 - 2.84) p < 0.001 2.74(2.63 - 2.85) p < 0.001 2.72(2.62 - 2.83) p < 0.001 
70—79     2.44(2.34 - 2.54) p < 0.001 2.44(2.34 - 2.54) p < 0.001 2.42(2.33 - 2.52) p < 0.001 
80+     1.46(1.39 - 1.55) p < 0.001 1.45(1.38 - 1.54) p < 0.001 1.45(1.37 - 1.53) p < 0.001 
IRSD        0.81(0.79 - 0.82) p < 0.001 0.82(0.80 - 0.83) p < 0.001 
Access          0.93(0.91 - 0.95) p < 0.001 
AIC 242793.2 242686.2 239122.6 238731.8 238680.6 
Variance 0.115 0.099 0.117 0.068 0.062 
PCV - -14.20% +1.48% -41.21% -46.19% 
ICC (%) 3.4 2.9 3.4 2.0 1.8 
MOR 1.38 1.350 1.39 1.282 1.268 
Proportional variance explained by Access to primary care: - 8.47%    
BMI - Body Mass Index;  IRSD - Index of Relative Socioeconomic Disadvantage; Model 1—null model at SA1 level; Model 2—M1 + Primary care access index of SA1s; Model 3—M1 + individual-
level:  age + sex; Model 4—Model 3 + Area level: Index of Relative Socioeconomic Disadvantage score of SA1s; Model 5—Model 4 + Primary care access index of SA1s; SA1 — Statistical area-level 
1
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All the null models indicated geographic variation in the distribution of all CMRFs at the SA1 level. Model 2s 
showed significant inverse associations between access index and all CMRFs except TC, which displayed a 
positive association with the access index. Model 3s adjusted CMRF models for individual-level age and sex, 
which accounted for 1.5% (obesity) to 87.3% (eGFR) of unexplained variation in the null model. Model 4s 
demonstrated significant inverse associations between area-level IRSD and all CMRFs except for TC after 
adjusting for individual-level factors. Total cholesterol again showed a positive association with IRSD scores. 
In the final models (M5s), the access index was found to be inversely associated with low HDL (HDL< 1 
mmol/l) and obesity (BMI≥ 30 kg/m2), after adjusting for individual and area-level factors. Including the access 
index in the final models did not attenuate associations between area-level disadvantage and CMRFs observed 
in M4s. In the final models, no significant association was found between primary care access and CMRFs 
except low HDL and obesity. 
Reductions in the AIC values were observed for all CMRFs except in TC and eGFR models from the null 
model (M1) to the final model (M5), indicating a better fit of the final models. The AIC for TC and eGFR 
models indicated M4 was the best fitting model for these CMRFs. In the unadjusted null models (M1s), low 
eGFR demonstrated the most area-level variance and high TC showed the least. The access only models (M2s) 
showed a reduction in the residual variance of all CMRFs from those of null models.  The proportional change 
in variance was highest for obesity (PCV =-14.2%) and lowest for TC (PCV = -1.7%). In Model 3s, adjusting 
for age and sex initially increased the residual variance of  FBSL (PCV = +1.9%), HbA1c (PCV = +3.0%), 
HDL (PCV = +15.3%) and BMI (PCV = +1.5%). In model 4s, adjusting the CMRFs for individual-level age 
and sex and area-level disadvantage resulted in major reductions of variance from -33.1% (in TC) to -93.3% 
(in eGFR).  In the final models (M5s), including access index in the models after adjusting for the covariates, 
had extended the reduction in variance in all CMRFs, except on TC and eGFR. Including the access index had 
been observed to increase the variance in the TC and eGFR final models, compared with the lower level model. 
The proportional variance specifically explained by access to primary care was minimal in the final models. 
Area-level primary care access explained 10.5% of the geographic variation in high ACR, followed by 8.5% 
variation of obesity and 6.6% variation of low HDL. The geographic variation explained by primary care 
access was close to zero for high FBSL (0.4%), high HbA1c (0.0%), high TC (-0.1%) and eGFR (-0.6%). 
Similarly, in the unadjusted models, the MORs, which indicate the odds of having a higher risk CMRFs test 
result for a person from the most, compared to the least, area-level disadvantage, were the highest among eGFR 
(τ2=0.189; ICC= 5.4%; MOR = 1.51) and the least among  TC (τ2 =0.025; ICC= 0.8%; MOR = 1.16). The 
ICCs of CMRFs in all the models were comparatively small (Table 6.6) in all the models. In the fully adjusted 
models, the ICCs further reduced and ranged between 0.4% and 1.8% in low eGFR and BMI respectively. 
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Table 6.6: Summary of model fit values and comparison of the models 
 
 FBSL HbA1c TC HDL ACR eGFR Obesity 
Model 1 Null Model 
 AIC 111022.8 50114.5 235931.6 130649.7 17130.0 167164.8 242793.2 
 𝜏2 0.101 0.103 0.025 0.071 0.092 0.189 0.115 
  ICC(%) 3.0 3.0 0.8 2.1 2.7 5.4 3.4 
  MOR 1.36 1.36 1.16 1.29 1.34 1.51 1.38 




AIC 110962.3 50105.9 235927.9 130601.4 17119.9 167113.4 242686.2 
𝜏2 0.091 0.100 0.025 0.064 0.085 0.176 0.099 
ICC(%) 2.7 3.0 0.8        1.9  2.5 5.1        2.9  
  MOR 1.334 1.353 1.163 1.273 1.321 1.492 1.350 
  PCV -9.98% -2.430% -1.69% -9.48% -7.92% -6.53% -14.20% 













𝜏2 0.103 0.106 0.020 0.081 0.073 0.024 0.117 
ICC(%) 3.0 3.1 0.6 2.4 2.2 0.7 3.4 
MOR 1.36 1.358 1.14 1.31 1.30 1.16 1.39 
PCV + 1.88 % + 3.02 % -21.76% +15.25% -20.53% - 87.26% +1.48% 
Model 4 Sex + Age  + IRSD Adjusted Model  
 
 
AIC 102652.6 49438.2 227193.8 122291.9 16510.8 115109.2 
 
238731.8 
 𝜏2 0.040 0.048 0.017 0.031 0.028 0.013 0.068 
  ICC(%) 1.2 1.4 0.5 0.9 0.9 0.4 2.0 
  MOR 1.209 1.231 1.133 1.183 1.175 1.113 1.282 
  PCV -60.90% -53.78% -33.11% -55.90% -69.14% -93.31% -41.21% 

















 𝜏2 0.039        0.047  0.017 0.029 0.025 0.013 0.062 
 ICC(%)       1.2 1.4 0.5 0.9        0.8  0.4 1.8 
 MOR 1.209 1.231 1.133 1.183 1.165 1.113 1.268 
 PCV -61.05% -53.80% -33.07% -59.05% -72.39% -93.26% -46.19% 
AIC - Akaike Information Criterion; 𝜏2 – residual variance; ICC - Intra-cluster Correlation Coefficients; MOR - Median Odds Ratio; 
PCV - Proportional Change in Variance; FBSL - Fasting Blood Sugar Level; HbA1c - Glycated Haemoglobin ; TC - Total 
Cholesterol; HDL - High Density Lipoprotein; ACR - Albumin Creatinine Ratio; eGFR - estimated Glomerular Filtration Rate. 
 
6.6 Discussion  
The study reports the area-level association between access to primary care service and distribution of CMRFs 
in the Illawarra-Shoalhaven region of Australia after adjusting for the area-level and individual-level 
covariates. Access to primary care was inversely associated with low HDL and obesity but was not associated 
with high FBSL, high HbA1C, high TC, high ACR and low eGFR. The geographic variation of CMRFs 
explained by primary care access was small and did not demonstrate any attenuating effect on the contribution 
of area-level disadvantage on the variation of CMRFs in the study region.  
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Primary care access was only associated with low HDL and obesity in models fully adjusted for individual- 
and area-level covariates. These findings question previously reported associations between primary care 
access and improved health.[24-28]  However, it should be noted that the current findings pertain only to the 
geographical/spatial accessibility of the primary health care services within 30 km distance of an SA1 centroid, 
rather than their actual usage and affordability. 
Primary care access was not associated with five out of the seven CMRFs analysed in this study. This was 
unexpected given the previous research findings, although it is worth noting that most of the previous research 
indicating inverse associations originated from the United States [24-28], though not all[23, 32, 34]. Related 
studies reported from Australia did not find any association between the GP supply and preventable 
hospitalisations after adjusting for sociodemographic and health characteristics of areas in the state of Victoria 
[58], and found that GP supply was not a significant predictor of preventable hospitalisation in a population 
sample from NSW[59]. GP supply  explained only a small proportion (2.9%) of the geographic variation in 
hospitalisation rates in  individuals aged ≥45 years in that study.[59] Importantly, it was reported in Australia 
that reductions in preventable hospitalisations are not necessarily associated with improved clinical 
outcomes[60], but the crude rates may reflect the existing morbidity burden on primary care services [60, 61].  
 
In keeping with previous reports from Australia, the current findings from an adult (≥18 years) sample from 
the study region in NSW demonstrated only 6.6 % to 10.5% of geographic variation in CMRFs could be 
attributed to geographic access to primary care services. This finding does not suggest that access to primary 
is unimportant in the study region, rather highlights the context of general primary health care service in 
Australia. Australia has universal health insurance and targeted patient benefit schemes such as ‘safety net 
thresholds’ to improve low-income and vulnerable populations groups’ access to health care services and the 
annual physician visits per capita of Australia (6.5) is much higher than that of United states (3.9) and the UK 
(5).[59, 62] It is possible that such strategies have been more effective in Australia in enhancing access to 
primary care service than in countries such as the United States, however their definitive implications are 
beyond the scope of the current study.[59] The higher risk CMRFs outcomes observed in the region could be 
attributable to a range of individual and area-level factors which are not analysed in this study which include 
individual-level SES, behavioural risk factors, area-level resources, service availability and performance.  The 
observed geographic variation in CMRFs in the study region could also be an actual reflection of the socio-
economic and health gradient characteristics intrinsic to this population beyond their access status to primary 
care services.  Previous research suggests that up to 57.8% of geographic variation in CMRFs is attributable 
to the area-level disadvantage in this study region.[63]  Certainly health system performance and the social 
distribution of wealth could play important roles in explaining the geographic variation of risk factors for the 
development of CVD.[64] However, the current findings suggest both the complexity of defining primary care 
access and desirability of future studies to gain more understanding of their performance measures.   
Primary care access was inversely associated with low HDL and obesity in the study region. While not 
disregarding the role of geographic access to primary care and the broader health system in reducing the rates 
of low HDL and obesity, it should also be noted that the areas in this study region with higher geographic 
access to primary care service are also the population hubs of the study region, with potentially better access 
to healthy food sources and exercise facilities which are not analysed in this study. The research literature 
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suggests that the availability of healthy food sources and exercise facilities can have a direct impact low HDL 
and obesity in individuals.[65-72] Therefore, the current findings call for future research directions to include 
more area-level and service-level variables and their interactions with geographic access to primary care in 
this study region to gain an in-depth understanding on the context of the observed inverse association of 
primary care access with low HDL and obesity. 
The primary care access index, derived from the study region ranged from 0 to 5.41 general partitioners per 
1000 people (mean = 2.1, SD = 0.77).  Multiple previous studies had reported inequalities in the geographic 
access to primary care services, using different enhanced versions of 2SFCA method (55, 56, 65, 57–64). For 
example, the spatial accessibility index derived from rural Otago in New Zealand, using the travel time 
distance, ranged between 1 to 10; where higher the score indicated a better access.[73] The accessibility index 
reported from Thimphu district in Bhutan ranged between 0 and 1, where 1 was the maximum access.[74] The 
spatial accessibility index of GP accessibility in England had been reported to range between 7.2 (South of 
England) and 13.3 (in London).[75] The access map of the study region (Figure 2) clearly shows a polarisation 
of the higher access indices along the northern and southern ends of the study region, thus a visible inequality 
in their distribution. The WHO recommends universal access to primary care for all populations, where 
geographic access is one part of physical access to primary care.[76] 
Area-level disadvantage explained more geographic variation in CMRFs than area-level access to primary 
care. Inclusion of the access index in the final model did not demonstrate any reduction in the variance 
explained by area-level disadvantage on the geographic variation of CMRFs. This finding supports the 
importance of overall socioeconomic development of areas to reduce CMRF risk. Moreover the ICC values of 
the final models were too small to suggest any meaningful area-level difference in the modelled CMRF 
variables. This would support the call for universal approaches for the prevention and control of CMRFs rather 
than any targeted area-level approaches; however with a proportional priority to disadvantaged populations in 
the study region.[24, 64, 77] 
The study has to be considered within its limitations. First, the cross-sectional nature of the study does not 
support causal inference. Second, the CMRFs data used in this study are from people already utilising health 
care service in the study area, so care should be taken in generalising the results to the overall population. 
Third, the study used a radial buffer distance of 30 km for access calculations rather than travel time/distance, 
because proprietary road network data were unavailable for this study. Usage of actual travel time/distance 
might have provided a better estimate of access to primary care service locations within this study region. 
Within the access index calculations, even though the 30 km buffer distance helped to include a maximum 
coverage of the population in relation with the geographic location of the primary care providers, this distance 
might have influenced the discriminatory accuracy of the SA1s in the multilevel analyses. 
The main strength of this study is the use of a large population-derived database comprising a wide range of 
CMRFs. The research adds to the very few studies which consider multiple CMRF variables from the same 
region.[14, 18, 20, 78-80] and is unusual for its hierarchical analysis of the associations between a range of 
CMRFs and primary care access in a widely dispersed population. 
Future research is required to investigate other area-level attributes contributing to the geographic variation of 
CMRFs in the study region. Our previous research has reported that area-level disadvantage contributes 14.7–
57.8% of the geographic variation in CMRFs. The current study extended the previous findings by identifying 
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the specific contribution of area-level primary care access, ranging between 0.0–10.5%. Further area-level 
analyses are required to identify other factors contributing to the geographic inequality of the CMRFs in the 
study region. 
6.7 Conclusion 
The findings of the study suggest that adults residing in areas that have a poor primary care access are more 
likely to be identified with low HDL and obesity.  However, the specific contribution of area-level primary 
care access was small when compared with the contribution of area-level disadvantage. The finding supports 
the importance of overall socioeconomic development of areas to reduce CMRF risk, while supporting 
universal approaches for the prevention and control of CMRFs which are proportional to the need and 
disadvantage level of the individuals.  Future research including other aspects primary care access such as 
physical/road network access, financial affordability and acceptance of the services might help to provide an 
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Chapter 7: General Discussion and Conclusion 
7.1 Introduction 
The thesis presents an epidemiological and geospatial analysis of the distribution of cardiometabolic risk 
factors (CMRFs) in the Illawarra-Shoalhaven region of NSW, Australia. It has presented the geographic 
variation in the distribution of individual CMRFs in the study region and has demonstrated the associations 
of area-level disadvantage and access to primary care with this variation. Additionally, it demonstrates the 
utility of routine clinical data for research concerning location specific population health approaches and 
for informing regional health care service commissioning.  
The publications arising from this study have contributed to the knowledge regarding the geographic 
variation of CMRFs and the contextual factors associated with CMRF distribution. The findings are 
important in the context of the global paradigm shift from infectious disease to non-communicable diseases 
as key drivers of illness burden, especially cardiovascular diseases (CVD) as the prime cause of death and 
health care expenditure worldwide. 
The final chapter of the thesis provides: an overall outline of achievement of the objectives of the study; a 
critical in-depth comparison of the findings of the study with international literature; and a discussion of 
the significance of the findings and future research directions. The chapter also discusses theoretical 
considerations along with the study’s methodological strengths and limitations, prior to presenting the 
conclusions. 
7.2 Major findings  
The study sought to investigate the geographic distribution of CMRFs and their associations with area-
level disadvantage and access to primary care in the study region. This was achieved by answering the 
following research questions sequentially: 
1. What is the existing level of evidence on the geographic and socioeconomic variation in the distribution 
of CMRFs internationally? 
2. What is the small-area level geographic distribution pattern of cardiometabolic risk factors, within the 
Illawarra-Shoalhaven region of NSW Australia?  
3. What proportion of any geographic variability in cardiometabolic risk factor prevalence is due to small-
area level socioeconomic status, within the Illawarra-Shoalhaven region of NSW Australia? 
4. What proportion of any geographic variability in cardiometabolic risk factor prevalence is due to 















The study answered the above research questions in a hierarchical manner, with the following outcomes:  
1. Systematic literature review of 24 eligible studies from multiple nations across the world revealed 
variation in the distribution of CMRFs at varying geographic scales. Among these, 16 studies 
demonstrated consistent associations between area-level socioeconomic disadvantage and higher 
prevalence of various CMRFs. These reports of associations were mostly independent of individual-
level factors and reported mainly from industrialised nations.  
2. There was significant geographic variation in the distribution of individual CMRFs in the study region 
in Australia. The variation included clustering of higher risk categories of: fasting blood sugar level 
(FBSL); glycated haemoglobin (HbA1c); total cholesterol (TC); high density lipoprotein (HDL); 
albumin creatinine ratio (ACR); estimated glomerular filtration rate (eGFR); body mass index (BMI); 
and diabetes mellitus (DM) status. The High-High (HH) clusters of CMRFs were found mainly along 
the highly populated eastern seaboard of the study region, where as the Low-Low (LL) clusters were 
predominantly in the less populated northern, central and southern areas of the study region. 
3. Area-level socioeconomic disadvantage was associated with all the analysed CMRFs after adjusting 
for individual-level covariates such as age-group and sex. The estimated proportion of the geographic 
variation in the higher risk CMRFs’ distribution explained by area-level socioeconomic disadvantage 
varied across the CMRFs. Area-level disadvantage explained 57.8% of the geographic variance in low 
HDL, 57.1% of variance of high FBSL, 53.3% of variance of high HbA1c, 51.2% of variance of high 
ACR, 41.8% of variance of low eGFR, 41.1% of variance of BMI and 14.7% of variance of high TC 
test results. These findings demonstrated a consistent burden of multiple higher risk CMRFs 
concentrated in areas of greater socioeconomic disadvantage. 
4. A primary care access map of the study region was plotted; and access was found to be lower along 
the sparsely populated central and western areas of the study region. The available primary care 
services were mainly concentrated along the populated eastern seaboard of the study region. Better 
primary care access was associated with lower levels of higher risk HDL and obesity. No significant 
area-level associations were found between primary care access and the remaining CMRFs, including 
high FBSL, high HbA1c, high TC, high ACR and low eGFR. The geographic variation in CMRFs 
explained by access to primary care was <=10.5%. 
The results have the potential to inform local and regional health care service planning and policy 
developments; and generate hypotheses internationally for area-level research based in similar settings. 
7.3 General discussion 
This section presents an overall discussion of the individual findings in this thesis. The section is divided 
into four subsections, to facilitate the presentation of the discussion based on the individual objectives of 
the study. 
7.3.1 Systematic Literature review on the distribution of CMRFs 
In study 1, I had systematically reviewed the existing literature reported globally on geographic and area-
level socioeconomic variation in the distribution of CMRFs. Geographic variation in the presence of one 
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or more CMRFs was reported from multiple nations.  Recent advances in GIS and analytical approaches 
were utilised in the studies reporting geographic variation in CMRFs.  
Area-level socioeconomic disadvantage was repeatedly demonstrated to be associated with higher 
cardiometabolic risk.[1] Higher disadvantage was also consistently reported to have an association with 
cardiovascular risk; whereas lower disadvantage was associated with reduced cardiovascular risk.  Such 
associations were often demonstrated independently of individual level characteristics such as 
socioeconomic status, education and duration of exposure to area.[1]  
The systematic review included only biological proxies of CMRFs. This is mainly due to the overall focus 
of this thesis on biological proxies of CMRFs, and the review was also intended to provide a background 
for their analyses. The thesis did not have any data for the examination of behavioral, dietary and activity 
related risk factors of individuals, hence these were not included in the review. 
Related systematic reviews published in this area of research had investigated associations for different 
geographically distributed factors with CVD. Chaix (2009) reviewed the associations between 
neighbourhood social environments and CHD and proposed a theoretical model of a mediating mechanism 
focussing on the social interactional environment.[2] Consistent associations of obesity or hypertension 
with lower levels of area socioeconomic status, urbanisation, street intersection, accessibility to 
supermarkets, social cohesion, service availability and residential density and higher levels of noise 
pollution and density of convenience stores, were reviewed and reported by Leal (2011).[3] Frequent 
inverse associations of common indices of area-level socioeconomic disadvantage with childhood obesity 
were reported in the UK.[4] A consistent association between socioeconomic disadvantage and central 
adiposity was reported by Slopen (2013).[5] All these reviews reported important methodological 
limitations and the need for further research in this area, which support the findings of the current review. 
Overall, the review indicated that disease patterns at smaller areas in a nation may significantly differ from 
national and regional prevalence reports. Thus small-area analysis is important in order to understand local 
patterns and requirements.[6] Small-area level analyses also have the potential to reveal area level contexts 
and dependencies of CMRFs and such analyses can highlight areas for targeted preventive 
interventions.[1]  
7.3.2 Geographic variation in the distribution of CMRFs in the study region 
Study 2 explored the geographic distribution of eight CMRFs in 980 conterminous geographic units within 
the Illawarra-Shoalhaven region of the NSW, Australia.[7] Higher rates and clustering of higher risk 
CMRFs were mostly observed along the more densely populated eastern seaboard of the study region. 
However, not all populated areas were involved in this pattern and less populated areas were also involved 
with higher rates of CMRFs, especially that of high TC. Spatial analyses had revealed significant spatial 
autocorrelation of all eight CMRFs and the clustering locations observed were different for each of the 
CMRFs.[7] 
The distribution of high TC values were generally reversed to those distributions described for other 
CMRFs.[7] The reasons for this observation are yet to be explored, but a possible prescribed medication 
treatment effect was suspected as the lower risk areas were often densely populated areas. It is possible 
that people residing in these areas had better access to health care services and more frequently prescribed 
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cholesterol-lowering drugs.[8, 9] However, not all densely populated areas were involved in this TC 
distribution pattern, so further research is required to identify the area-level factors contributing to this 
paradoxical distribution pattern of TC. 
The findings regarding the geographic variation in the distribution of CMRFs are supported by previous 
reports internationally.[10-17] In the UK, geographic variation in the prevalence of risk factors such as 
obesity, smoking, diabetes, hypertension and high cholesterol were reported across four main regions: 
South England; Midlands and Wales; Scotland; and North England.[17] A higher prevalence of CMRFs 
was reported in southern Spain (Andalusia), which was found in close association with sedentary lifestyle 
and markers of socioeconomic disadvantage, after adjusting for individual level covariates.[14]Variation 
in the distribution of diabetes, high BMI (≥ 25 kg/m2), abdominal obesity, hypertension, high cholesterol 
and low glomerular filtration rate were reported at both canton and municipality levels in Luxemburg, 
Western Europe.[10] 
The contribution of the current study is its ability to describe a wide range of CMRFs simultaneously 
across the same time period and same geographic region. In addition, it is one of few studies reporting the 
distribution of multiple parameters from regional Australia. Previous studies from Australia had reported 
geographic variation in being diagnosed with DM among adults living in Sydney.[11] Another study 
reported geographic variation in glycated haemoglobin (HbA1c) values across 767 Census Collection 
Districts (CDs) in Adelaide.[13] The current finding builds on previous research by investigating the 
distribution of a wide range of CMRFs, across population catchments including urban, rural and semirural 
areas. The evidence of the small-area level variation of multiple CMRFs in this study is significant and 
consistent across all CMRFs, which included clustering of the pathology test results of high FBSL, high 
HbA1c, high TC, low HDL, high ACR, low eGFR, obesity and diabetes. 
The study focusses on the geographic distribution of eight individual CMRFs rather than the aggregate 
count of risk factors in one person and their subsequent analyses and mapping. The latter method might 
be helpful in generating a ‘single map’ of ‘geographic variations in SA1-level per capita counts of “higher 
risk” risk factors for the region’ to indicate areas of higher CVD risk. But the ‘single map’ will not tell 
which risk factor is high in an area and what kind of health care resources are required in those areas to 
address these risks. As one of the main intentions of this program of research was to inform regional health 
care service commissioning and their resource allocation, it was important that the study outcomes aligned 
with existing clinical practice to make the results potentially useful for any further planning and 
implementation strategies.[18] What is practiced in a clinical context is the treatment and management of 
the individual components of CMRFs. [18] Also, it should be noted that the study sample is a cohort of 
pathology service users who may not be representative of the SA-1 populations within the study area, 
which also makes it methodologically more appropriate to use within-cohort denominators.  
The findings of the study enabled comparisons of the areas which have demonstrated clustering of various 
CMRFs. In addition to providing useful results demonstrating areas of significant geospatial clustering of 
various CMRFs for area-level health care commissioning, the results also facilitated generation of 
hypothesis for further research on the association of area-level factors which attribute to this clustering.  
Regarding the location of the identified high-high clusters of higher risk CMRFs findings, subsequent 
stage 3 analyses (presented in Chapter 5) demonstrated that the ‘higher risk’ CMRFs findings were 
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positively associated with area-level socioeconomic disadvantage, except for TC which demonstrated an 
inverse trend. This finding can also be retrospectively applied to chapter 4 results to see that deprived 
areas and their neighbourhoods are more likely to be identified with high-high clusters of ‘higher risk’ 
CMRFs, except TC results. For illustrative purposes, an explicit mapping of the areas of high-high 
clustering and higher area-level disadvantage using the study data set is presented here (Fig 7.1). In the 
maps, it can be observed that areas of high-high clustering are more likely to be areas of higher area-level 
disadvantage though not absolutely, which provides a thoughtful link to the next stage findings presented 
in this chapter.
 
Figure 7.1:  Local Moran’s I cluster maps showing high-high and low-low spatial associations of CMRFs; 
and the areas of higher area-level disadvantage, within the Illawarra Shoalhaven region of the NSW 
Australia. 
7.3.3 Association of area-level disadvantage with all CMRFs 
Study 3 found consistent evidence for association between area-level disadvantage and CMRFs in the 
study region.[19] In the individual-level age and sex adjusted models, the odds of a higher risk CMRF 
finding increased with increasing area-level disadvantage among all CMRFs except TC. Total cholesterol 
alone demonstrated an inverse pattern of association with increasing area-level disadvantage. The 
contribution of area-level disadvantage to the observed geographic variance in CMRFs was the highest for 
low HDL (57.8%), followed by high FBSL (57.1%); high HbA1c (53.3%); high ACR (51.2%); low eGFR 
(41.8%); and obesity (41.1%) test results. The contribution of area-level disadvantage was comparatively 
less for the geographic variance of high TC (14.7%).[19] 
The TC test results stood apart from the other findings of this study. However, the HDL findings were not 
consistent with the area-level findings of TC results, even though both are components of the lipid profile. 
This suggested the possibility of a medication effect on TC in these areas, where the lipid lowering drugs 
have a less consistent effect in raising HDL than in lowering TC.[20] However the reason for the inverse 
association demonstrated by TC test results were not within the scope of the current research, but the non-
consistent patterns explains possible role of confounders not identified within the study.  
The eGFR models demonstrate a very high magnitude of ORs in the higher age groups in Model 2 and 
Model 4. In table 5.4, where the frequency and proportion of individual CMRF test findings are reported, 
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it can be found that the proportion of higher risk eGFR findings in the reference age group 18-29 years is 
very low (0.03%) in comparison with the highest 80+ years age group (5.52%), which is around is 184 
times higher and may well be the order of magnitude the ORs suggest. Therefore it is likely that these 
much-magnified ORs found in the higher age groups of eGFR test findings in Model 2 and Model 4 are 
due to the effect of very low proportion of higher risk eGFR findings in the reference age group and very 
high number of findings in the upper age groups.   I have presented a sensitivity test for using different 
reference age groups, in Table 7.1. As shown in the table, changing the reference group only makes a 
relative difference in their ORs, but not any change in their corresponding interpretation.  
Table 7.1:  Sensitivity analysis of the Odd’s ratios of low eGFR, using different age reference groups.  
 
 
In addition, it is also noted that combining 18-29 and 30-39 years as a reference group, only makes a 
relative difference in their ORs but not any absolute or interpretive difference. This is because the 
proportion of higher risk eGFR findings in the 30-39 years age group is lower (0.04%) too. The original 
and modified Table 5.10 is copied below in Table 7.2 for reference purposes, and the changed values are 
marked in red.





Table 7.2: A comparison of the Multilevel logistic regression model summaries for the area-level analyses of the association between low 
eGFR (eGFR < 60 mL/min/1.73m2) and relative socioeconomic disadvantage, with the original and combined age groups. 
 
*** - p<0.001; eGFR - estimated Glomerular Filtration Rate;  IRSD - Index of Relative Socioeconomic Disadvantage; Most D – Most Disadvantaged; LRT – Likelihood ratio test; Model 1—null model at 
SA1 level; Model 2—M1 + individual-level:  age + sex; Model 3—Model 1+ Area level: IRSD quintiles of SA1s; Model 4—Model 1+Model 2 + Model 3; NS – Not significant; SA1 — Statistical area-level 1.




The ICCs of the final models were low and suggest very limited area-level contextual effects and support a 
homogenic contribution of areas proportional to the level of disadvantage. The ICCs of CMRFs in all the 
models were comparatively small in all the models. In fully adjusted models, the ICCs were further reduced 
and ranged between 0.4% and 2.0% in low eGFR and BMI respectively. As per the interpretation framework 
proposed by Merlo et al (2019), an ICC value less than 10% is indicative of very little geographic 
difference.[21] However, this has to be interpreted along with the traditional geographic comparisons such as 
the proportion of the individuals who are affected with higher risk CMRF outcomes. Therefore, a small 
geographic difference indicates homogeneity of the higher risk CMRF findings within geographic units.[21] 
Such a situation would call for balanced universal approaches to prevent and control the higher risk CMRFs, 
with a proportional focus to the need and disadvantage level of affected populations.[22, 23] However, it is 
also worth noting that when the exposure to an agent is homogenic in a community, traditional epidemiological 
methods are not very helpful in identifying markers of susceptibility.[24] 
The findings of the study add to the existing evidence on the association between area-level disadvantage and 
CMRFs through the fixed effect estimates of the multilevel regression models.[19, 25, 26] Previous research 
from Australia demonstrated inverse and positive associations of area-level education and area-level income 
respectively with cardiometabolic syndrome in a prospective cohort [26], and advocated population 
interventions based on area-level socioeconomic disadvantage to reduce cardiometabolic risks[25]. The study 
extends previous reports by providing evidence for a range of CMRFs regarding their association with area-
level disadvantage. The findings thus demonstrate the occurrence of multiple higher risk CVD risk factors in 
disadvantaged areas. Importantly, the specific contributions of area-level disadvantage to the geographic 
variance of multiple CMRFs were identified through the random effect estimates of the models, which is 
unique in the literature and highly informative for area-appropriate health care service commissioning.  
7.3.4 Association of area-level primary care access with CMRFs 
Study 4 was done in two stages. Stage 1 focussed on deriving the area-level primary care access index of the 
study region, whereas stage 2 aimed to analyse area-level associations between primary care access and the 
CMRFs.  
The access index was higher mainly along the eastern seaboard of the study region, but low and <=1.6 per 
1000 people along the western and central areas which were relatively less densely populated. A total of 165 
primary care service locations with 611 general practitioners were identified within the study region in 2016. 
The service locations were mostly along the populated eastern coastal strip of the study region. The primary 
care access index of the study region was derived using a two-step floating catchment area method (2SFCA), 
which accounted for both the supply (available providers) and demand (based on the total population) of the 
primary care services within a specified spatial distance.[27] After sensitivity analyses, a spatial buffer 
distance of 30 km was chosen to measure the primary care access, from both the geographic centroids of the 
small-areas within the study region and the service provider locations.  This distance was observed to provide 
a better coverage of the geographic centroids and services providers, considering the sparsely populated areas 
and the distant locations of the primary care providers. The derived primary care access index of the small-
areas within the study region ranged between 0 and 5.4 general partitioners per 1000 people (mean = 2.1, SD 
= 0.77).  




The area-level associations between access to primary care service and distribution of CMRFs in the study 
region were explored. Area-level primary care access inversely associated with low HDL and obesity after 
adjusting for individual-level age, sex, and area-level disadvantage. Primary care access was not associated 
with any of the remaining CMRFs, including high FBSL, high HbA1c, high TC, high ACR and low eGFR. 
Comparison of the models based on measures of are-level variation demonstrated that area-level primary care 
access explained 10.5% of the geographic variation in high ACR, followed by 8.5% variation of obesity and 
6.6% variation of low HDL. The geographic variation explained by primary care access was close to zero for 
high FBSL (0.4%), high HbA1c (0.0%), high TC (-0.1%) and eGFR (-0.6%). %). Thus, the observed 
geographic variation in CMRFs explained by area-level primary care access is found to be minimal, especially 
in comparison with variation explained by area-level disadvantage which was up to 57.8 % in the previous 
study. The findings are consistent with the previous related reports from Australia. This does not undermine 
the crucial role of primary care access in the study region but does reflect both the complexity of defining 
access and desirability of future research on the performance measures of primary care in the study region. 
Also, it is important to note that even though no association was found between geographic access to primary 
care and most of the CMRFs, the unadjusted crude rates of higher risk presented in this study directly indicate 
the existing burden on the primary care system in the study region and the related requirement of resources 
and their appropriate delivery to effectively prevent and control CMRFs within the region. Thus, irrespective 
of the null association findings reported in this study, sufficient resources and their supply would be required 
to effectively control and manage the observed crude rates of CMRFs in the study region.  Effective control 
and management of existing CMRFs in the study region is expected to reduce the rates of higher risk CMRFs 
in the study region and thus their CVD related hospitalisation events and their further burden on the health 
care system – which is the leading cause of death and health care expenditure in Australia. 
These results may also result from contextual factors contributing to the geographic variation of CMRFs, over 
and beyond primary care access. Area-level disadvantage explained more geographic variation in CMRFs than 
area-level access to primary care. Inclusion of the access index in the final model did not demonstrate any 
reducing effect on the variance explained by the area-level disadvantage on the geographic variation of 
CMRFs. This finding supports the importance of overall socioeconomic development of areas to reduce CMRF 
risk.[22-24] Future research is required to investigate other area-level attributes contributing to the geographic 
variation of CMRFs in the study region. This research has reported that area-level disadvantage contributes 
14.7–57.8% of the geographic variation in CMRFs. My current findings extended the previous findings by 
identifying the specific contribution of area-level primary care access, ranging between 0.0–10.5%. Further 
area-level analyses are required to identify other factors contributing to the geographic variation of the CMRFs 
in the study region. 
7.4 Theoretical underpinnings of the findings 
This section presents a general discussion on the links of study findings to existing theories. The discussions 
are based on the concept that the phenomena of the population-level patterns of health are not naturally 
occurring random events, but are underpinned to how societies are organized.[28] Two theories are discussed 
in this section in comparison with the major components and outcomes of the individual studies in this thesis. 




7.4.1 Socio-ecological theory 
The evidence from this thesis is consistent with Socio-ecological theory, proposed by Urie Bronfenbrenner in 
1989.[29] The theory was further developed by Daniel Stokols in 1996 to explain the dynamic interrelations 
among individuals and environmental factors.[30] The thesis findings are most consistent with Stokols’s 
application of Socio-ecological theory. 
As per Daniel Stokols, Socio-ecological theory highlights the dynamic relationship between individuals and 
their surroundings.[31] The contextual factors of an individual can be linked with the aetiology of multiple 
diseases and risk factors, including CVD. Socio-ecological analyses examine the day to day exposures of 
individuals to various contextual factors, such as social, demographic and physical environments. Socio-
ecological theory suggests that certain environmental contexts within an individual’s life situation can exert 
disproportionate effects on their health and wellbeing. These influential settings can be viewed as high impact 
’leverage points’ for enhancing or reducing one’s health and well-being. Further, Stokols emphasises that 
rather than allocating large amounts of resources to modify individual-level behaviours, it is sometimes more 
effective to focus and change the ‘health intermediaries’, such as policies and decisions to facilitate the desired 
individual level outcomes.[31]  
The study findings are supported by Stokol’s Socio-ecological theory applications.[31] Area-level 
disadvantage contributes to the social environments of individuals living in that area. Area-level disadvantage 
(or more specifically its components) may constitute common ‘leverage’ points for the multiple CMRFs 
analysed in this study. The geographic access to primary care can be considered as the physical environment 
which has an influencing effect on the ongoing prevention and management of all the CMRFs analysed in this 
study. The implications of the findings of this study are bi-directional in relation to the past and future policies 
which determine these environments. Therefore, the related policies in the past might have caused this finding 
and the current findings have the potential to contribute evidence for the related policy changes in future. 
7.4.2 Ecosocial theory 
The findings of the study are also supported by the Ecosocial theory proposed by Nancy Krieger of the Harvard 
School of Public Health in 1994.[32] The theory specifies that distributions of disease and risk factors are 
determined at multiple levels and its analyses must incorporate all the possible levels. Further, the theory 
assumes that all factors in the multiple levels must be considered in concert, as they work cohesively in a 
synergistic way in explanation of the risk distribution. 
The key constructs of Ecosocial theory are: 1) embodiment; 2) pathways to embodiment; 3) the cumulative 
interplay of exposure, susceptibility and resistance; and the 4) agency and accountability. Embodiment denotes 
the incorporation of the social and biological world into an individual's body. Pathways to embodiment imply 
various contextual ways which interplay with the embodiment. Pathways to embodiment can affect an 
individual through various spatio-temporal scales across the life course and can be expressed at multiple levels 
including individual, community and population levels.[33]  
Cumulative Interplay explains how people with different contextual factors have different susceptibility and 
risk factors to diseases, mainly based on their unique spatio-temporal factors, interaction with the groups and 
systems and the discrimination and inequality faced throughout their life course.[33] Agency and 
Accountability argue that the State is a responsible agent in the patterns of disease distribution in a given 




society.[33] Thus, the theory suggests that the social system that creates discrimination and inequalities are 
also responsible for the patterns of disease observed in a society.[33] 
Further, Krieger expands the last construct to include that the accountability of epidemiologists and public 
health researchers in the identification and reporting of the health disparities.  This obligation is envisaged as 
a call to become an activist, rather than researchers, when injustice is observed in inequity.[33] 
The current study aligns with the Ecosocial theory of public health in multiple ways. The population 
distributions of CMRFs were identified in the study through describing the geographic variation in CMRF 
distribution in the study region. Social determinants or gradients at area-level were used as both predictors and 
covariates at different stages of the study, through the use of area-level Index of Relative Socioeconomic 
Disadvantage (IRSD). Differences in area-level access to primary care can also be seen as an area-level 
gradient, which is included as an explanatory variable in the study. Gender differences were adjusted at all 
stages of the study as an individual-level covariate. The study also accounts for the levels in the theory and 
had adopted a multilevel analysis in respect to the nesting of individual data within areas and thus within the 
study region. Overall, the study has implications regarding the Accountability of the State Agency and 
recommends changes in the political, economic and ecosystem environments to reduce the observed variation 
in multiple CMRFs in the study region. 
7.5 Significance of the research 
The findings of the study contribute evidence for practice and policy developments at regional, national and 
international levels. 
a) Regional level 
The findings from this study will contribute to the planning of area-level prevention and control of CMRFs, 
which is important in the context of CVD being the prime cause of death and health care expenditure in many 
industrialised nations, including Australia. The study also demonstrates a feasible approach for using 
population derived regional data for informing the planning and resource allocation of the health care services 
of the same region. Centralised approaches of prevention may not always suit regional requirements, but the 
use of local data can provide evidence for regional health care service planning and related policy 
developments. 
b) National level  
In Australia, previous reports have acknowledged that the health inequalities experienced by Australians are 
shaped by their broader socioeconomic circumstances.[34] Australians living in poor socioeconomic areas 
were reported as subjected to: early death [35]; higher risk for heart disease and diabetes [36]; higher mortality 
rate [37]; poor mental and physical health [38]; and to have mothers with low birthweight babies[39]. People 
living in poor socioeconomic areas in Australia were also reported to disproportionately experience: 
employment restriction due to a disability [34]; unemployment and drug abuse [40]; childhood exposure to 
tobacco smoke [34]; proportionally low spending on medical and health care [41]; and delay in consultations 
with dental professionals due to cost [42]. 
These previous reports had clearly suggested that a ‘social gradient of health’ exists in Australia.[34] The 
current study contributes to an understanding as to how these nationally recognized social gradients can be 
addressed by health services locally, i.e. the geographic distributions of health risks and the contribution of 




disadvantage can be objectively measured and resource allocation decisions made accordingly. In addition, at 
least as far as primary care access is concerned, the data suggest new thinking needs to be applied to addressing 
the inequalities at a health service level. Thus, the study provides indication of pathways from national statistics 
to evidence based-pathways for action on the ground, especially at regional level. 
In addition, Australia’s National Health Performance Framework recognises the importance of socioeconomic 
contexts on health determinants.[34] The framework includes socioeconomic circumstances in the 
determinants of health and access in the health system performance.[34] Determinants of health are the factors 
that influence health and illness. Many of the key determinants of health arise from the day to day life of an 
individual, mainly from the circumstances in which individuals live and work. The biomedical determinants 
of individual health are intertwined with the behavioural, environmental and social determinants of health.[34] 
c) Global significance 
Increasing evidence of the relationship between area-level factors and health outcomes leads us to a 
appreciation of human sensitivity to social environments. Social environments may either strengthen or 
undermine the health of individuals and communities because of their pervasive effects, which are known as 
the 'social determinants of health'.[43] 
The World Health Organization (WHO) has described social determinants as: 
“...the circumstances in which people grow, live, work and age and the systems put in place to deal with illness. 
The conditions in which people live and die are, in turn, shaped by political, social and economic 
forces…”.[44] 
 These determinants are often underplayed by economic policies and political systems leading to inequalities 
in health outcomes.[45] When these determinants are the result of simply unavoidable differences, they are 
considered as inequalities. However avoidable inequalities are considered as inequities and unjust; and require 
appropriative policy initiatives to increase equity and social justice. According to WHO, the social 
determinants can be seen as the ‘cause of the causes’, thus the fundamental determinant that influences health.  
The figure illustrates on the inward influence of the general socioeconomic environmental conditions through 
the social and community networks to the individual health.[34] The thesis provides consistent evidence on 
the contributing role of socioeconomic contexts on the geographic variations of risk factors and thus future 
disease. 
Implications for health care service planning 
It is clear from the study that there exists geographical variation in the distribution of multiple CMRFs in the 
Illawarra-Shoalhaven region of  NSW, Australia.[7] Area-level disadvantage was consistently associated with 
a range of CMRFs analysed in this study and explained a major proportion of the geographic variation in 
cardiometabolic risk distribution in the study region.[19] Higher access to primary care was associated with 
lower risk values of HDL and obesity after adjusting for age, sex and area-level disadvantage but was not 
associated with the remaining CMRFs.[46] Geographic access to primary care explained only a minimal 
proportion of the geographic variation of the higher risk CMRFs in the study region.[46] Thus, the study 
underpins the importance of the overall socioeconomic development of the areas for the area-level prevention 
and management of CMRFs and desirability of future research concerning the performance measures of 
primary care in this study region. 




With regard to the area-level health care service commissioning, the thesis findings support universal 
interventions for the prevention and control of CMRFS with a proportional priority to the need and 
disadvantage level of the populations.  As per this, the most disadvantaged areas in the study region could gain 
the highest proportion of allocation of services and resources based on the identified need. A prioritised service 
and resource allocations proportional to the disadvantage level of the areas might bring down the rates of 
higher risk CMRFs, and eventually the rates of future CVD related hospitalisations and health care expenditure 
in the study region. 
Also, it should be noted that the demonstrated non associations and the minimal contributions of the 
geographic access to primary care on the geographic variation of higher risk CMRFs should not undermine 
the contributions and existing the burden on primary care to routinely monitor and control the distributed 
CMRFs in the study region. The findings only indicate the need for future studies on other aspects of primary 
care access and their performance measures. 
7.6 Future directions and recommendations  
The section provides recommendations for policy, practice and research, including technical and content area 
considerations. 
7.6.1 Future policy directives: Better health through improving social determinants 
The WHO Commission on Social Determinants of Health (CSDH) has made global recommendations to 
reduce the health inequity between areas through acting on area-level disadvantage.[47] Improving the 
socioeconomic contexts/determinants of health is identified as the most suitable way to reduce health 
inequalities, targeting a better health for all across areas.[47] 
Evidence from the current study suggests that improvements in the overall socio-economic context of 
disadvantaged areas may reduce the inequity and thus social injustice, of the observed variation in the 
distribution of CMRFs in the study region. It is estimated that  half a million Australians could avoid chronic 
illness, $2.3 billion in yearly hospital costs saved and the Pharmaceutical Benefits Scheme prescriptions could 
be reduced by 5.3 million, if the health inequality between the most and least disadvantaged areas were 
closed.[48] 
The current study provides consistent evidence over multiple parameters for the contributing role of area-level 
socioeconomic disadvantage in the geographic inequalities in chronic disease parameters. The study also 
provides some evidence for lower risk factors in areas with better access to primary care. Over and above these 
findings, the study also demonstrates data and methodological approaches to address the health inequalities by 
health services and regional area-level planning authorities.  
The WHO recommends adopting a ‘health in all policy’ approach to address the socioeconomic determinants 
of health. The approach suggests policies and interventions from all sectors and levels – to focus and be 
oriented with the health of individuals and thus of populations and nations.[49] However, there are still many 
barriers in adopting a socioeconomic determinant approach.  
7.6.2 Future Research directions for the extension of current findings 
The area-level associations of high TC were often the reverse to other CMRFs analysed in this study. This 
indicates a need for further studies to explore individual and area-level factors contributing to the geographic 
distribution of high TC findings in the study region. 




Extension of the findings of this study requires inclusion of additional individual and area-level factors to help 
explain the geographic variation of CMRFs. The current study explains a maximum of 54.7% (on low HDL) 
of area-level variation. Inclusion of more individual and area-level factors may help to derive the contribution 
of the remaining factors not included in the current study. Other individual and area-level factors not 
considered in this study but could be considered in future, include: individual-level SES[50]; type of 
neighbourhood food outlets[51-54]; physical activity resources [55-57]; residential density and service 
availability[58]; social cohesion or social capital [59] of the SA1s; environmental pollution[60]; effect of  
diurnal cycles of light and day, sunlight exposure, seasons, altitude, latitude and greenspaces [61]; other 
environmental risk factors[62]; and effect of existing area-level policy interventions to reduce CVD risk [63].  
7.7 Thesis strength and limitations 
A key strength of this study is that it simultaneously analysed a range of eight individual CMRFs identified 
from the same study region. Consistent evidence on multiple risk factors adds to the diverse nature of the 
distribution and associations of the risk factors analysed. 
The multilevel analytical approaches used in the study accounts for the nesting of individual-level data within 
different geographic areas. The principal task of multilevel modelling was to decompose the total individual 
level variance in its components.[21] Area-level generalisations of the findings were possible with the use of 
random intercepts in a multilevel model. Multilevel models allowed for the estimation of associations between 
specific area-level characteristics and binary measures of individual-level CMRF outcomes. It also allowed 
for the analysis of small-area variation and their indices, without disregarding the within-group individual-
level variations.[21] 
Also, the study used the smallest available geographic units for the area-level analyses. Statistical Area level 
1 (SA1) is the smallest geographic unit for the release of census data in 2011 ABS census.[57] Level 1 
Statistical Areas generally have a population of 200 to 800 persons (400 average) and the ISR covers a total 
of 980 conterminous SA1s. The use of small-area in the models has the potential to improve the estimate 
quality and enhance the area-level precision of understanding the health inequalities.[64] 
The study region covers both urban and rural areas and the CMRF data used in the study have a near census 
coverage of the residential population.[7, 65]  However, area-level impacts of rural and urban areas were not 
analysed in this study as the study region in this thesis is dichotomously divided into rural areas in the south 
and urban areas in the north. Hence, including a rural-urban analysis would likewise be not informative. While 
acknowledging possible impacts of rural-urban status on the global distribution of CMRFs, the geographic 
nature of the study region in this thesis is considered not suitable for such analyses. 
 The CMRFs data used in the study were population derived and consisted of data extracted from 256, 525 
adult residents of ISR, including 144, 418 (56.3%) women. Overall, the Illawarra-Shoalhaven region in 
Australia had an estimated residential population of 369, 469 in Australian Bureau of Statistic (ABS) Census 
of Population and Housing in year 2011, of which 285, 385 (77.24%) were adults (>=18 years). This indicates 
the population coverage of the study data, even though obtained from a privately functioning network of 
service providers. 
The study has to be considered with its limitations: Firstly, the cross-sectional design of the study precludes 
any causal inferences. In addition, the non-linear and time varying effects of covariates analysed in this study 
restrict generalisability of their findings.[66] Secondly, the study data were obtained from people already using 




health care service facilities from the region. This limits representation of point-estimates to the general 
population.[66] However, it should also be noted that the study sample had a near census coverage of the adult 
population residing in this region during the study period. Also it should be noted that further individual-level 
data additions were not possible with this dataset as the de-identification process precluded the inclusion of 
any further individual level data. Thus the de-identified dataset does not support any further individual-level 
explorations into lifestyle related risk factors such as high blood pressure, poor dietary habits, inadequate 
exercise, sedentary life style patterns and smoking.  
Thirdly, the individual and area-level explanatory variables in this thesis are limited. The de-identified dataset 
used in this thesis does not support any further explorations into individual-level attributes such as individual-
level SES, hypertension, poor dietary habits, inadequate exercise, sedentary lifestyle patterns, and smoking.  
Area-level explanatory variables were limited to area-level disadvantage and primary care access of the study 
region. Other area-level factors not analysed in this study, but with potential to be associated with the outcome 
variables, could include the type of neighbourhood food outlets [51-54]; physical activity resources [55-57]; 
residential density and service availability[58]; social cohesion or social capital [59] of the SA1s; 
environmental pollution [60]; effect of diurnal cycles of light and day, sunlight exposure, seasons, altitude, 
latitude and greenspaces [61]; other environmental risk factors[62]; and effect of existing area-level policy 
interventions to reduce CVD risk [63]. I acknowledge that adjusting for a spectrum of individual and area-
level covariates could potentially derive a more precise estimate of the contribution of area-level disadvantage 
in the study region. However, it should also be noted that unravelling the individual and area-level attributions 
of the observed geographic variation of CMRFs were not the primary intention in this thesis, but informing 
regional health care service commissioning on the evidence-based need for targeted area-level approaches for 
the prevention and control of the observed CMRFs distribution in the study region which is achieved in this 
thesis.  
The standard practice in Australia and globally is to use the raw and/or standardised rates to inform health care 
service commissioning as they are a more realistic representation of the volume of morbidity distributed in a 
population.[34] Previous research indicates that unpacking the effects of covariates should be both attributable 
and responsive to policy changes[67, 68], and research reports from Australia indicate that adjusted rates may 
mask the actual volume of service requirments in an area[69]. Also it is worth noting that albeit the health 
service planning principles in Australia is person focused, the actual design/types of planning are done is for:1) 
geographical catchments; 2) population groups; 3) clinical service streams/areas such as, prevention, primary 
care, ambulatory care, acute care, sub-acute care and mental health.[70] The study 3 reports age and sex 
standardised effects of area-level disadvantage on CMRFs, and  these estimates are more likely to be 
informative for area-level health care service commissioning and related health policy developments rather 
than a spectrum of covariate adjusted estimates. A classic complex    systems    model    of    public    health    
conceptualises  health  inequalities  as  outcomes  of  a  multitude  of  interdependent  elements  within  a  
connected  whole.[71] However, it is worth noting that rhetoric complex systems approaches to public health 
in academic research is only rarely operationalized to generate relevant policies.[71, 72] Complex attribution 
structuring should definitely be of academic research interest but may actually complicate and possibly nullify 
the information required for the health care service commissioning. Therefore, while acknowledging the 
possible direct and subtle attributions of a range of individual and area-level covariates on the estimated effects 




of area-level disadvantage on CMRFs, their unravelling is not intended in this thesis given them main purpose 
of this study that is to inform area-level health care service commissioning.  
Fourthly, the IRSD measure used in the study has limitations intrinsic to aggregate measures. The IRSD is one 
of four Socio‐Economic Indexes for Areas (SEIFA) based on socioeconomic status. The IRSD summarises a 
range of measures of relative socioeconomic disadvantage of people and households within SA1s and includes: 
level of income; education; employment; family structure; disability; housing; transportation; and internet 
connection.[65] The IRSD scores of the SA1s were accessed from the published data of 2011 Australian 
census and a higher score indicated lower levels of disadvantage.[65] Despite the widespread acceptance of 
these measures in the Australian literature, the aggregate nature of this measure does not account for the 
heterogeneity of the people residing within a given area.[73] Fifthly, the primary care access measured in this 
study is limited to a radial buffer distance of 30 km. The 2SFCA method used in the study to calculate access 
uses this radial buffer distance to define the catchment areas both from the service provider locations and from 
the geographic centroids of the analysis units. In the preliminary stage of this study, sensitivity analyses were 
performed using 1 km, 16 km and 30 km spatial buffer distances. The 1 km radial buffer distance from the 
primary care provider locations covered only 545 (56%) SA1 centroids in the study region, whereas as a 16 
km radial buffer distances covered 973 (~99%) and 30 km radial buffer distance covered 978 (~100%) SA1 
centroids.  Therefore, a radial buffer distance of 30 km was chosen to determine the primary care access of the 
SA1s. This radial distance was observed to cover the mixed rural, semi-rural and urban distribution of the 
population in the study region well, more adequately than the distances used in the sensitivity analyses. 
Finally, the multilevel logistic regression models and the variance partitioning approach adopted in this thesis 
has limitations intrinsic to their methodology. The  assumptions of the standard multilevel logistic regression 
modelling methods adopted in this thesis would not be able to account for the autocorrelation of the area-level 
residuals (if any) of the models. Simulated results comparing the outcomes of standard multilevel models and 
spatial models indicate that both of these methods produce similar fixed effect estimates, but can vary in their 
random effect estimates.[74] Previous work demonstrates that both the multilevel and spatial models tend to 
overestimate the corresponding random effects variances compared with hybrid models.[74, 75] However, we 
observe that this potential overestimation is not likely to be substantial in the thesis results as the area-level 
variance shown in all the models was quite small. This is demonstrated by the very low ICC and MOR values 
of our models, which can be interpreted as demonstrating   very small or no area-level difference.[21] In 
addition, hybrid models are harder to adopt for use with individual level de-identified data such as the data 
used in this thesis.[74, 75] More accurate geo-referencing of individuals would be necessary to implement 
such models, especially to account for the correlation of residuals of neighbouring units compared with those 
far apart.[75] We observe that is beyond the scope of our data type and location specifications. We also 
observed that artificial/simulated attempts to overcome this data specification requirement through random 
distribution of samples at constant distances within areas,[75] would not sufficiently reflect the actual nature 
and distribution of populations in our study areas especially as it consists of a range of highly dense and very 
sparsely populated areas within the study region.  While acknowledging this limitation, I believe the effects 
of this are not critical in the results. Also, the variance partitioning approach adopted in this thesis may not 
fully reflect the impact of contextual variables, especially the interactions among area-level and individual-
level factors. It is possible that there could be existing relations between the lower-level variable (e.g. higher 




age group of the sample), which changes as a function of the upper-level variable (e.g. higher area-level 
disadvantage) but not captured within the variance partitioning approach of the binary outcome CMRF 
variables of the study.[76] Analysis of such cross-level interactions and between variable interactions were  
not a focus in this thesis though they might be of potential epidemiological utility [59], as their outcomes were 
not believed to add information for health care service planning  which is the primary intention of this research. 
Notwithstanding these limitations, the thesis is novel in that it analysed a range of CMRFs across a widely 
dispersed population and included both rural and urban residents. In addition, the thesis used six years (year 
2012 – 2017) of CMRF tests data from the region in the hierarchical multilevel analyses. The findings of the 
thesis indicate that there is a significant geographic variation in the distribution of CMRFs in the study region. 
Those residing in the most disadvantaged areas are more likely to be identified with higher risk CMRFs than 
those in lower disadvantage areas. Also, the thesis suggests higher odds of being identified with low HDL and 
obesity with reduced access to primary care.  However, the low ICC and MOR values of the area-level models 
in the thesis do not support for contextual approaches. Rather, the findings of the study support a proportionate 
universalism approach in which health resources are made universally available but proportional to the need 
and disadvantage level of the affected population.[22, 23] 
7.8 Conclusion 
The thesis has made a significant contribution to understanding the geographic variation of cardiometabolic 
risk factors in the Illawarra-Shoalhaven region of NSW, Australia. The study reports associations of area-level 
disadvantage and area-level access to primary care with CMRF distribution. The findings arising from this 
thesis have demonstrated that area-level disadvantage explains a large proportion of the geographic variation 
of CMRFs in the study region. The results support future investigations into whether public health activities 
or interventions in primary care, targeted to localities with greater area-level disadvantage, can ameliorate 
CMRFs. Based on the findings, the thesis recommends evidence based universal and proportionate 
interventions to priority populations for the prevention and control of CMRFs. These findings can be used to 
inform regional health care service commissioning and related policy developments; and are highly relevant 
in the context of the global paradigm shift from communicable diseases to cardiovascular diseases (CVD) as 
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Appendix I: Search stratecgy 
Appendix I (a): Literature Search Strategy  for Article 1) 
Database: Ovid MEDLINE(R) <2001 to November 30, 2018> 
Search Strategy: 
--------------------------------------------------------------------------------  
1     cardiometabolic.ti, ab, mp. (6616) 
2     cardio metabolic.ti, ab, mp. (1069) 
3     metabolic syndrome.ti, ab, mp. (42423) 
4     metabolic risk.ti, ab, mp. (3856) 
5     Geographic.ti, ab, mp. (69264) 
6     Geospatial.ti, ab, mp. (1148) 
7     Spatial.ti, ab, mp. (211880) 
8     regional variation.ti, ab, mp. (3211) 
9     area socioeconomic.ti, ab, mp. (147) 
10     neighbo?rhood socioeconomic.ti, ab, mp. (658) 
11     area poverty.ti, ab, mp. (38) 
12     neighbo?rhood deprivation.ti, ab, mp. (346) 
13     1 or 2 or 3 or 4 (49526) 
14     5 or 6 or 7 or 8 9 or 10 or 11 or 12 (274223) 
15     13 and 14 (166) 


















Appendix I (b): Search URLs for Article 1 













Search history  
 ( TITLE-ABS-KEY ( geographic  OR  geospatial  OR  spatial  OR  regional  AND  variation )  OR  TITLE-
ABS-KEY ( area  AND  socioeconomic  OR  area  AND  socioeconomic  OR  neighbo?rhood  AND  
socioeconomic  OR  area  AND  poverty  OR  neighbo?rhood  AND  deprivation )  AND  TITLE-ABS-KEY 
( cardiometabolic  OR  "cardio metabolic"  OR  "metabolic syndrome"  OR  "metabolic risk" ) )  AND  
PUBYEAR  >  2000  AND  ( LIMIT-TO ( LANGUAGE ,  "English" ) )  AND  ( LIMIT-TO ( 
EXACTKEYWORD ,  "Human" )  OR  LIMIT-TO ( EXACTKEYWORD ,  "Humans" )  OR  EXCLUDE ( 
EXACTKEYWORD ,  "Adolescent" )  OR  EXCLUDE ( EXACTKEYWORD ,  "Nonhuman" )  OR  
EXCLUDE ( EXACTKEYWORD ,  "Child" ) ) 











Filters activated: Publication date from 2001/01/01 to 2018/11/30, Humans, English, Adult: 19+ years. 
 








Appendix II: List of Excluded Full Text Studies With Reason in Article 1 
 Excluded studies Reason 
1 Inoue, Y., et al. Neighborhood Characteristics and 
Cardiovascular Risk among Older People in Japan: 
Findings from the JAGES Project. PLoS ONE .[Electronic 
Resource] 11, e0164525 (2016).  
‘Accident prone perception ‘is the 
ASED proxy measurement. 
 
2 Sundquist, K., Eriksson, U., Mezuk, B. & Ohlsson, H. 
Neighborhood walkability, deprivation and incidence of 
type 2 diabetes: a population-based study on 512, 061 
Swedish adults. Health Place 31, 24-30 (2015).  
‘Neighbourhood deprivation’ is 
used as a control in analyses. 
 
3 Congdon, P. Estimating diabetes prevalence by small area 
in England. J Public Health (Oxf) 28, 71-81 (2006).  
Methodology oriented paper. 
4 Mezuk, B. et al. Depression, neighborhood deprivation and 
risk of type 2 diabetes. Health Place 23, 63–69 (2013). 
Depression patients are the study 
population. 
 
5 Stoddard, P. J. et al. Neighborhood deprivation and change 
in BMI among adults with type 2 diabetes: the Diabetes 
Study of Northern California (DISTANCE). Diabetes Care 
36, 1200–1208 (2013). 
Diabetic patients are the study 
population. 
 
6 Chaikiat, A., Li, X., Bennet, L. & Sundquist, K. 
Neighborhood deprivation and inequities in coronary heart 
disease among patients with diabetes mellitus: a multilevel 
study of 334, 000 patients. Health Place 18, 877–882 
(2012). 
Diabetic patients are the study 
population. 
 
7 Yu, Z., et al. Obesity related metabolic abnormalities: 
distribution and geographic differences among middle-
aged and older Chinese populations. Prev Med 48, 272-278 
(2009) 
Non-continuous geographic units 
(i.e prevalence in two cities in the 
north and south of country are 
compared, and its urban/ rural cross 
differences were focussed) 
8 Chichlowska, K.L., et al. Individual and neighborhood 
socioeconomic status characteristics and prevalence of 
metabolic syndrome: the Atherosclerosis Risk in 
Communities (ARIC) Study. Psychosom Med 70, 986-992 
(2008). 
No results on discrete CMRFs or its 
association with ASED. 
9 Ardern, C.I. & Katzmarzyk, P.T. Geographic and 
demographic variation in the prevalence of the metabolic 
syndrome in Canada. Can 31, 34-46 (2007). 
No results on discrete CMRFs or its 






10 Traissac, P., et al. Abdominal vs. overall obesity among 
women in a nutrition transition context: geographic and 
socio-economic patterns of abdominal-only obesity in 
Tunisia. Population health metrics 13, 1-1 (2015). 
Obesity results are not presented 
due to small (1.4%) overall 
prevalence (waist circumference 
defined as abdominal adiposity is 
focussed). 
11 Jones, M. & Huh, J. Toward a multidimensional 
understanding of residential eighbourhood: a latent profile 
analysis of Los Angeles neighborhoods and longitudinal 
adult excess weight. Health Place 27, 134-141 (2014) 
Geographic area based results were 
not available. Also minimal data on 
ASED – but three types of 
neighbourhoods based on ‘social 
context variables’ were identified 
in the study. 
13 Kandala N-B, Manda SOM, Tigbe W, Mwambi H, 
Stranges S. Geographic distribution of cardiovascular 
comorbidities in South Africa: a national cross-sectional 
analysis. Journal of Applied Statistics 2014;41(6):1203-
1216 
Age group of the study sample 
(aged 15 and over) are under the 
review defined adult age group (18 





Appendix III: PRISMA 2009 Checklist for Article 1 
Section/topic  # Checklist item  
Reported on 




Geographic and area-level socioeconomic variation in cardiometabolic risk factor distribution: A systematic review of the literature 1 
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT  2 
Structured 
summary  
2 Provide a structured summary including, as applicable: background; objectives; data sources; 
study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; 
results; limitations; conclusions and implications of key findings; systematic review registration 
number.  
2 
INTRODUCTION  3-4 
Rationale  3 Describe the rationale for the review in the context of what is already known.  3 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, 
interventions, comparisons, outcomes, and study design (PICOS).  
4 
METHODS  4-6 
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if 
available, provide registration information including registration number.  
4 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., 




7 Describe all information sources (e.g., databases with dates of coverage, contact with study 
authors to identify additional studies) in the search and date last searched.  
4-5 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that 
it could be repeated.  
4-5 
 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, 







10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) 
and any processes for obtaining and confirming data from investigators.  
5-6 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made.  
5-6 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of 
whether this was done at the study or outcome level), and how this information is to be used in any 




13 State the principal summary measures (e.g., risk ratio, difference in means).  6 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including 




















Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication 




16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), 
if done, indicating which were pre-specified.  
6 
RESULTS  6-11 
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with 




18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, 
follow-up period) and provide the citations.  
7-11 
Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if available, any outcome level assessment (see 





20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary 
data for each intervention group (b) effect estimates and confidence intervals, ideally with a 





21 Present results of each meta-analysis done, including confidence intervals and measures of 
consistency.  
NA 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias across studies (see Item 15).  13 
Additional 
analysis  
23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-




DISCUSSION  11-13 
Summary of 
evidence  
24 Summarize the main findings including the strength of evidence for each main outcome; 
consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).  
11 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., 





Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications 
for future research.  
12 
FUNDING  15 
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); 
role of funders for the systematic review.  
15 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): 





Appendix IV: SIMLR Data Extraction Document 
Appendix IV (a): SIMLR Study Data Extraction and Supply Documentation 
This document describes the preparation and extraction of data from the Southern.IML Research (SIMLR) 
Study database for the project listed below. Access to, and use of, these data are subject to all conditions 
imposed by a responsible Human Research Ethics Committee, the SIMLR Data Access Agreement and the 
SIMLR Study Management Committee. You should contact the SIMLR Management Committee and your 
responsible Human Research Ethics committee immediately if you are unable to comply with any conditions 
of access, or use or if you become aware that any of these conditions have been breached. 
Project: An epidemiological study of chronic disease parameters at regional level, in view 
of developing a cardiometabolic risk map to facilitate regional planning activities. 
Researcher(s): Renin Toms, Andrew Bonney, Xiaoqi Feng, Darren Mayne 
Ethics reference: 2017/124 
Data extraction by: Darren Mayne 
Data extraction date: Initial:  06 February 2018 
Updated: 23 March 2018  
Updated: 09 April 2018 (fixed incorrectly assigned SA1 location at time 
of testing) 
Data extraction format: Coma Separated Values (*.CSV) 
File names: RMBST288_TOMS_RENIN_PHD_DATA_EXTRACT_20180409.CSV 
Number of records: 256, 526 
Document version: 1.1 
Document date: 09 April 2018 
 
Study sample 
Data were extracted from the SIMLR database for all non-pregnant persons aged ≥18 years with ≥1 
cardiometabolic analyte result between 01 January 2012 and 31 December 2017. For each person, the most 
recent cardiometabolic test result was extracted to maximise its temporal alignment with residential location at 
time pathology testing. 
Variables 
Sex 
The sex of individual patients is based on that recorded for their most recent episode of care (test result). We 
have received previous advice from Southern.IML Pathology Pty Ltd that this value is considered the most 
accurate record of gender status. 
Diabetes status 
Fasting blood sugar level (FBSL) tests within  24 months of glycated haemoglobin (HbA1c) test dates were 
matched for each individual. Each testing record was then coded as algorithm-positive for diabetes if either the 
HbA1c result was ≥ 6.5% or had an associated FBSL result ≥ 7.0 mmol/L within 24 months. Diabetes case 
definition status (diab_status) was set to “Yes” for patients the first time the algorithm criterion was met, and 
then propagated throughout the data set for subsequent testing records. The diabetes diagnosis date (diab_date) 
corresponds to the date of the HbA1c or FBSL used to assign algorithm-positive status, which may be used as 
a proxy for time with disease. We are currently preparing a paper on the performance of this algorithm for 
identifying patients with diabetes in administrative databases that you will be able to reference. 
Cardiometabolic analytes 
The extract includes the following cardiometabolic analyte variables: fasting blood sugar levels (FBSL), 
glycated haemoglobin (HbA1c), high density lipoprotein (HDL) and total (TC) cholesterol, albumin creatine 
ratio (ACR), estimated Glomerular Filtration Rate (eGFR), and body mass index (BMI). For each of these 
analytes the following variables are provided: collection date (collection_date); age group at time of collection 
(collection_age05grp); test value in standard units (test_value_num); geocoding match status for residential 





time of collection (sa1_2011_code); 2011 Index of Relative Socioeconomic Advantage/Disadvantage for 
geocoded SA1 at time of collection (irsad_2011_quintile); 2011 Index of Relative Socioeconomic 
Disadvantage for geocoded SA1 at time of collection (irsd_2011_quintile); 2011 Index of Economic Resources 
for geocoded SA1 at time of collection (ier_2011_quintile); 2011 Index of Education and Occupation for 
geocoded SA1 at time of collection (ieo_2011_quintile). For most records, geocoding-based variables will be 
the same for all analytes; however, as the collection date between analytes increases for an individual, so does 
the probability that they will have moved to a residential location in a different quintile. We recommend using 
the quintile covariates that correspond to the outcome in your analysis. 
Data completeness 
Two data completeness variables are included in the extract to guide case selection for analysis. The number 
of missing test results (nmiss_test_results) indicates the number of analytes with missing values either because 
the test has never been requested or the most recent test predates 01 January 2012. The complete case status 
(complete_case) variable indicates if the current record is complete (complete_case = Y, i.e. no missing test 
results) or incomplete (complete_case = N, i.e. ≥ 1 missing analyte). 
Table A.1 Variable names, types, values and descriptions for study data 
Variable Type Values Description 
enc_project_id Character  Encrypted patient identifier 
epi_sex Character M = Male 
F = Female 
Sex 
diab_status Character No 
Yes (incident) 
Yes (prevalent) 
Diabetes status from SIMLR 
classification algorithm 
diab_date Date YYYY-MM-DD Diabetes date from SIMLR 
classification algorithm 
fbsl_collection_date Date YYYY-MM-DD Fasting BSL collection date 














Fasting BSL age group 
fbsl_test_value_num Numeric 0.7–43.9 Fasting BSL test value (mmol/L) 
fbsl_geo_match_status Character Exact address 
Exact street 
Exact suburb 
Fasting BSL geocoding match status 
fbsl_sa1_2011_code Character 11-digit ABS code Fasting BSL SA1 of residence 
fbsl_irsad_2011_quintile Character Q1 = Quartile 1 (Disadv) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Adv) 
Fasting BSL IRSAD quintile 
fbsl_irsd_2011_quintile Character Q1 = Quartile 1 (Most) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Least) 





Variable Type Values Description 
fbsl_ier_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
Fasting BSL IER quintile 
fbsl_ieo_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
Fasting BSL IEO quintile 
hba1c_collection_date Date YYYY-MM-DD HbA1c collection date 














HbA1c collection age group 
hba1c_test_value_num Numeric 2.6–17.8 HbA1c test value (%) 
hba1c_geo_match_status Character Exact address 
Exact street 
Exact suburb 
HbA1c geocoding match status 
hba1c_sa1_2011_code Character 11-digit ABS code HbA1c SA1 of residence 
hba1c_irsad_2011_quintile Character Q1 = Quartile 1 (Disadv) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Adv) 
HbA1c IRSAD quintile 
hba1c_irsd_2011_quintile Character Q1 = Quartile 1 (Most) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Least) 
HbA1c IRSD quintile 
hba1c_ier_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
HbA1c IER quintile 
hba1c_ieo_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
HbA1c IEO quintile 





Variable Type Values Description 














HDL collection age group 
hdl_test_value_num Numeric 0.06–5.76 HDL test value (mmol/L) 
hdl_geo_match_status Character Exact address 
Exact street 
Exact suburb 
HDL geocoding match status 
hdl_sa1_2011_code Character 11-digit ABS code HDL SA1 of residence 
hdl_irsad_2011_quintile Character Q1 = Quartile 1 (Disadv) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Adv) 
HDL IRSAD quintile 
hdl_irsd_2011_quintile Character Q1 = Quartile 1 (Most) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Least) 
HDL IRSD quintile 
hdl_ier_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
HDL IER quintile 
hdl_ieo_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
HDL IEO quintile 
tc_collection_date Date YYYY-MM-DD TC collection date 














TC collection age group 
tc_test_value_num Numeric 1.08–39.42 TC test value (mmol/L) 
tc_geo_match_status Character Exact address 
Exact street 
Exact suburb 





Variable Type Values Description 
tc_sa1_2011_code Character 11-digit ABS code TC SA1 of residence 
tc_irsad_2011_quintile Character Q1 = Quartile 1 (Disadv) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Adv) 
TC IRSAD quintile 
tc_irsd_2011_quintile Character Q1 = Quartile 1 (Most) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Least) 
TC IRSD quintile 
tc_ier_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
TC IER quintile 
tc_ieo_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
TC IEO quintile 
acr_collection_date Date YYYY-MM-DD ACR collection date 














ACR collection age group 
acr_test_value_num Numeric 0.1–1291.5 ACR test value (mcg/L) 
acr_geo_match_status Character Exact address 
Exact street 
Exact suburb 
ACR geocoding match status 
acr_sa1_2011_code Character 11-digit ABS code ACR SA1 of residence 
acr_irsad_2011_quintile Character Q1 = Quartile 1 (Disadv) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Adv) 
ACR IRSAD quintile 
acr_irsd_2011_quintile Character Q1 = Quartile 1 (Most) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Least) 
ACR IRSD quintile 
acr_ier_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 





Variable Type Values Description 
acr_ieo_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
ACR IEO quintile 
egfr_collection_date Date YYYY-MM-DD eGFR collection date 














eGFR collection age group 
egfr_test_value_num Numeric 2–91 
91 = >60 or >90 
eGFR test value (mL/min/1.73m2) 
egfr_geo_match_status Character Exact address 
Exact street 
Exact suburb 
eGFR geocoding match status 
egfr_sa1_2011_code Character 11-digit ABS code eGFR SA1 of residence 
egfr_irsad_2011_quintile Character Q1 = Quartile 1 (Disadv) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Adv) 
eGFR IRSAD quintile 
egfr_irsd_2011_quintile Character Q1 = Quartile 1 (Most) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Least) 
eGFR IRSD quintile 
egfr_ier_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
eGFR IER quintile 
egfr_ieo_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
eGFR IEO quintile 





Variable Type Values Description 














BMI collection age group 
bmi_test_value_num Numeric 11.2–181.0 BMI test value (kg/m2) 
bmi_geo_match_status Character Exact address 
Exact street 
Exact suburb 
BMI geocoding match status 
bmi_sa1_2011_code Character 11-digit ABS code BMI SA1 of residence 
bmi_irsad_2011_quintile Character Q1 = Quartile 1 (Disadv) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Adv) 
BMI IRSAD quintile 
bmi_irsd_2011_quintile Character Q1 = Quartile 1 (Most) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (Least) 
BMI IRSD quintile 
bmi_ier_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
BMI IER quintile 
bmi_ieo_2011_quintile Character Q1 = Quartile 1 (Low) 
Q1 = Quartile 2 
Q1 = Quartile 3 
Q1 = Quartile 4 
Q1 = Quartile 5 (High) 
BMI IEO quintile 
nmiss_test_results Numeric 0–6 Number of missing test results 
complete_case Character Y = Yes 
N = No 







Appendix IV (b): Data Extraction Program 
 
**************************************************************************; 
* Program:    SIMLR_PREVALENT_DIABETES_2010_TO_2014 
* Version:    01 
* Author:     Darren Mayne   
* Date:       28 November 2016 
* Contact:    darren.mayne@health.nsw.gov.au   
* Purpose:    Extracts data from SIMLR Study database for diabetes 
incidence 
* Sub macros: METADATA 
* Notes:      Requires access to the SIMLR_GEO_MERGED.accdb database on the 
*             \\shares3.its.uow.edu.au\1000206_simlr_raw$ share 
* 
*             Share location 




*             hba1c_mean_updated_year = financial year NOT calendar year 
*==========================================================================  
* PARAMETERS:  
* -Name---------------- -Description---------------------------------------  
*                                              
*==========================================================================  
* AMENDMENT HISTORY: 
* -Ini- -Date-- -Id---- -Description---------------------------------------  
*                        
*==========================================================================  
* This is public domain software. No guarantee as to suitability or 
accuracy is  
* given or implied. Users use this code entirely at their own risk. 
**************************************************************************; 
 
**** Session settings ****; 
 








    %if %upcase(&load) eq YES %then %do; 
        %include "S:\1000206_simlr_raw\SIMLRGEO\_merged_extracts\SIMLR 
Standardised Data Extracts Code.sas"; 











    create table seifafmt as 





            "$sa1adv" as fmtname,  
            ses_sa1_2011_code as start,  
            ses_irsad_2011_quintile as label,  
            "C" as type 
        from ses; 
    insert into seifafmt 
        select 
            "$sa1dis" as fmtname,  
            ses_sa1_2011_code as start,  
            ses_irsd_2011_quintile as label,  
            "C" as type 
        from ses; 
    insert into seifafmt 
        select 
            "$sa1ier" as fmtname,  
            ses_sa1_2011_code as start,  
            ses_ier_2011_quintile as label,  
            "C" as type 
        from ses; 
    insert into seifafmt 
        select 
            "$sa1ieo" as fmtname,  
            ses_sa1_2011_code as start,  
            ses_ieo_2011_quintile as label,  
            "C" as type 
        from ses; 
quit; 
             
proc format library=work cntlin=seifafmt; 
    value age05grp 
        18-24   = "18-24" 
        25-29   = "25-29" 
        30-34   = "30-34" 
        35-39   = "35-39" 
        40-44   = "40-44" 
        45-49   = "45-49" 
        50-54   = "50-54" 
        55-59   = "55-59" 
        60-64   = "60-64" 
        65-69   = "65-69" 
        70-74   = "70-74" 
        75-79   = "75-79" 
        80-84   = "80-84" 
        85-high = "85+" 








**** Reference list of test codes and names ****; 
 
* Create Test Name display format; 
 
proc sql; 
    create table TestName as 
        select distinct 
            res_test_code,  





            res_test_name 
    from WORK.RES 
    order by res_test_code; 
quit; 
 
**** Create Episode-Results table with one result per day ****; 
 
* NOTE: Some patients have multiple results for the same test per day. As 
we 
        have no reason to prefer one over the other(s) we simply average 
over 




    create table WORK.EPIRES as 
        select 
            a.epi_patient_id,  
            a.epi_sex,  
            a.epi_collection_date,  
            a.epi_collection_age,  
            a.epi_study_id,  
            b.res_test_code,  
            b.res_test_mnemonic,  
            mean(b.res_test_value_num) as res_test_value_num length=8 
informat=best. format=best.,  
            count(*) as res_test_count length=3 informat=best. format=best. 
        from WORK.EPI as a inner join WORK.RES as b on 
a.epi_episode_id=b.res_episode_id 
        where a.epi_sex ~= "P" /*and year(a.epi_collection_date) >= 2012*/ 
        group by  
            a.epi_patient_id,  
            a.epi_sex,  
            a.epi_collection_date,  
            a.epi_collection_age,  
            a.epi_study_id,  
            b.res_test_code,  
            b.res_test_mnemonic 
        order by  
            a.epi_patient_id,  
            b.res_test_code,  
            a.epi_collection_date; 
    create index epi_patient_id 
        on work.epires (epi_patient_id);  
quit; 
 






1.  No HbA1c before 01-JAN-2012 AND  
 
    i.  1+ HbA1c on or after 01-JAN-2012 AND 
 
        a.    HbA1c >= 6.5% (WHO, 2011; ABS, 2013) OR 










1.  1+ HbA1c on or after 01-JAN-2012 AND 
 
    i.  1+ HbA1c before 01-JAN-2012 AND 
 
        a. HbA1c >= 6.5%  (WHO, 2011; ABS, 2013) OR 





* Extract HbA1c results and match to Fasting BSL results within 12 months; 
 
proc sql; 
    create table _diabetes as 
        select 
            epi_patient_id,  
            epi_collection_date,  
            res_test_code,  
            res_test_mnemonic,  
            res_test_value_num  
        from epires 
        where res_test_code = "E0190" and year(epi_collection_date) <= 2017 
        order by epi_patient_id, epi_collection_date; 
    create table diabetes as 
        select 
            a.epi_patient_id,  
            a.epi_collection_date,  
            a.res_test_code,  
            a.res_test_mnemonic,  
            a.res_test_value_num,  
            b.epi_collection_date as fbsl_collection_date,  
            b.res_test_value_num as fbsl_test_value_num,  
            case 
                when (b.epi_collection_date = .) then (a.res_test_value_num 
>= 6.5) 
                else (b.res_test_value_num >= 7.0) * (-365 <= 
(a.epi_collection_date - b.epi_collection_date) <= 365) 
            end as diabetes length=3 informat=1. format=1.,  
            min(case 
                when (calculated diabetes = 1) then a.epi_collection_date 
                else "31DEC2999"d 
            end) as diab_diag_date length=8 informat=best. 
format=yymmddd10. 
        from _diabetes as a 
            left join (select * from epires where res_test_code = "C0210") 
as b 
        on a.epi_patient_id = b.epi_patient_id  
        group by a.epi_patient_id 
        having diabetes = 1 and (2012 <= year(a.epi_collection_date) <= 
2017) 
        order by a.epi_patient_id, a.epi_collection_date, 
b.epi_collection_date; 
    drop table _diabetes; 
quit; 
 
* Extract first (diagnostic) HbA1c result: 
 
  If 01-JAN-2003 to 31-DEC-2011 then prevalent case 







    set diabetes; 
    by epi_patient_id; 
 
        diabetes = diabetes + (diab_diag_date <= "31DEC2011"d); 
 
        if first.epi_patient_id then output; 
run; 
 
**** Select most recent test result for each patient ****; 
 
* Select in-scope tests; 
 
data _epires; 
    set epires(drop = res_test_count); 
    by epi_patient_id res_test_code epi_collection_date; 
    where res_test_code in ("C0080", "C0090", "C0169", "C0210", "C1855", 
"C7920", "E0190"); 
 




* Transpose into long format; 
 
proc transpose data=_epires out=_epires; 
    var epi_collection_date 
        epi_collection_age 
        epi_study_id 
        res_test_value_num; 
    by  epi_patient_id 
        epi_sex 
        notsorted res_test_mnemonic; 
run; 
* Get value ranges; 
 
proc sql; 
    create table test_value_ranges as 
        select 
            res_test_mnemonic,  
            min(col1) as minimum,  
            max(col1) as maximum 
        from _epires 
        where index(_name_, "num") >= 1 
        group by res_test_mnemonic; 
quit; 
 
* Create unique names for variable properties for each test; 
 
data _epires; 
    attrib epi_patient_id                                         label = " 
" 
           epi_sex                                                label = " 
" 
           res_test_variable length=$25 informat=$25. format=$25. label = " 
" 
           value                                                  label = " 
"; 






        res_test_variable = compress(res_test_mnemonic || substr(_name_, 
4)); 
 
    drop res_test_mnemonic _name_; 
run; 
 
* Transpose into wide format; 
 
proc transpose data=_epires out=_epires; 
    var value; 
    by epi_patient_id  
       epi_sex ; 
    id res_test_variable; 





**** Create final data set ****; 
 
* Combine test results, diabetes status, and geographic variables; 
 
proc sql noprint; 
    select max(length(put(epi_patient_id, best.))) * 2 into :idlen from 
_epires; 
    create table rmbst288 as 
        select 
            a.epi_patient_id,  
            trim(left(put(a.epi_patient_id, best.))) as enc_project_id 
length=&idlen label="Encrypted patient identifier",  
            . as raw_project_id length=8,  
            a.epi_sex label="Sex",  
 
            case 
                when (b.diabetes = .) then "No" 
                when (b.diabetes = 1) then "Yes (incident)" 
                when (b.diabetes = 2) then "Yes (prevalent)" 
                else "" 
            end as diab_status length=15 informat=$15. format=$15. 
label="Diabetes status from SIMLR classification algorithm",  
            b.diab_diag_date as diab_date label="Diabetes status=yes date 
from SIMLR classification algorithm",  
 
            /*a.fbsl_study_id, */ 
            a.fbsl_collection_date format=yymmddd10. label="Fasting BSL 
collection date",  
            put(a.fbsl_collection_age, age05grp5.) as 
fbsl_collection_age05grp length=5 informat=$5. format=$5. label="Fasting 
BSL age group",  
            a.fbsl_test_value_num label="Fasting BSL test value 
(mmol/L)",  
            c.geo_match_status as fbsl_geo_match_status label="Fasting 
BSL geocoding match status",  
            c.geo_sa1_2011_code as fbsl_sa1_2011_code label="Fasting BSL 
SA1 of residence",  
            put(c.geo_sa1_2011_code, $sa1adv2.) as 
fbsl_irsad_2011_quintile length=2 informat=$2. format=$2. label="Fasting 
BSL IRSAD quintile",  
            put(c.geo_sa1_2011_code, $sa1dis2.) as 
fbsl_irsd_2011_quintile length=2 informat=$2. format=$2. label="Fasting 
BSL IRSD quintile",  
            put(c.geo_sa1_2011_code, $sa1ier2.) as fbsl_ier_2011_quintile 
length=2 informat=$2. format=$2. label="Fasting BSL IER quintile",  
            put(c.geo_sa1_2011_code, $sa1ieo2.) as fbsl_ieo_2011_quintile 
length=2 informat=$2. format=$2. label="Fasting BSL IEO quintile",  
 
            /*a.hba1c_study_id, */ 
            a.hba1c_collection_date format=yymmddd10. label="HbA1c 
collection date",  
            put(a.hba1c_collection_age, age05grp5.) as 
hba1c_collection_age05grp length=5 informat=$5. format=$5. label="HbA1c 
collection age group",  
            a.hba1c_test_value_num label="HbA1c test value (%)",  
            d.geo_match_status as hba1c_geo_match_status label="HbA1c 
geocoding match status",  
            d.geo_sa1_2011_code as hba1c_sa1_2011_code label="HbA1c SA1 




            put(d.geo_sa1_2011_code, $sa1adv2.) as 
hba1c_irsad_2011_quintile length=2 informat=$2. format=$2. label="HbA1c 
IRSAD quintile",  
            put(d.geo_sa1_2011_code, $sa1dis2.) as 
hba1c_irsd_2011_quintile length=2 informat=$2. format=$2. label="HbA1c 
IRSD quintile",  
            put(d.geo_sa1_2011_code, $sa1ier2.) as 
hba1c_ier_2011_quintile length=2 informat=$2. format=$2. label="HbA1c IER 
quintile",  
            put(d.geo_sa1_2011_code, $sa1ieo2.) as 
hba1c_ieo_2011_quintile length=2 informat=$2. format=$2. label="HbA1c IEO 
quintile",  
 
            /*a.hdl_study_id, */ 
            a.hdl_collection_date format=yymmddd10. label="HDL collection 
date",  
            put(a.hdl_collection_age, age05grp5.) as 
hdl_collection_age05grp length=5 informat=$5. format=$5. label="HDL 
collection age group",  
            a.hdl_test_value_num label="HDL test value (mmol/L)",             
            e.geo_match_status as hdl_geo_match_status label="HDL 
geocoding match status",  
            e.geo_sa1_2011_code as hdl_sa1_2011_code label="HDL SA1 of 
residence",  
            put(e.geo_sa1_2011_code, $sa1adv2.) as 
hdl_irsad_2011_quintile length=2 informat=$2. format=$2. label="HDL IRSAD 
quintile",  
            put(e.geo_sa1_2011_code, $sa1dis2.) as hdl_irsd_2011_quintile 
length=2 informat=$2. format=$2. label="HDL IRSD quintile",  
            put(e.geo_sa1_2011_code, $sa1ier2.) as hdl_ier_2011_quintile 
length=2 informat=$2. format=$2. label="HDL IER quintile",  
            put(e.geo_sa1_2011_code, $sa1ieo2.) as hdl_ieo_2011_quintile 
length=2 informat=$2. format=$2. label="HDL IEO quintile",  
 
            /*a.tc_study_id, */ 
            a.tc_collection_date format=yymmddd10. label="TC collection 
date",  
            put(a.tc_collection_age, age05grp5.) as 
tc_collection_age05grp length=5 informat=$5. format=$5. label="TC 
collection age group",  
            a.tc_test_value_num label="TC test value (mmol/L)",  
            f.geo_match_status as tc_geo_match_status label="TC geocoding 
match status",  
            f.geo_sa1_2011_code as tc_sa1_2011_code label="TC SA1 of 
residence",  
            put(f.geo_sa1_2011_code, $sa1adv2.) as tc_irsad_2011_quintile 
length=2 informat=$2. format=$2. label="TC IRSAD quintile",  
            put(f.geo_sa1_2011_code, $sa1dis2.) as tc_irsd_2011_quintile 
length=2 informat=$2. format=$2. label="TC IRSD quintile",  
            put(f.geo_sa1_2011_code, $sa1ier2.) as tc_ier_2011_quintile 
length=2 informat=$2. format=$2. label="TC IER quintile",  
            put(f.geo_sa1_2011_code, $sa1ieo2.) as tc_ieo_2011_quintile 
length=2 informat=$2. format=$2. label="TC IEO quintile",  
 
            /*a.acr_study_id, */ 
            a.acr_collection_date format=yymmddd10. label="ACR collection 
date",  
            put(a.acr_collection_age, age05grp5.) as 
acr_collection_age05grp length=5 informat=$5. format=$5. label="ACR 
collection age group",  




            g.geo_match_status as acr_geo_match_status label="ACR 
geocoding match status",  
            g.geo_sa1_2011_code as acr_sa1_2011_code label="ACR SA1 of 
residence",  
            put(g.geo_sa1_2011_code, $sa1adv2.) as 
acr_irsad_2011_quintile length=2 informat=$2. format=$2. label="ACR IRSAD 
quintile",  
            put(g.geo_sa1_2011_code, $sa1dis2.) as acr_irsd_2011_quintile 
length=2 informat=$2. format=$2. label="ACR IRSD quintile",  
            put(g.geo_sa1_2011_code, $sa1ier2.) as acr_ier_2011_quintile 
length=2 informat=$2. format=$2. label="ACR IER quintile",  
            put(g.geo_sa1_2011_code, $sa1ieo2.) as acr_ieo_2011_quintile 
length=2 informat=$2. format=$2. label="ACR IEO quintile",  
 
            /*a.egfr_study_id, */ 
            a.egfr_collection_date format=yymmddd10. label="eGFR 
collection date",  
            put(a.egfr_collection_age, age05grp5.) as 
egfr_collection_age05grp length=5 informat=$5. format=$5. label="eGFR 
collection age group",  
            a.egfr_test_value_num label="eGFR test value 
(mL/min/1.73m2)",  
            h.geo_match_status as egfr_geo_match_status label="eGFR 
geocoding match status",  
            h.geo_sa1_2011_code as egfr_sa1_2011_code label="eGFR SA1 of 
residence",  
            put(h.geo_sa1_2011_code, $sa1adv2.) as 
egfr_irsad_2011_quintile length=2 informat=$2. format=$2. label="eGFR 
IRSAD quintile",  
            put(h.geo_sa1_2011_code, $sa1dis2.) as 
egfr_irsd_2011_quintile length=2 informat=$2. format=$2. label="eGFR IRSD 
quintile",  
            put(h.geo_sa1_2011_code, $sa1ier2.) as egfr_ier_2011_quintile 
length=2 informat=$2. format=$2. label="eGFR IER quintile",  
            put(h.geo_sa1_2011_code, $sa1ieo2.) as egfr_ieo_2011_quintile 
length=2 informat=$2. format=$2. label="eGFR IEO quintile",  
 
            /*a.bmi_study_id, */ 
            a.bmi_collection_date format=yymmddd10. label="BMI collection 
date",  
            put(a.bmi_collection_age, age05grp5.) as 
bmi_collection_age05grp length=5 informat=$5. format=$5. label="BMI 
collection age group",  
            a.bmi_test_value_num label="BMI test value (kg/m2)",  
            i.geo_match_status as bmi_geo_match_status label="BMI 
geocoding match status",  
            i.geo_sa1_2011_code as bmi_sa1_2011_code label="BMI SA1 of 
residence",  
            put(i.geo_sa1_2011_code, $sa1adv2.) as 
bmi_irsad_2011_quintile length=2 informat=$2. format=$2. label="BMI IRSAD 
quintile",  
            put(i.geo_sa1_2011_code, $sa1dis2.) as bmi_irsd_2011_quintile 
length=2 informat=$2. format=$2. label="BMI IRSD quintile",  
            put(i.geo_sa1_2011_code, $sa1ier2.) as bmi_ier_2011_quintile 
length=2 informat=$2. format=$2. label="BMI IER quintile",  
            put(i.geo_sa1_2011_code, $sa1ieo2.) as bmi_ieo_2011_quintile 
length=2 informat=$2. format=$2. label="BMI IEO quintile",  
 
            nmiss(a.fbsl_test_value_num,  
                  a.hba1c_test_value_num,  




                  a.tc_test_value_num,  
                  a.acr_test_value_num,  
                  a.egfr_test_value_num,  
                  a.bmi_test_value_num) as nmiss_test_results length=3 
informat=1. format=1. label="Number of missing test results",  
            case 
                when (calculated nmiss_test_results = 0) then "Y" 
                else "N" 
            end as complete_case length=1 informat=$1. format=$1. label 
"Complete case (no missing test results)" 
        from _epires as a 
            left join diabetes as b on a.epi_patient_id=b.epi_patient_id 
            left join geo as c on a.epi_patient_id=c.geo_patient_id and 
a.fbsl_study_id = c.geo_study_id 
            left join geo as d on a.epi_patient_id=d.geo_patient_id and 
a.hba1c_study_id = d.geo_study_id 
            left join geo as e on a.epi_patient_id=e.geo_patient_id and 
a.hdl_study_id = e.geo_study_id 
            left join geo as f on a.epi_patient_id=f.geo_patient_id and 
a.tc_study_id = f.geo_study_id 
            left join geo as g on a.epi_patient_id=g.geo_patient_id and 
a.acr_study_id = g.geo_study_id 
            left join geo as h on a.epi_patient_id=h.geo_patient_id and 
a.egfr_study_id = h.geo_study_id 
            left join geo as i on a.epi_patient_id=i.geo_patient_id and 
a.bmi_study_id = i.geo_study_id 
        order by a.epi_patient_id; 
quit; 
 
**** Document data set ****; 
 
proc contents data=rmbst288 OUT=rmbst288_vars(keep=name label type 
varnum) noprint nodetails; 
run; 
 
    proc sort data=rmbst288_vars; 
        by varnum; 
    run; 
 
proc export data=rmbst288_vars 
    
outfile="\\ad.uow.edu.au\Shares\1000389_toms\Documentation\RMBST288_TOMS_
RENIN_PHD_DATA_EXTRACT_VARS_20180204.CSV"  
    dbms=csv  
    replace; 
run; 
 






* Output in CSV format; 
 
proc export data=rmbst288 outfile=extract dbms=csv replace; 
run; 
 
* Open ZIP package; 
 





* Add CSV data file to the ZIP package; 
 
ods package add file=extract; 
 
* Finalise package compression; 
 
ods package publish archive 
    properties(archive_name = 
"RMBST288_TOMS_RENIN_PHD_DATA_EXTRACT_20180204.zip" 
               archive_path = 
"\\ad.uow.edu.au\Shares\1000389_toms\Data"); 
 
* Close the package; 
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